Citations

Citations to this article as recorded by  

• Redefining Liver Transplantation Indications for Hepatic Malignancies in the Era of Precision Transplant Oncology: An Up-to-Date Narrative Review
  Mario Romeo, Fiammetta Di Nardo, Carmine Napolitano, Paolo Vaia, Claudio Basile, Giusy Senese, Annachiara Coppola, Patrizia Iodice, Simone Olivieri, Alessandro Federico, Marcello Dallio
  Journal of Clinical Medicine.2026; 15(10): 3579.     CrossRef
• Shrinking Giants: On the Feasibility of Downsizing Hepatocellular Carcinoma with Immunotherapy Prior to Liver Transplantation
  Juraj Prejac, Domina Kekez, Hana Lučev, Borna Ćutić, Viktor Domislović, Vibor Šeša, Gordan Adžić, Marin Golčić
  Journal of Clinical Medicine.2026; 15(10): 3923.     CrossRef

Citations

Citations to this article as recorded by  

• Reply to correspondence on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”
  Eun Ji Jang, Pil Soo Sung
  Clinical and Molecular Hepatology.2026; 32(1): e115.     CrossRef
• Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography: A Potential Imaging Biomarker for Predicting Response to Combination Immunotherapy in Hepatocellular Carcinoma
  Masatoshi Kudo
  Liver Cancer.2025; 14(5): 511.     CrossRef

Citations

Citations to this article as recorded by  

• Establishment and evaluation of an immortalized dzo kidney cell line
  Wenkai Liu, Cong Xu, Jiamin Wang, Na Sun, Zhongren Ma, Jin Zhao, Jianguo Chen, You Li, Zilin Qiao
  Scientific Reports.2025;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Correspondence to editorial on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”
  Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo
  Clinical and Molecular Hepatology.2026; 32(1): e79.     CrossRef
• Molecular stratification of hepatocellular carcinoma by metabolic-signaling pathways guides precision immunotherapy and TACE therapy
  Binghua Li, Yanchao Xu, Yican Zhu, Yukun Zhang, Zijie Wu, Tianci Luo, Laizhu Zhang, Weiwei Hu, Decai Yu
  Clinical and Molecular Hepatology.2026; 32(1): e16.     CrossRef
• Reply to correspondence on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”
  Eun Ji Jang, Pil Soo Sung
  Clinical and Molecular Hepatology.2026; 32(1): e115.     CrossRef
• A novel link between tumor cell metabolism and patient prognosis: Editorial on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”
  Eun Ji Jang, Pil Soo Sung
  Clinical and Molecular Hepatology.2026; 32(1): 420.     CrossRef
• Zonation, Zonation, Zonation: The Real Estate of the Liver
  Tyler M. Yasaka, Chang Kyung Kim, Vik Meadows, Satdarshan P. Monga
  Annual Review of Pathology: Mechanisms of Disease .2026; 21(1): 185.     CrossRef
• Single-cell RNA sequencing and spatial transcriptomic analysis reveal a distinct population of G6PD+ cells with aberrant bile acid metabolism in hepatocellular carcinoma
  Xing Jiang, Haiyan Quan, Ting Yin, Hailun Yao, Yajun Li, Bin Peng, Xinye Yuan, Weiguang Zeng, Honghui Chen, Rong Li
  Frontiers in Immunology.2026;[Epub]     CrossRef
• Overexpression of S100 Calcium-Binding Protein A2 is Associated With Poor Prognosis in Hepatocellular Carcinoma
  Xiaopeng Chen, Shaoqing Ma, Wenlong Zeng, Chuiguo Huang, Jianyang Guo
  Cancer Control.2026;[Epub]     CrossRef
• Correspondence to letter to the editor on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”
  Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo
  Clinical and Molecular Hepatology.2026; 32(2): e241.     CrossRef
• Critical flaws in the molecular classification of HCC based on metabolic zonation: Letter to the editor on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”
  Yongzhi Xie, Xiangyu Zhu, Qi Liang
  Clinical and Molecular Hepatology.2026; 32(2): e144.     CrossRef
• Clinical applications of immunogenomics in hepatocellular carcinoma
  James K. Carter, Daniel C. Cameron, Augusto Villanueva
  Clinical and Molecular Hepatology.2026; 32(2): 511.     CrossRef
• Unveiling the Intricate Dance: Signaling Pathways in Liver Cancer Metabolism and Immunity
  Yichi Xu, Bo Wen, Dai Zhang, Fangxin Tang, Shu Liu
  Current Oncology Reports.2026;[Epub]     CrossRef
• Clinical Prediction of Glycolysis-Driven Molecular Subclass of Hepatocellular Carcinoma without Transcriptomic Profiling
  Tomoko Aoki, Masatoshi Kudo, Satoshi Ogiso, Genki Okumura, Megumi Hoshino, Yuka Nakamura, Ryo Morisue, Shohei Koyama, Naoshi Nishida, Kohei Hanaoka, Kazuko Sakai, Yutaka Kurebayashi, Masakatsu Tsurusaki, Masahiro Morita, Atsushi Takebe, Takaaki Murase, Ke
  Liver Cancer.2026; : 1.     CrossRef
• Integrative Profiling of Metabolic CYP Expression, DNA Mutation Rates, and Immune Cell Infiltration for Survival Prognosis in Hepatocellular Carcinoma
  Mona Dawood, Axel Guthart, Ednah Ooko, Ralf Weiskirchen, Thomas Efferth, Joelle C. Boulos
  Livers.2026; 6(3): 50.     CrossRef
• Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography: A Potential Imaging Biomarker for Predicting Response to Combination Immunotherapy in Hepatocellular Carcinoma
  Masatoshi Kudo
  Liver Cancer.2025; 14(5): 511.     CrossRef

Citations

Citations to this article as recorded by  

• The Rac1-USP11 feedback amplification loop: a radiation-activated engine driving radioresistance in hepatocellular carcinoma
  Kaixiao Zhou, Yabo Jiang, Jiahao Guo, Haobo Zhang, Yuhao Hu, Xuanyu Meng, Yecheng Li, Shaohua Wei, Jian Wang, Xubiao Wei, Shuqun Cheng, Jianping Cao, Yang Jiao
  British Journal of Cancer.2026; 134(3): 391.     CrossRef
• From Photons to Protons in Gastrointestinal Cancers: A Journey of Transition, Awe, Challenge, and Renewed Hope
  Ashu Abhishek
  International Journal of Particle Therapy.2026; 19: 101299.     CrossRef
• Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach
  Jeong Ha Lee, Nalee Kim, Jeong Il Yu, Hee Chul Park, Sungkoo Cho, Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Joon Hyeok Lee, Yong-Han Paik, Moon Seok Choi, Minsuk Kwon, Jung Yong Hong, Gyu-Seong Choi, Woo Kyoung Jeong, M
  European Journal of Cancer.2026; 237: 116593.     CrossRef
• Current Advances in Proton FLASH Radiotherapy in Abdominal Cancers
  Xiao Wang, Yin Zhang, Xinxin Zhang, Zhenyu Xiong, Keying Xu, Ning J. Yue, Chi Ma
  Cancers.2026; 18(5): 758.     CrossRef
• Should we prioritize proton beam therapy before making a decision on orthotopic liver transplantation for unresectable hepatoblastoma?
  Yi-Wen Hsiao, Yi-Lun Wang, Chen-Kan Tseng, Tsung-Yen Chang, Shih-Hsiang Chen, Tang-Her Jaing
  The Turkish Journal of Pediatrics.2026; 68(2): 324.     CrossRef
• Artificial intelligence-enhanced Couinaud segmentation for precision liver cancer therapy
  Liang Qiu, Wenhao Chi, Xiaohan Xing, Praveenbalaji Rajendran, Mingjie Li, Yuming Jiang, Oscar Pastor-Serrano, Sen Yang, Yuanfeng Ji, Qiang Wen
  Biomedical Signal Processing and Control.2026; 120: 110100.     CrossRef
• Cold-spot driven local failure after stereotactic body radiation therapy for colorectal liver metastases
  Hyunju Shin, Jeong Il Yu, Hee Chul Park, Sang Hoon Seo, Seong Hyeon Yun, Woo Yong Lee, Hee Cheol Kim, Yong Beom Cho, Yoon Ah Park, Jung Wook Huh, Jung Kyong Shin, Young Suk Park, Jeeyun Lee, Seung Tae Kim, Sung Hee Lim, Ji Eun Shin, Nalee Kim
  Frontiers in Oncology.2026;[Epub]     CrossRef
• Proton beam therapy with or without transarterial chemoembolization for hepatocellular carcinoma: a propensity score matching analysis
  Jen-Yu Cheng, Hee Chul Park, Jeong Il Yu, Nalee Kim, Jeong Ha Lee, Sung Koo Cho, Dongho Hyun, Yong-Han Paik
  British Journal of Radiology.2026; 99(1182): 1221.     CrossRef
• Deep learning-based dose prediction in proton beam therapy for hepatocellular carcinoma: comparison of network architectures and loss functions
  Shuta Ogawa, Noriyuki Kadoya, Takahiro Kato, Ryohei Kato, Ryota Tozuka, Yuki Narita, Sho Oyama, Masao Murakami, Keiichi Jingu
  Journal of Radiation Research.2026; 67(3): 369.     CrossRef
• Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocol
  Keisuke Koroki, Masaru Wakatsuki, Sadahisa Ogasawara, Hirokazu Makishima, Taro Watabe, Haruka Anzai, Makoto Fujiya, Midori Sawada, Takahiro Tsuchiya, Keiichi Katayama, Ryohei Yoshino, Ryo Izai, Teppei Akatsuka, Chihiro Miwa, Takuya Yonemoto, Sae Yumita, M
  BMJ Open.2026; 16(6): e115731.     CrossRef
• Progress in Treatment of Hepatocellular Carcinoma Combined with Portal Vein Cancer Thrombus
  锐 王
  Advances in Clinical Medicine.2026; 16(07): 368.     CrossRef
• Mitochondria-Targeted Icaritin Nanoparticles Induce Immunogenic Cell Death in Hepatocellular Carcinoma
  Siyu Chen, Yiyang Sun, Yangla Xie, Yanpeng Liu, Haitao Hu, Chang Xie, Shengjun Xu, Zhouxing Zhang, Jing Zhang, Youqing Shen, Xiao Xu, Nasha Qiu
  ACS Applied Materials & Interfaces.2025; 17(2): 2899.     CrossRef
• Comparison of Prognostic Outcomes Between Repeat Liver Resection and Particle Therapy for Patients with Recurrent Hepatocellular Carcinoma
  Tatsuki Kusuhara, Hidetoshi Gon, Kazuki Terashima, Shohei Komatsu, Yoshiro Matsuo, Sunao Tokumaru, Hirochika Toyama, Masahiro Kido, Tomoaki Okimoto, Takumi Fukumoto
  Annals of Surgical Oncology.2025; 32(2): 1073.     CrossRef
• Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
  Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D. Parikh, Ghassan K. Abou-Alfa, Amit G. Singal, Ju Dong Yang
  Clinical and Molecular Hepatology.2025; 31(Suppl): S228.     CrossRef
• Efficacy and safety of radiotherapy combined with immune checkpoint inhibitors for advanced or unresectable hepatocellular carcinoma: A systematic review and meta-analysis
  Qibin Wu, Xia Zhao, Chong Yang, Yinglin Yuan, Hongji Yang, Qiang Fu
  Critical Reviews in Oncology/Hematology.2025; 211: 104730.     CrossRef
• Proton beam therapy in the management of hepatocellular carcinoma
  Kenneth S. H. Chok, Tiffany Y. T. Joeng, Darren M. C. Poon
  Expert Review of Gastroenterology & Hepatology.2025; 19(5): 495.     CrossRef
• Micro-Nano Convergence-Driven Radiotheranostic Revolution in Hepatocellular Carcinoma
  Yisheng Peng, Hui Liu, Mengmeng Miao, Xu Cheng, Shangqing Chen, Kaifei Yan, Jing Mu, Hongwei Cheng, Gang Liu
  ACS Applied Materials & Interfaces.2025; 17(20): 29047.     CrossRef
• Combination of radiotherapy and ICIs in advanced hepatocellular carcinoma: A systematic review of current evidence and future prospects (Review)
  Cheng Ma, Xinlin Yu, Xialin Zhang, Lihong Su, Ou Jiang, Ran Cui
  Oncology Letters.2025; 30(1): 1.     CrossRef
• Multidisciplinary strategies including local treatment to achieve drug‑free status after atezolizumab plus bevacizumab treatment in hepatocellular carcinoma
  Nobuaki Ishihara, Shohei Komatsu, Yoshihiko Yano, Yoshimi Fujishima, Jun Ishida, Masahiro Kido, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Hiroaki Yanagimoto, Hirochika Toyama, Yuzo Kodama, Takumi Fukumoto
  Oncology Letters.2025; 30(4): 1.     CrossRef
• Proton Beam Therapy Provides Longer Survival and Preserves Muscle Mass in Hepatocellular Carcinoma Compared to TACE+RFA
  Takuto Nosaka, Ryotaro Sugata, Yosuke Murata, Yu Akazawa, Tomoko Tanaka, Kazuto Takahashi, Tatsushi Naito, Masahiro Ohtani, Kenji Takata, Tetsuya Tsujikawa, Yoshitaka Sato, Yoshikazu Maeda, Hiroyasu Tamamura, Yasunari Nakamoto
  Cancers.2025; 17(17): 2849.     CrossRef
• Current application status of proton beam therapy for gastrointestinal tumors
  Jingwen Zhang, Han Zhou, Benxin Zhao, Tian Liu, Chang Guo, Wenjing Fei, Zetian Shen
  Oncologie.2025; 27(6): 855.     CrossRef
• A contrast‑enhanced CT histogram‑driven nomogram for predicting post‑radiotherapy liver regeneration in hepatocellular carcinoma
  Bo Liu, Yuan Xu, Xijie Zhang, Wei Qi, Bo Ren, Wenjia Kong, Wence Zhou
  Radiation Oncology.2025;[Epub]     CrossRef
• Highly permeable and tumor-selective killing Doxil for efficient cancer therapy
  Yidan Shen, Yiyang Sun, Yangla Xie, Yanpeng Liu, Zile Shao, Siyu Chen, Zhengxing Lian, Chang Xu, Fei Lv, Jinyi Tong, Youqing Shen, Nasha Qiu
  Nano Research.2025; 18(12): 94907987.     CrossRef
• Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC
  Jong Geun Park, Pu Reun Roh, Min Woo Kang, Sung Woo Cho, Suhyun Hwangbo, Hae Deok Jung, Hyun Uk Kim, Ji Hoon Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Young Kyoung You, Ho Joong Choi, Jae Yong Ryu, Pil Soo Sung
  Hepatology.2024; 80(5): 1074.     CrossRef
• Clinical outcomes and safety of external beam radiotherapy with extensive intrahepatic targets for advanced hepatocellular carcinoma: A single institutional clinical experience
  Sunmin Park, Chai Hong Rim, Won Sup Yoon
  Saudi Journal of Gastroenterology.2024; 30(6): 399.     CrossRef
• Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy
  Sang Min Yoon
  Clinical and Molecular Hepatology.2023; 29(4): 977.     CrossRef

Citations

Citations to this article as recorded by  

• Omitted variable bias and validation circularity: a computational audit of the APHPBA score
  Xiangbo Ma, Wei Li
  HPB.2026;[Epub]     CrossRef
• A systematic review and time-specific meta-analysis of hepatocellular carcinoma risk prediction models
  Jingru Huang, Wenwen Jiang, Chaoqiang Jiang, Weisen Zhang, Feng Zhu, Jing Pan, Tai Hing Lam
  Oncology and Translational Medicine.2026;[Epub]     CrossRef
• Hepatitis B core-related antigen as a multifaceted biomarker in chronic hepatitis B: implications for immune activity and hepatocellular carcinoma prediction
  Kwon Yong Tak, Seok Hwan Kim, Myeong Jun Song
  The Korean Journal of Internal Medicine.2026; 41(4): 636.     CrossRef
• Racing toward the future of chronic hepatitis B management: Achieving functional cure and enhancing hepatocellular carcinoma surveillance through precision medicine
  Yaru Shi, Rong Fan
  Interdisciplinary Medicine.2025;[Epub]     CrossRef
• La prise en charge de l'hépatite B chronique: mise à jour 2025 des lignes directrices de l'Association canadienne pour l'étude du foie et de l'Association pour la microbiologie médicale et l'infectiologie Canada
  Carla Osiowy, Fernando Alvarez, Carla S. Coffin, Curtis L. Cooper, Scott K. Fung, Hin Hin Ko, Sébastien Poulin, Jennifer van Gennip
  Canadian Liver Journal.2025; 8(2): 402.     CrossRef
• The management of chronic hepatitis B: 2025 Guidelines update from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada
  Carla Osiowy, Fernando Alvarez, Carla S Coffin, Curtis L Cooper, Scott K Fung, Hin Hin Ko, Sébastien Poulin, Jennifer van Gennip
  Canadian Liver Journal.2025; 8(2): 368.     CrossRef
• Prediction Model for Familial Aggregated HBV‐Associated Hepatocellular Carcinoma Based on Serum Biomarkers
  Linmei Zhong, Guole Nie, Qiaoping Wu, Honglong Zhang, Haiping Wang, Jun Yan
  Cancer Reports.2025;[Epub]     CrossRef
• LEAST as a novel prediction model of hepatocellular carcinoma development in patients with chronic hepatitis B: a multi-center study
  Jingjing Song, Jie Li, Zhigang Ren, Wen Xie, Jinhua Shao, Xiaoxiao Zhang, Yang Zhou, Fajuan Rui, Xiaoqing Wu, Qiuling Wang, Zuxiong Huang, Chao Sun, Yuemin Nan
  BMC Medicine.2025;[Epub]     CrossRef
• Validation of the Texas Hepatocellular Carcinoma Risk Index Predictive Model for Hepatocellular Carcinoma in Asian Cohort
  Jeong-Ju Yoo, Young-Gi Song, Ji Eun Moon, Young Seok Kim, Sang Gyune Kim
  Clinical Gastroenterology and Hepatology.2024; 22(9): 1953.     CrossRef
• Risk predictive model for the development of hepatocellular carcinoma before initiating long‐term antiviral therapy in patients with chronic hepatitis B virus infection
  Junjie Chen, Tienan Feng, Qi Xu, Xiaoqi Yu, Yue Han, Demin Yu, Qiming Gong, Yuan Xue, Xinxin Zhang
  Journal of Medical Virology.2024;[Epub]     CrossRef
• Correspondence to editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”
  Xiaoqian Xu, Hong You, Jidong Jia, Yuanyuan Kong
  Clinical and Molecular Hepatology.2024; 30(4): 994.     CrossRef
• Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B pati
  Beom Kyung Kim
  Clinical and Molecular Hepatology.2024; 30(4): 656.     CrossRef
• Reply to correspondence on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”
  Beom Kyung Kim
  Clinical and Molecular Hepatology.2024; 30(4): 1044.     CrossRef

Citations

Citations to this article as recorded by  

• Global, regional, and national burden of liver cancer due to hepatitis B, 1990–2021 and projections to 2051: a systematic analysis of the Global Burden of Disease Study 2021
  Peipei Yang, Wenjie Huang, Yuanyuan Xu, Qiurong Li, Xinyan Shu, Jiaqian Zuo, Wenqin Ren, Yujie Huang, Yuhao Teng, Peng Shu
  European Journal of Gastroenterology & Hepatology.2026; 38(2): 178.     CrossRef
• Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage: Correspondence to editorial on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”
  Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming-Lung Yu
  Clinical and Molecular Hepatology.2026; 32(1): e68.     CrossRef
• Digital pathology-based prognostic model for hepatocellular carcinoma: Integrating pathomics signatures with clinical parameters for recurrence prediction and biological interpretation
  Qi Wang, Yuxi Huang, Yu Zhang, Yu Zhu, Peng Hu, Yongfu Xu, Zhen-yu Jiang, Long Liu, Shao-wei Li
  Computer Methods and Programs in Biomedicine.2026; 275: 109180.     CrossRef
• Serum Outperforms Plasma for Glypican-3 Quantification in Hepatocellular Carcinoma—A Prospective Comparative Study
  Ming-Tze Yang, Jiunn-Min Wang, Chen-Shiou Wu, Shou-Wu Lee, Hsin-Ju Tsai, Chia-Chang Chen, Ying-Cheng Lin, Hui-Fen Liu, Teng-Yu Lee
  Journal of Clinical Medicine.2026; 15(2): 448.     CrossRef
• Integrated spatial and single-cell transcriptomics reveals RPL8 as a prognostic biomarker and therapeutic target in hepatocellular carcinoma
  Jinna Tan, Junzhu Liang, Yaoyang Li, Jiaqian He, Hui Yin, Hemeng Wu, Yuzhen Luo, Mingfen Li, Fuli Long, Hongsheng Lin
  Translational Oncology.2026; 64: 102663.     CrossRef
• Risk Scores for Stratifying Hepatocellular Carcinoma and Optimizing Surveillance Strategies
  Yu-Ping Chang, Yun-Chu Chen, Chen-Hua Liu
  Cancers.2026; 18(1): 158.     CrossRef
• Diagnostic Performance Comparison of AFP, PIVKA-II, GALAD Model, and ASAP Model Across Two Chemiluminescence Immunoassay Platforms for Hepatocellular Carcinoma
  Yuan Huang, Rui Ding, Yue Cui, Peng Li, Jie Niu, Guan-Hua Wang, Xu-Zhen Qin
  Journal of Hepatocellular Carcinoma.2026; Volume 13: 1.     CrossRef
• Development and validation of the APTNM staging system: Integration of serum biomarkers with TNM classification for enhanced prognostic stratification following hepatectomy for hepatocellular carcinoma
  Xin Li, Yi-Fei Liu, Chen-Yao Zhou, Jun Lu, Guo-Wei Wang, Zi-Jie Tang, Zi-Chao Tu, Yong-Yi Zeng, Wei Guo, Ji-Li Li, Jia-Hao Xu, Chao Li, Ming-Da Wang, Feng Shen, Fei Wu, Tian Yang
  European Journal of Surgical Oncology.2026; 52(2): 111384.     CrossRef
• Artificial Intelligence Applications in the Diagnosis, Treatment, and Prognosis of Hepatocellular Carcinoma
  Ming-Ying Lu, Jacky Chung-Hao Wu, Henry Horng-Shing Lu, Mohammed Eslam, Ming-Lung Yu
  Gut and Liver.2026; 20(1): 5.     CrossRef
• Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patients
  Alberto Izquierdo-Martínez, Ángela Rojas, Ricardo Rubio-Sánchez, Inmaculada Dominguez-Pascual, Manuel Romero-Gómez, Daniel Fatela-Cantillo
  Advances in Laboratory Medicine / Avances en Medicina de Laboratorio.2026; 7(1): 43.     CrossRef
• 68Ga-FAPI-04 PET/CT in the Diagnosis of Hepatocellular Carcinoma Associated with Cirrhosis: Diagnostic Value, Correlation Between PET Parameters of the Tumor and Its Size, and PIVKA-II Levels
  Zhamilya Zholdybay, Zhanar Zhakenova, Bekzhan Issamatov, Madina Gabdullina, Yevgeniya Filippenko, Suriya Yessentayeva, Galymzhan Alisherov, Jandos Amankulov, Ildar Fakhradiyev
  Diagnostics.2026; 16(2): 249.     CrossRef
• Development and validation of six-parameter laboratory-based prognostic model (APHPBA score) for patients undergoing hepatectomy for hepatitis B virus-related hepatocellular carcinoma
  Yi-Fei Liu, Hong Wang, Ya-Hao Zhou, Xin Li, Zu-Chao Du, Zi-Jie Tang, Wen-Long Zhai, Yong-Yi Zeng, Ting-Hao Chen, Yong-Kang Diao, Zi-Chao Tu, Li-Hui Gu, Han Wu, Feng Shen, Ming-Da Wang, Lai Wang, Fei Wu, Tian Yang
  HPB.2026; 28(5): 635.     CrossRef
• Diagnosis and Treatment Report of a Case of Small Hepatocellular Carcinoma With Left Adrenal Metastasis and Hemorrhage in an Elderly Male Hepatitis B Virus Carrier
  Guanyu Zhou, Fan Wu, Tianhe Feng, Tianqi Lin
  Clinical Case Reports.2026;[Epub]     CrossRef
• Gamma-Glutamyl Transferase Improves Biological Risk Stratification in Living Donor Liver Transplantation for Hepatocellular Carcinoma
  Abu Bakar Hafeez Bhatti, Muhammad Usman Shafique, Muhammad Nauman Ul Haq, Hajira Ghairat, Jamshaid Anwar, Zafar Ali
  Journal of Gastrointestinal Cancer.2026;[Epub]     CrossRef
• Serum Raman spectroscopy combined with PCA-CNN model for the diagnosis of hepatitis B, liver cirrhosis, and Hepatocellular Carcinoma
  Baiyun Wang, Liang Zhang, Guohua Wu, Longfei Yin, Xuewen Long, Ting Mei, Yishu Tang
  Vibrational Spectroscopy.2026; 143: 103896.     CrossRef
• The prognostic significance and clinical application of Mac-2 binding protein glycosylation Isomer, Lectin-Reactive α-Fetoprotein Fraction, and protein induced by vitamin K Absence-II in resectable hepatocellular carcinoma
  Yoriko Nomura, Norifumi Harimoto, Kazuaki Hashimoto, Kazuki Takeishi
  Surgery Today.2026; 56(7): 1369.     CrossRef
• Deciphering the contribution of 5’-tiRNA- Lys-CTT as an emerging early diagnostic biomarker for hepatocellular carcinoma
  Abinash Nayak
  Discover Oncology.2026;[Epub]     CrossRef
• Prediction of Tumor Progression After Microwave Ablation of Hepatocellular Carcinoma by Contrast-Enhanced Ultrasound Combined with Immunohistochemical Markers
  Tian-Tian Dong, Ming Li, Yuan-Yuan Li, Ci Yin, Fang Nie
  Journal of Hepatocellular Carcinoma.2026; Volume 13: 1.     CrossRef
• Research Progress of Liquid Biopsy Technology in the Early Diagnosis of Hepatocellular Carcinoma
  佳玮 李
  Advances in Clinical Medicine.2026; 16(03): 271.     CrossRef
• AFP/PIVKA-II double-positive status indicates a high-risk subtype of hepatocellular carcinoma in liver transplantation: retrospective cohort study and phosphoproteome evaluation
  Chenhao Xu, Xingyu Luo, Xixi Fang, Ze Xiang, Renyi Su, Wenzhi Shu, Zhisheng Zhou, Yisu Song, Zhengyang Lu, Shusen Zheng, Xiao Xu, Xuyong Wei, Zhe Yang
  International Journal of Surgery.2026; 112(3): 7373.     CrossRef
• Liver Transplantation Criteria for Hepatocellular Carcinoma: A Systematic Review
  Deny Budiman, Chong Woo Chu, Jongwook Oh, Jeong Hee Kang, Taslim Poniman, Laila Kurnia Pramono, Ricarhdo Valentino Hanafi
  Transplantation Proceedings.2026; 58(4): 748.     CrossRef
• Optimizing the Evaluation of Biomarkers for Hepatocellular Carcinoma Surveillance
  Haiyan Yang, Siru Zhao, Rong Fan
  Gastroenterology.2026;[Epub]     CrossRef
• Hepatocellular Carcinoma Over Three Decades: from Screening Evolution to Integrated Therapeutic Strategies
  Ke Huang, Myoung Ok Kim
  Journal of Cancer Prevention.2026; 31(2): 54.     CrossRef
• Protein induced by vitamin K absence or antagonist-II in hepatocellular carcinoma with normal alpha-fetoprotein: Current advances and controversies
  Xi-Ming Wang, Hui-Gang Li, Jin-Xin Xu, Xiang Wu, Hong Li
  World Journal of Gastrointestinal Oncology.2026;[Epub]     CrossRef
• Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis
  Qi Zhang, Zhenwu Lei, Hezi Qing, Xingwu Xie
  Frontiers in Immunology.2026;[Epub]     CrossRef
• The Critical Role of GALNTs‐Regulated O‐GalNAc Glycosylation in Cancer Malignancy
  Jiahao Liu, Sihan Wu, Ge Zhang, Jiehan Li, Yuhan Yin, Aman Uiiah, Sanfei Peng, Yang Fu
  The FASEB Journal.2026;[Epub]     CrossRef
• Integrated serum proteomics and metabolomics reveal an INR-associated multi-omics signature in hepatocellular carcinoma
  Yuying Cai, Lingna Lyu, Jiayi Ma, Xiaoru Wang, Wenxia Ma, Jiming Yin, Shanshan Wang
  Clinical Proteomics.2026;[Epub]     CrossRef
• Application of Health Examination in Early Screening of Tumors
  Bing Han, Ruixue Wang
  Seminars in Ultrasound, CT and MRI.2026;[Epub]     CrossRef
• The Use of Non‐Contrast Abbreviated MRI for the Detection of Recurrent Hepatocellular Carcinoma in Postoperative Surveillance
  Jianwei Chen, Yuemin Zhu, Dechun Zheng, Liting Wen, Juyi Wu, Qiuyuan Yue, Zhuting Fang
  Journal of Magnetic Resonance Imaging.2026;[Epub]     CrossRef
• Prognostic value of serum aldo-keto reductase family 1 member B10 in hepatocellular carcinoma
  Yun-Ling Du, Chang-Jiang Shi, Fang-Yuan Gao, Shou-Jun Xie, Meng-Na Zhang, Zhu-Qing Zhang, Wei Qiu, Ying Ming
  World Journal of Gastrointestinal Surgery.2026;[Epub]     CrossRef
• Prognostic value of PIVKA-II and routine perioperative laboratory indices for recurrence prediction after curative resection of hepatocellular carcinoma
  Yangyu Mo, Yaxian Wu, Miantao Wu, Yingchun Zhou
  Clinica Chimica Acta.2026; 591: 121174.     CrossRef
• Evaluation of metabolite biomarker candidates in detecting HCC in patients with liver cirrhosis
  Md Mamunur Rashid, Rency S. Varghese, Muhammad Salman Sajid, Zaki A. Sherif, Alexander Kroemer, Habtom W. Ressom
  Metabolomics.2026;[Epub]     CrossRef
• tRF-34-P4R8YP9LON4VHM may serve as a promising potential diagnostic biomarker for hepatocellular carcinoma
  Yuchen Guo, Minjie Huang, Yuyuan Lu, Tianxin Xu, Xinqi Ge, Yan Huang, Wei Zong, Kan Ni
  Scientific Reports.2026;[Epub]     CrossRef
• CRAPT-M: An effective prognostic predictor for hepatocellular carcinoma patients treated with locoregional-bevacizumab-immunotherapy
  Ze-Hao Zheng, Rui Xiao, Na Liu, Ben-Yi He, Wei Yu, Zhong-Shi Wu, Min-Shan Chen, Jie Mei, Dan-Dan Hu, Rong-Ping Guo
  World Journal of Gastroenterology.2026;[Epub]     CrossRef
• APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update
  Hong You, Rakhi Maiwall, Jing Chen, Sang Hoon Ahn, Kadir Dokmeci, Xiaoguang Dou, Manal El-Sayed, Jian-Gao Fan, Rino Gani, Zhiliang Gao, Jacob George, Hasmik Ghazinian, George Goh, Saeed Hamid, Jinlin Hou, Shang-Chin Huang, Dong Ji, Jidong Jia, Tatsuo Kand
  Hepatology International.2026;[Epub]     CrossRef
• ST2, PIVKA-II, CEA, CA125 and their combinations in elderly liver metastases cancers: Development of a diagnostic scoring model
  Yun Cheng, Yan-Sha Sun, Yong-Ming He
  World Journal of Gastrointestinal Oncology.2026;[Epub]     CrossRef
• Classification and early diagnostic markers of Primary hepatic carcinoma: a comprehensive review
  Xinyao Liu, Lin Gong, Weiran Kong, Jie Kong, Yang Zhang, Chuantao Yuan, Shuai Chen
  Biomarkers in Medicine.2026; : 1.     CrossRef
• Surveillance for Hepatocellular Carcinoma in Cirrhosis: End of Monopoly for Serum Alpha Fetoprotein
  Lung-Yi Mak, Man-Fung Yuen
  Gastroenterology.2025; 168(2): 217.     CrossRef
• Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies
  Jinlin Hou, Thomas Berg, Arndt Vogel, Teerha Piratvisuth, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Katarina Malinowsky, Peter Findeisen, Johannes Kolja Hegel, Wenzel Schöning, Kairat Madin, Konstantin Kroeniger, Henry Lik-Yuen Chan, Ashish Sharma
  JHEP Reports.2025; 7(2): 101263.     CrossRef
• Establishment of sex-specific reference intervals for PIVKA-II in Southwest China: A real-world data analysis
  Bin Wei, Yalin Zheng, Lixin Li, Limei Luo, Ying Guo
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2025; 62(3): 202.     CrossRef
• Comparative Validation of Prediction Models for HCC Outcomes in Living Donor Liver Transplantation: Superiority of Tumor Markers to Imaging Study
  Hwa‐Hee Koh, Minyu Kang, Deok‐Gie Kim, Jae Hyon Park, Eun‐Ki Min, Jae Geun Lee, Myoung Soo Kim, Dong Jin Joo
  Journal of Gastroenterology and Hepatology.2025; 40(3): 626.     CrossRef
• Rapid evaluation of hepatocellular carcinoma by detecting plasma exosomes with time-resolved fluorescence immunochromatographic test strips
  Jiaming Li, Jianfen Su, Minghui Li, Yaofen Wu, Huiqiang Chen, Xihua Fu, Hongliang Yao, Jinping Chen, Yuntao Liu, Jie Zan
  Microchimica Acta.2025;[Epub]     CrossRef
• Prognostic Value of the ASAP Score for Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multicenter Analysis of 1,239 Patients
  Tian Yang, Dong-Xu Yin, Yong-Kang Diao, Ming-Da Wang, Xian-Ming Wang, Yong-Yi Zeng, Zhong Chen, Han Liu, Fu-Jie Chen, Yu-Chen Li, Jia-Hao Xu, Han Wu, Lan-Qing Yao, Xin-Fei Xu, Chao Li, Li-Hui Gu, Alfred W. Chieh Kow, Timothy M. Pawlik, Feng Shen
  Journal of Clinical and Experimental Hepatology.2025; 15(3): 102497.     CrossRef
• Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target
  Chao Xu, Litao Liang, Guoqing Liu, Yanzhi Feng, Bin Xu, Deming Zhu, Wenbo Jia, Jinyi Wang, Wenhu Zhao, Xiangyu Ling, Yongping Zhou, Wenzhou Ding, Lianbao Kong
  Cancer Cell International.2025;[Epub]     CrossRef
• Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study
  Yoshitaka Saegusa, Yuki Imaoka, Masahiro Ohira, Tsuyoshi Kobayashi, Naruhiko Honmyo, Michinori Hamaoka, Takashi Onoe, Daisuke Takei, Koichi Oishi, Tomoyuki Abe, Toshihiro Nakayama, Miho Akabane, Kazunari Sasaki, Hideki Ohdan
  Journal of Gastrointestinal Surgery.2025; 29(4): 101980.     CrossRef
• 3D synergistic tumor-liver analysis further improves the efficacy prediction in hepatocellular carcinoma: a multi-center study
  Yurong Jiang, Jiawei Zhang, Zhaochen Liu, Jinxiong Zhang, Xiangrong Yu, Danyan Lin, Dandan Dong, Mingyue Cai, Chongyang Duan, Shuyi Liu, Wenhui Wang, Yuan Chen, Qiyang Li, Weiguo Xu, Meiyan Huang, Sirui Fu
  BMC Cancer.2025;[Epub]     CrossRef
• Teaching design for chapter “primary liver cancer” in surgery course based on the clinical theory and clerkship synchronization model in the era of New Medicine
  Feng Ye, Qiang Cai, Xiaoyong Gong, Jiajun Ren, Ruixin Sun, Chang Liu, Xiaoli Wang, Yuan Qiao
  Global Medical Education.2025; 2(1): 149.     CrossRef
• Development and validation of a new prognostic tool for hepatocellular carcinoma undergoing resection: The Weighted Alpha-Fetoprotein Tumor Burden Score (WATS)
  Tonghui Lu, Kailing Xie, Yan Chen, Mingxiu Ma, Yaming Guo, Tianqiang Jin, Chaoliu Dai, Feng Xu
  European Journal of Surgical Oncology.2025; 51(6): 109677.     CrossRef
• Divergent trends in cirrhosis and liver cancer highlight the ongoing efforts required for hepatitis elimination
  Grace Lai-Hung Wong, Henry Lik-Yuen Chan
  Hepatology.2025; 82(5): 1056.     CrossRef
• CA19-9, CEA and PIVKA-Ⅱ as a novel panel of serum markers for diagnosis of pancreatic cancer
  Meifang Wang, Hongying Bu, Weijia Luo, Xi Zeng, Guodong Chen, Yingchun He, Deliang Cao
  Clinical Biochemistry.2025; 137: 110902.     CrossRef
• Tumor burden score combined with AFP and PIVKA-II (TAP score) to predict the prognosis of hepatocellular carcinoma patients after radical liver resection
  Zhan-Cheng Qiu, You-Wei Wu, Jun-Long Dai, Wei-Li Qi, Chu-Wen Chen, Yue-Qing Xu, Jun-Yi Shen, Chuan Li, Tian-Fu Wen
  Langenbeck's Archives of Surgery.2025;[Epub]     CrossRef
• The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer
  Yue Liu, Wenrong Jiang, Xiangxiao Li, Hu Zhao, Shiwen Wang
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 513.     CrossRef
• 5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation
  Danjun Song, Zhou Zhang, Jiaping Zheng, Wei Zhang, Jiabin Cai
  Biomarker Research.2025;[Epub]     CrossRef
• Des-γ-carboxy Prothrombin in hepatocellular carcinoma post-operative recurrence risk evaluation
  Xinting Pan, Yang Zhou, Zhenli Li, Pengfei Guo, Jianyang Zeng, Xiuqing Dong, En Hu, Liman Qiu, Zhixiong Cai, Geng Chen, Xiaolong Liu
  Communications Medicine.2025;[Epub]     CrossRef
• Assessing the Validity of the AASLD Surgical Treatment Algorithm in Patients with Early-Stage Hepatocellular Carcinoma
  Aryoung Kim, Byeong Geun Song, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Myung Ji Goh, Dong Hyun Sinn
  Gut and Liver.2025; 19(2): 265.     CrossRef
• Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
  Meng Sha, Jun Wang, Jie Cao, Zhi-Hui Zou, Xiao-ye Qu, Zhi-feng Xi, Chuan Shen, Ying Tong, Jian-jun Zhang, Seogsong Jeong, Qiang Xia
  Clinical and Molecular Hepatology.2025; 31(Suppl): S285.     CrossRef
• Key prognostic factors in transarterial chemoembolization combined with sorafenib treatment for hepatocellular carcinoma with portal vein tumor thrombosis
  Zilun Lei
  American Journal of Cancer Research.2025; 15(2): 517.     CrossRef
• tRF-23-R9J89O9N9:A novel liquid biopsy marker for diagnosis of hepatocellular carcinoma
  Kangfeng Jin, Zhiyun Mao, Yelan Tang, Wei Feng, Shaoqing Ju, Rongrong Jing, Jianhui Chen, Wei Zong
  Clinica Chimica Acta.2025; 572: 120261.     CrossRef
• Cost‐Effective Identification of Hepatocellular Carcinoma from Cirrhosis or Chronic Hepatitis Virus Infection Using Eight Methylated Plasma DNA Markers
  Tian Yang, Mingda Wang, Nanya Wang, Mingxin Pan, Yu Xu, Qiancheng You, Lanqing Yao, Jiahao Xu, Lihui Gu, Xiaodong Sun, Lei Zhang, Jiayue Xu, Bingsi Li, Guoqiang Wang, Shangli Cai, Guoyue Lv, Feng Shen
  Advanced Science.2025;[Epub]     CrossRef
• Paracancerous binuclear hepatocytes assessed by computer program is a novel biomarker for short term recurrence of hepatocellular carcinoma after surgery
  Yifan Zhang, Yiquan Lu, Nan Wang, Fengjie Hao, Yongjun Chen, Xiaochun Fei, Junqing Wang
  Scientific Reports.2025;[Epub]     CrossRef
• Preoperative identification of hepatocellular carcinoma from focal liver lesions ≤ 20 mm in high-risk patients using clinical and contrast-enhanced ultrasound features
  Xin-Yuan Hu, Yi-Kang Sun, Yao Miao, Xiao-Ling Chen, Dan Lu, Bo-Yang Zhou, Li-Fan Wang, Chong-Ke Zhao, Hao-Hao Yin, Xiao-Long Li, Zi-Tong Chen, Ya-Qin Zhang, Ming-Rui Zhu, Xin Guan, Er-Xuan Wu, Hong Han, Li-Ping Sun, Qing Lu, Hui-Xiong Xu
  European Journal of Radiology.2025; 187: 112076.     CrossRef
• Plasma methylated HIST1H3G as a non-invasive biomarker for diagnostic modeling of hepatocellular carcinoma
  Weiwei Zhu, Huifen Wang, Yudie Cai, Jun Lei, Jia Yu, Ang Li, Zujiang Yu
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Postoperative regular follow-up in hepatocellular carcinoma: Transforming early detection into survival gains
  Alfred Wei Chieh Kow
  Hepatobiliary & Pancreatic Diseases International.2025; 24(3): 237.     CrossRef
• New insights into biomarkers and risk stratification to predict hepatocellular cancer
  Katrina Li, Brandon Mathew, Ethan Saldanha, Puja Ghosh, Adrian R. Krainer, Srinivasan Dasarathy, Hai Huang, Xiyan Xiang, Lopa Mishra
  Molecular Medicine.2025;[Epub]     CrossRef
• The immune-reinforcements of Lenvatinib plus anti-PD-1 and their rationale to unite with TACE for unresectable hepatocellular carcinoma treatment
  Jiayun Jiang, Hui Zhang, Yanjiao Ou, Jiejuan Lai, Yulan Huang, Wenyun Cai, Chong Li, Leida Zhang, Yu Fu
  Immunology Letters.2025; 275: 107003.     CrossRef
• HES V2.0 surpasses GALAD for HCC detection: a review of multi-dimensional biomarker scores and studies
  Fouad Jaber, Hashem B. El-Serag
  Hepatic Oncology.2025;[Epub]     CrossRef
• Integrated spatial and single cell transcriptomics identifies PRKDC as a dual prognostic biomarker and therapeutic target in hepatocellular carcinoma
  Wenpeng Pang, Yunyong Wang, Xiaohang Lu, Minpeng Li, Fuli Long, Songlin Chen, Yuan Yu, Mingfen Li, Hongsheng Lin
  Scientific Reports.2025;[Epub]     CrossRef
• Hepatocellular Carcinoma: The Search for an Optimal Screening Test
  Sara Haj Ali, Shahd I Alqato, Amjad M Almansi, Noor S Haj Ali, Mohammad A Amaireh
  Middle East Journal of Digestive Diseases.2025; 17(1): 31.     CrossRef
• Invited commentary on “Tumor biology characteristics score based on alpha-fetoprotein and prothrombin induced by vitamin K absence-II predicts recurrence and survival after curative resection for hepatocellular carcinoma: a multicenter cohort study”
  Abu Bakar Hafeez Bhatti
  Journal of Gastrointestinal Surgery.2025; 29(7): 102076.     CrossRef
• Development of a chitosanase 3-like protein 1 assay kit and study of its application in patients with hepatocellular carcinoma
  Min Liu, Yanru Qiu, Erfu Xie, Pu Qian, Shuxian Yang, Simin Zhao, Wenjun Yan, Xuan Huang, Shuang Han
  BMC Biotechnology.2025;[Epub]     CrossRef
• Predictability of clinical outcomes after external beam radiotherapy for hepatocellular carcinoma according to tumor marker dynamics
  Sunmin Park, Chai Hong Rim, Young Kul Jung, Hyung Joon Yim, Hwan Hoon Chung, Won Sup Yoon, Gregory Tiao
  PLOS One.2025; 20(5): e0323450.     CrossRef
• Tumor marker pseudoprogression and immune-related cholangitis during conversion therapy for massive hepatocellular carcinoma: a case report
  Xiaodong Zhang, Luyi Zhang, Shuangying Zhao, Lingling Dai, Huayu Li, Xudong Wu, Huanjun Yan, Rongfeng Lin, Kelei Zhu
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Current and new strategies for hepatocellular carcinoma surveillance
  Natchaya Polpichai, Chongkonrat Maneenil, Pojsakorn Danpanichkul, Chitchai Rattananukrom, Ashok Choudhury, Yu Jun Wong, Pimsiri Sripongpun, Suthat Liangpunsakul, Apichat Kaewdech
  Gastroenterology Report.2025;[Epub]     CrossRef
• Alpha-fetoprotein: A Multifaceted Player in Cancer Biology
  Mete Ucdal, Yigit Yazarkan, Gamze Sonmez, Basak Celtikci, Yasemin Balaban
  Euroasian journal of hepato-gastroenterology.2025; 15(1): 72.     CrossRef
• Erratum to “Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study” [J Gastrointest Surg 29 (2025) 101980]
  Yoshitaka Saegusa, Yuki Imaoka, Masahiro Ohira, Tsuyoshi Kobayashi, Naruhiko Honmyo, Michinori Hamaoka, Takashi Onoe, Daisuke Takei, Koichi Oishi, Tomoyuki Abe, Toshihiro Nakayama, Miho Akabane, Kazunari Sasaki, Hideki Ohdan
  Journal of Gastrointestinal Surgery.2025; 29(8): 102129.     CrossRef
• Hepatocellular Carcinoma: Review of Indian Literature
  Vaishnavi Konda, Shanthi Vijayaraghavan
  Gastroenterology, Hepatology and Endoscopy Practice.2025; 5(3): 95.     CrossRef
• Long-Term Prognostic Value of AFP and PIVKA-II in HCC After Living Donor Liver Transplantation: A Single-Center Retrospective Study
  Saran Ochir Gongor, YoungRok Choi, Gayoung Kim, Min Kyoung Kim, Sang Hyuk Park, Jiyoung Kim, Jae-Yoon Kim, Su young Hong, Jeong-Moo Lee, Suk Kyun Hong, Kwang-Woong Lee
  Transplant International.2025;[Epub]     CrossRef
• Prothrombin-induced by vitamin K absence II as a prognostic factor in living donor liver transplantation for hepatocellular carcinoma
  Abu Bakar Hafeez Bhatti, Usman Shafique, Nazish Ahmed, Ghazanfar Abbas, Muslim Atiq, Haseeb Haider Zia, Nusrat Yar Khan, Atif Rana
  Scientific Reports.2025;[Epub]     CrossRef
• Evaluation of serum hsa_tsr014055 as a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma
  Jing Xu, Bairong Chen, Jing Qi, Jinran Wu, Wei Feng, Kangfeng Jin, Hongyi Bao, Lin Chen, Feng Wang
  Annals of Medicine.2025;[Epub]     CrossRef
• Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC
  Antonella Farina, Gaia Cicolani, Valentina Viggiani, Matteo Maini, Antonio Angeloni, Emanuela Anastasi
  International Journal of Molecular Sciences.2025; 26(15): 7581.     CrossRef
• Preoperative ASAP score predicts recurrence and survival following curative hepatic resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter cohort study
  Dongxu Yin, Zixuan Wang, Chao Li, Huixuan Fan, Zichao Tu, Yongkang Diao, Zijie Tang, Yongyi Zeng, Han Wu, Lihui Gu, Lanqing Yao, Xinfei Xu, Feng Shen, Mingda Wang, Tian Yang
  European Journal of Surgical Oncology.2025; 51(10): 110361.     CrossRef
• Sex disparity in hepatocellular carcinoma recurrence after curative liver resection: a multicenter comprehensive analysis
  Mu-Gen Dai, Si-Yu Liu, Qing Xu, Wen-Feng Lu, Lei Liang, Jun-Wei Liu, Kun Zhang, Bin Ye
  European Journal of Gastroenterology & Hepatology.2025; 37(11): 1275.     CrossRef
• Clinical performance of GAAD score, alpha-fetoprotein, and PIVKA-II in diagnosing hepatocellular carcinoma in the Vietnamese cohort
  Thuy Thi Thu Pham, Dat Tan Ho, Toan Bao Nguyen, Hai Thanh Phan
  Discover Oncology.2025;[Epub]     CrossRef
• CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on Immunotherapy
  Shou-Wu Lee, Yi-Jie Huang, Ying-Cheng Lin, Hsin-Ju Tsai, Chia-Chang Chen, Chung-Hsin Chang, Teng-Yu Lee, Yen-Chun Peng
  Cancers.2025; 17(18): 3058.     CrossRef
• Targeting glypican-3 as a new frontier in liver cancer therapy
  Chen-Shiou Wu, Teng-Yu Lee, Hsu-Wen Chao
  World Journal of Hepatology.2025;[Epub]     CrossRef
• Early PIVKA-II Response Associated with Treatment Efficacy and Survival Outcomes for Patients with Advanced Hepatocellular Carcinoma Receiving Immune Checkpoint Inhibitors and Targeted Therapy
  Zheng-Kang Fang, Yu-Ting Xiao, Xia Feng, Zhe-Jin Shi, Si-Yu Liu, Yang Yu, Li-Ming Jin, Dong-Sheng Huang, Cheng-Wu Zhang, Jun-Wei Liu, Lei Liang
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 2235.     CrossRef
• Nanomaterial-Mediated Electrochemical and Optical Biosensors and Their Application in Tumour Marker Detection
  Xinlan Wang, Jingyi Hei, Tao Zhao, Xiyu Liu, Yong Huang
  Sensors.2025; 25(18): 5902.     CrossRef
• Combined Analysis of Protein Induced by Prothrombin Induced by Vitamin K Absence (PIVKA) and Alpha-L-Fucosidase (AFU) with Alpha-Fetoprotein (AFP) May Improve the Diagnostic Efficacy for Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B
  Haisong Hou, Ruiqiang Weng, Liu Liang, Wendao Han
  International Journal of General Medicine.2025; Volume 18: 6031.     CrossRef
• Leveraging artificial intelligence to validate traditional biomarkers and drug targets in liver cancer recovery: a mini review
  Shengjian Wu, Xiaoqiao Chen, Yuxiu Ji, Chi Zhang, Yujie Xie, Bin Liang
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Pilot Study of PIVKA-II in the Prognostic Assessment of Hepatocellular Carcinoma in Chronic Viral Hepatitis: Comparative Findings from HBV and HCV Cohorts from a Single Center in Serbia
  Ivana Milošević, Nataša Nikolić, Sanja Stanković, Ana Filipović, Jovana Ranin, Irena Paunović, Jelena Simić, Branko Beronja
  Biomedicines.2025; 13(11): 2653.     CrossRef
• Clinical Implications and Novel Insights into Adolescent Primary Liver Cancer: A Nightmare for Adolescents?
  Huidong Guo, Xiaojun Chen, Rong Li, Jianzhen Shen, Donghui Gan, Yue Yin, Hehui Zhang, Jiachen Xie, Longfei Xie, Yanquan Liu
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 2513.     CrossRef
• MRI-based 2.5D deep learning and radiomics effectively predicted microvascular invasion and Ki-67 expression in hepatocellular carcinoma
  Hongmei Yu, Depeng Kong, Xiaojun Mo, Ju Huang, Jie Wu, Yang Wang, Feizhou Du, Nima Broomand Lomer,
  PLOS One.2025; 20(11): e0336579.     CrossRef
• 5’-transfer RNA halve-lysine-CTT as a promising biomarker for early detection of hepatocellular carcinoma
  Jie Yuan, Wen-Chao Gu, Tian-Xin Xu, Xian-Juan Shen, Xian Li, Lei Shen, Yan Zhang, Shao-Qing Ju
  World Journal of Gastrointestinal Oncology.2025;[Epub]     CrossRef
• Protein Induced by Vitamin K Absence or Antagonist‐II: Significantly Elevated in Obstructive Jaundice and Sepsis Patients Without Hepatocellular Carcinoma
  Ke Zhang, Xiarui Ye, Xianran Fu
  Journal of Clinical Laboratory Analysis.2025;[Epub]     CrossRef
• Rapid Detection and Purification of Extracellular Vesicles for Hepatocellular Carcinoma Screening Using a Plasmonic Metasurface Integrated with the Kolmogorov–Arnold Network
  Jiaheng Zhu, Chenhongmei Wang, Tianhao Huang, Lihuang Zeng, Qiang Niu, Xinyue Huang, Hanyang Chen, Mengqi Jiang, Baichang Deng, Yiming Yan, Xiaohui Liu, Junjie Chen, Yinong Xie, Jiaqing Shen, Wei Chen, Yuan Gao, Kaibin Chen, Xiangyujie Lin, Lijun Zeng, Bo
  ACS Nano.2025; 19(49): 41557.     CrossRef
• Early screening for liver cancer must be performed
  Zi-Han Liu, Wen-Jun Wang, Shuang-Suo Dang
  World Journal of Hepatology.2025;[Epub]     CrossRef
• Adjuvant Sintilimab with or without Anti-VEGF Therapy After Resection in Hepatocellular Carcinoma with Microvascular Invasion: A Multicenter Retrospective Study
  Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Yi-Tao Zheng, Yun-Feng Shan, Shu-Qun Cheng
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 2735.     CrossRef
• Exosomal microRNAs in Hepatocellular Carcinoma: Diagnostic and Prognostic Applications
  Sarang Kim, Nayeon Gu, Tae-Su Han
  Convergence Hepatology.2025; 1(1): 44.     CrossRef
• Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels
  Kuan-Jung Huang, Chun-Ting Ho, Pei-Chang Lee, San-Chi Chen, Chien-An Liu, Shu-Cheng Chou, I-Cheng Lee, Yi-Hsiang Huang, Jiing-Chyuan Luo, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
  Journal of the Chinese Medical Association.2025; 88(12): 915.     CrossRef
• The predictive value of dynamic changes in neutrophil-to-lymphocyte ratio for the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization
  Junyu Zhou, Jiaqian Gao, Qi He, Kai Lei, Wenfeng Zhang, Yue Li
  Discover Oncology.2025;[Epub]     CrossRef
• Serum Biomarkers for Hepatocellular Carcinoma: A Comparative Review of Traditional and Emerging Markers
  Min Kyung Park
  Journal of Digestive Cancer Research.2025; 13(3): 242.     CrossRef
• Role of protein induced by vitamin-K absence-II in transplanted patients with HCC not producing alpha-fetoprotein
  Quirino Lai, Takashi Ito, Samuele Iesari, Toru Ikegami, Daniele Nicolini, Zoe Larghi Laureiro, Massimo Rossi, Marco Vivarelli, Tomoharu Yoshizumi, Etsurou Hatano, Jan Lerut
  Liver Transplantation.2024; 30(5): 472.     CrossRef
• PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP‐negative hepatocellular carcinoma patients after liver resection
  Zhan‐cheng Qiu, You‐wei Wu, Wei‐li Qi, Chuan Li
  Cancer Medicine.2024;[Epub]     CrossRef
• Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma
  Ming-Da Wang, Yong-Kang Diao, Lan-Qing Yao, Zhong-Qi Fan, Ke-Chun Wang, Han Wu, Li-Hui Gu, Jia-Hao Xu, Chao Li, Guo-Yue Lv, Tian Yang
  iLIVER.2024; 3(1): 100083.     CrossRef
• Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
  Wei Teng, Hung-Wei Wang, Shi-Ming Lin
  Liver Cancer.2024; 13(5): 468.     CrossRef
• Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions
  Xiaoling Long, Huan Zeng, Yun Zhang, Qiulong Lu, Zhao Cao, Hong Shu
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 607.     CrossRef
• Celestial Insights: Unraveling the Role of miR-3682-3p in Hepatocellular Carcinoma
  Pei-Dong Miao, Ying Li, Yu-Dong Jiang
  Clinical and Translational Gastroenterology.2024; 15(4): e00690.     CrossRef
• Research progress of protein induced by vitamin K absence or antagonist II in liver transplantation for hepatocellular carcinoma
  Zheyu Zhou, Qiaoyu Liu, Jinsong Liu, Wenwen Li, Shuya Cao, Jiawei Xu, Jun Chen, Xiaoliang Xu, Chaobo Chen
  Heliyon.2024; 10(9): e30622.     CrossRef
• Optimizing care of HBV infection and HBV-related HCC
  Shi Yan Lee, Benjamin Kai Yi Nah, Jazleen Leo, Jia Hong Koh, Daniel Q. Huang
  Clinical Liver Disease.2024;[Epub]     CrossRef
• Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
  Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
  Clinical and Molecular Hepatology.2024; 30(3): 360.     CrossRef
• Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients
  Mingda Wang, Guojun Qian, Hongmei Xiao, Xingkai Liu, Liyang Sun, Zhong Chen, Kongying Lin, Lanqing Yao, Chao Li, Lihui Gu, Jiahao Xu, Xiaodong Sun, Wei Qiu, Timothy M Pawlik, Wan Yee Lau, Guoyue Lv, Feng Shen, Tian Yang
  The Oncologist.2024; 29(12): e1723.     CrossRef
• The ARH score, a practical guide to decision-making for retreatment with hepatic arterial infusion chemotherapy in hepatocellular carcinoma patients
  Jie Mei, Chengyou Yu, Feng Shi, Renguo Guan, Shaohua Li, Chong Zhong, Rongping Guo, Wei Wei
  International Immunopharmacology.2024; 138: 112551.     CrossRef
• Monocyte distribution width as a promising biomarker for differential diagnosis of chronic hepatitis, cirrhosis, and hepatocellular carcinoma
  Sheng Lin, Xinyao Yang, Xin Yang, Minjie Tang, Xiaobao Yao, Yuchen Ye, Qunfang Huang, Jinlan Huang, Jiejuan Li, Qiang Yi, Wennan Wu, Shiqi Li, Yaru Lei, Bin Yang, Can Liu, Qishui Ou, Zhen Xun
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment
  Rosmawati Mohamed, Wendy Wang, Tawesak Tanwandee, Irsan Hasan, Cam Phuong Pham, Young-Suk Lim, Sheng-Nan Lu, Murallitharan Munisamy, Thi Thanh Huong Tran, Evy Ratnawati, Wattana Sukeepaisarnjaroen, Mahir Karababa, Chee-Kiat Tan
  Journal of Gastrointestinal Cancer.2024; 55(3): 1333.     CrossRef
• Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma
  Ji Yeon Lee, Pil Soo Sung
  Gut and Liver.2024; 18(4): 558.     CrossRef
• Prognosis of Patients with Hepatocellular Carcinoma Treated with TACE: A New Score Combining Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin
  Shang-Yu Lu, Han-Yao Sun, Yan Zhou, Xi Luo, Sheng Liu, Wei-Zhong Zhou, Hai-Bin Shi, Wei Yang, Wei Tian
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1979.     CrossRef
• CEUS LI-RADS in Combination With the Serum Biomarker-Based ASAP Model Improves the Diagnostic Performance of HCC in High-Risk Patients
  Rong Wen, Yuting Peng, Yiqiong Liang, Yuquan Wu, Haiyuan Li, Yanxia Chen, Yan Qin, Zhiyuan Wen, Huanyu Cui, Yun He, Hong Yang
  Ultrasound in Medicine & Biology.2024; 50(11): 1739.     CrossRef
• Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma
  Lung-Yi Mak
  Journal of Liver Cancer.2024; 24(2): 145.     CrossRef
• Construction and evaluation of a liver cancer risk prediction model based on machine learning
  Ying-Ying Wang, Wan-Xia Yang, Qia-Jun Du, Zhen-Hua Liu, Ming-Hua Lu, Chong-Ge You
  World Journal of Gastrointestinal Oncology.2024; 16(9): 3839.     CrossRef
• Early identification of hepatocellular carcinoma patients at high-risk of recurrence using the ADV score: a multicenter retrospective study
  Shuya Cao, Zheyu Zhou, Chaobo Chen, Wenwen Li, Jinsong Liu, Jiawei Xu, Chunlong Zhao, Yihang Yuan, Zhenggang Xu, Huaiyu Wu, Guwei Ji, Xiaoliang Xu, Ke Wang
  World Journal of Surgical Oncology.2024;[Epub]     CrossRef
• Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
  Yau-Tuen Chan, Cheng Zhang, Junyu Wu, Pengde Lu, Lin Xu, Hongchao Yuan, Yibin Feng, Zhe-Sheng Chen, Ning Wang
  Molecular Cancer.2024;[Epub]     CrossRef
• Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma
  Tong-Guo Miao, Shi-Ya Zhang, Yun-Jing Zhang, Dong Ma, Yue-Min Nan
  Scientific Reports.2024;[Epub]     CrossRef
• Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma
  Minami Yamauchi, Masamitsu Maekawa, Toshihiro Sato, Yu Sato, Masaki Kumondai, Mio Tsuruoka, Jun Inoue, Atsushi Masamune, Nariyasu Mano
  Metabolites.2024; 14(9): 513.     CrossRef
• Comparison of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma patients: a SEER population-based propensity score matching study
  Xi Wang, Xinqun Chai, Ruiya Tang, Yunjie Xu, Qinjunjie Chen
  Updates in Surgery.2024; 76(8): 2755.     CrossRef
• Multi-stage mechanisms of tumor metastasis and therapeutic strategies
  Zaoqu Liu, Jingqi Chen, Yuqing Ren, Shutong Liu, Yuhao Ba, Anning Zuo, Peng Luo, Quan Cheng, Hui Xu, Xinwei Han
  Signal Transduction and Targeted Therapy.2024;[Epub]     CrossRef
• An Early Increase in IL-10 and TNF-α Levels Following Atezolizumab Plus Bevacizumab Treatment Predicts Survival in Advanced Hepatocellular Carcinoma Patients: A Prospective Cohort Study
  Soon Kyu Lee, Soon Woo Nam, Ji Won Han, Jung Hyun Kwon
  Cancers.2024; 16(20): 3543.     CrossRef
• Prediction of microvascular invasion in hepatocellular carcinoma with conventional ultrasound, Sonazoid-enhanced ultrasound, and biochemical indicator: a multicenter study
  Dan Lu, Li-Fan Wang, Hong Han, Lin-Lin Li, Wen-Tao Kong, Qian Zhou, Bo-Yang Zhou, Yi-Kang Sun, Hao-Hao Yin, Ming-Rui Zhu, Xin-Yuan Hu, Qing Lu, Han-Sheng Xia, Xi Wang, Chong-Ke Zhao, Jian-Hua Zhou, Hui-Xiong Xu
  Insights into Imaging.2024;[Epub]     CrossRef
• Cross-sectional study on the diagnostic significance of plasma exosomal miRNAs in HBV-related hepatocellular carcinoma
  Xiaoyuan Hu, Fa Huang, Jiyou Yao, Jiaxian Lv, Jialuo Mai, Ning Li, Minqiang Lu
  Journal of Translational Medicine.2024;[Epub]     CrossRef
• Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy
  Teng Zhang, Wengang Li, Qian Chen, Weiping He, Jing Sun, Dong Li, Quan Wang, Xuezhang Duan
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
  Yeshong Park, Ho-Seong Han, Seung Yeon Lim, Hyelim Joo, Jinju Kim, MeeYoung Kang, Boram Lee, Hae Won Lee, Yoo-Seok Yoon, Jai Young Cho
  Medicina.2024; 61(1): 12.     CrossRef
• Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study
  Yi Jiang, Ke Su, Han Li, Chenjie Wang, Zhenying Wu, Jiali Chen, Zhiyao Zhang, Kun He, Yunwei Han
  Investigational New Drugs.2024;[Epub]     CrossRef
• What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
  Min Kyung Park, Yoon Jun Kim
  Clinical and Molecular Hepatology.2023; 29(2): 332.     CrossRef
• Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan
  San-Chi Chen
  Clinical and Molecular Hepatology.2023; 29(2): 352.     CrossRef
• Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
  Shu An, Xiaoxia Zhan, Min Liu, Laisheng Li, Jian Wu
  Diagnostics.2023; 13(8): 1442.     CrossRef
• Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma
  Yanjie Yang, Nan Du, Jingqin Ma, Zhijie Peng, Bo Zhou, Jiaze Yu, Xin Zhou, Wen Zhang, Zhiping Yan
  Journal of Hepatocellular Carcinoma.2023; Volume 10: 1897.     CrossRef
• Attenuation of binuclear hepatocytes in the paracancerous liver tissue is associated with short‐term recurrence of hepatocellular carcinoma post‐radical surgery
  Yifan Zhang, Nan Wang, Fengjie Hao, Yongjun Chen, Xiaochun Fei, Junqing Wang
  The FASEB Journal.2023;[Epub]     CrossRef
• Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
  Tianying Ren, Xu Hou, Xin Zhang, Dongliang Chen, Juan Li, Yingnan Zhu, Zhiheng Liu, Dawei Yang
  Heliyon.2023; 9(11): e21906.     CrossRef
• Protein induced by vitamin K absence or antagonist II: Experience to date and future directions
  Libin Dong, Xun Qiu, Fengqiang Gao, Kai Wang, Xiao Xu
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2023; 1878(6): 189016.     CrossRef
• Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area
  Joo Hyun Oh, Jonghyun Lee, Eileen L. Yoon, Soung Won Jeong, Soon Sun Kim, Young Eun Chon, Sang Bong Ahn, Dae Won Jun
  Cancers.2023; 16(1): 150.     CrossRef

Citations

Citations to this article as recorded by  

• Tumor-associated macrophages in hepatocellular carcinoma: Cellular plasticity and therapy resistance in crosstalk
  Tianhao Zhang, Xi Zhao, Tingting Gao, Fang Ma
  Journal of Pharmaceutical Analysis.2026; 16(1): 101384.     CrossRef
• Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: Molecular mechanisms and therapeutic implications
  Jayanta Das, Bhupen Barman, Phulen Sarma, Bipul Kumar Das, Rajiv Chetia, Partha Pratim Kalita
  Biochemistry and Biophysics Reports.2026; 45: 102403.     CrossRef
• RNA splicing dysregulation in hepatocellular carcinoma: Molecular mechanisms, therapeutic targets, and intervention strategies—A comprehensive review
  Shuai Xiong, Lei Hu, Yun-Yang Sun, Wei Huang, Xiao-Yu Hu
  Biomedicine & Pharmacotherapy.2026; 195: 119025.     CrossRef
• Targeting Tumor-Associated Macrophages and Cancer-Associated Fibroblasts to Overcome Therapeutic Resistance in Hepatocellular Carcinoma
  Hyo Jung Cho, Minsu Kwon, Judith A. Varner
  Clinical Cancer Research.2026; 32(7): 1196.     CrossRef
• Syringin disrupts the DLAT/MYC axis to dampen TAM polarization and suppress hepatocellular carcinoma progression
  Lingyun Xiao, Jiawei Lv, Yuan Lu, Zun Li, Liang-Mei Yang, Zheng Li, Shu Liang, Ke-Bin Huang, Xiongjun Wang
  Acta Pharmaceutica Sinica B.2026; 16(6): 3680.     CrossRef
• Interventional therapy for hepatocellular carcinoma in the immunotherapy era: From mechanism exploration to materials innovation
  Bufu Tang, Jiaqi Yang, Wangting Xu, Guangzhi Wang, Weishi Ye, Changyu Li, Juncheng Wan, Yongjie Zhou, Caihong Yu, Chaoqiao Jin, Zhiping Yan, Xudong Qu, Wen Zhang
  Biomaterials.2026; 333: 124208.     CrossRef
• PCBP1 suppresses autophagic degradation of STAT6 to promote M2-like TAM polarization in hepatocellular carcinoma
  Yue Luo, Xinyu Zhang, Haoyi Yang, Yuxin Yao, Hao Wu, Zhu Zhang, Dongjie Ye, Banglun Pan, Xiaoqian Wang, Nanhong Tang
  Cellular Signalling.2026; 145: 112588.     CrossRef
• Single-Cell Transcriptomic Profiling Reveals Immunometabolic Reprogramming and Cell-Cell Communication in the Tumor Microenvironment of Human Hepatocellular Carcinoma
  Miguel Ángel Díaz-Campos, Enrique Hernández-Lemus
  International Journal of Molecular Sciences.2026; 27(12): 5397.     CrossRef
• Tumor-Associated Macrophages in Hepatocellular Carcinoma: From Ontogeny and Heterogeneity to Immune Evasion and Therapeutic Targeting
  Yuhao Su, Yuxin Liang, Deyuan Zhong, Yahui Chen, Shuo Shuo Ma, Xiaolun Huang
  Journal of Hepatocellular Carcinoma.2026; Volume 13: 1.     CrossRef
• Association of IL4I1+ M2-like macrophages in tumor microenvironment with poor prognosis in hepatocellular carcinoma: insights from bioinformatics and experimental validation
  Tao Yang, Yi Lu, Yu-Qin Li, Xu-Hui Bao, Hui-Ping Lu, Wu-Jun Xiong
  Frontiers in Immunology.2026;[Epub]     CrossRef
• Construction of an Oxidative Stress Risk Model to Analyze the Correlation Between Liver Cancer and Tumor Immunity
  Ying Liu, Yufeng Li, Li Chen, Weina Zha, Jing Zhang, Kun Wang, Chunhai Hao, Jianhe Gan
  Current Cancer Drug Targets.2025; 25(1): 49.     CrossRef
• The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies
  Shuairan Zhang, Hang Dong, Xiuli Jin, Jing Sun, Yiling Li
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(3): 167676.     CrossRef
• Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment
  Haoqiang Yang, Jinghui Li, Yiting Niu, Tao Zhou, Pengyu Zhang, Yang Liu, Yanjun Li
  Frontiers in Immunology.2025;[Epub]     CrossRef
• C-reactive protein to albumin ratio combined with the Systemic Inflammatory Response Index predicts the prognosis of patients undergoing radical hepatectomy
  Shao-Long Lu, Qing-Yuan Zhang, Yuan-Quan Zhao, Hua-Lin Wu, Jie Lin, Peng Zhu, Zheng-Jun Qin, Xiao-Bo Wang, Jie Chen
  BMC Cancer.2025;[Epub]     CrossRef
• The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype–phenotype study
  Jaejun Lee, Jung Hoon Cha, Hee Sun Cho, Keungmo Yang, Hyun Yang, Heechul Nam, Mi Young Byun, Seok Keun Cho, Jinsung Park, Hyuk Wan Ko, Seong Wook Yang, Pil Soo Sung, Si Hyun Bae
  Journal of Gastroenterology.2025; 60(10): 1284.     CrossRef
• Periostin-integrin signaling in hepatocellular carcinoma: from biological function to clinical application
  Jun Lei, Yong Liu, Shuai Yuan, Xiaxia Yuan, Qi Yuan
  Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
• Relationships Among Serological Indicators and In Vitro High-Throughput Drug Sensitivity Screening Results in Patients with Hepatocellular Carcinoma
  Xu Feng, Guo-Ying Feng, Jie Tao, Yu-Pei Ao, Xin-Hua Wu, Shi-Guai Qi, Zheng-Rong Shi, Ling-Yun Gao
  Combinatorial Chemistry & High Throughput Screening.2025; 28(11): 1927.     CrossRef
• Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma
  Zongbo Dai, Yu Wang, Ning Sun, Chengshuo Zhang
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease
  Tongguo Miao, Xianzhe Lou, Shiming Dong, Xiaoxiao Zhang, Weiwei Guan, Ying Zhang, Lu Li, Xiwei Yuan, Dong Ma, Yuemin Nan
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 145.     CrossRef
• Immune microenvironment in hepatocellular carcinoma: current concepts and the role of blockade of immune checkpoints
  E.L. Bueverova, O.Yu. Zolnikova, M.A. Paltzev
  Molekulyarnaya Meditsina (Molecular medicine).2024; 22(1): 3.     CrossRef
• Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC
  Jong Geun Park, Pu Reun Roh, Min Woo Kang, Sung Woo Cho, Suhyun Hwangbo, Hae Deok Jung, Hyun Uk Kim, Ji Hoon Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Young Kyoung You, Ho Joong Choi, Jae Yong Ryu, Pil Soo Sung
  Hepatology.2024; 80(5): 1074.     CrossRef
• Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma
  Ji Kim, Young Kim, Hee-Chul Nam, Chang-Wook Kim, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Ho Jong Chun, Jung Oh, Suho Kim, Sung Lee, Pil Sung
  Oncology Letters.2024;[Epub]     CrossRef
• Liver cancer from the perspective of single-cell sequencing: a review combined with bibliometric analysis
  Yanwei Ji, Qi An, Xinyu Wen, Zhou Xu, Zhengyuan Xia, Zhongyuan Xia, Qinyong Hu, Shaoqing Lei
  Journal of Cancer Research and Clinical Oncology.2024;[Epub]     CrossRef
• Machine learning model reveals roles of interferon‑stimulated genes in sorafenib‑resistant liver cancer
  Deok Seo, Ji Park, Hee Jung, Min Kang, Byung Kang, Dong Lee, Jae Lee, Seung Yoon, Jeong Jang, Jae Ahn, Pil Sung
  Oncology Letters.2024;[Epub]     CrossRef
• Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma
  Ji Won Han, Min Woo Kang, Soon Kyu Lee, Hyun Yang, Ji Hoon Kim, Jae-Sung Yoo, Hee Sun Cho, Eun Ji Jang, Deok Hwa Seo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
  Liver Cancer.2024; : 1.     CrossRef
• Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis
  Jung Hoon Cha, Na Ri Park, Sung Woo Cho, Heechul Nam, Hyun Yang, Eun Sun Jung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung, Si Hyun Bae
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Recent Advances in Immune-based Therapy for Hepatocellular Carcinoma
  Kyung Won Park, Tae Hoon Park, Eun Ji Jang, Pil Soo Sung
  Journal of Digestive Cancer Research.2024; 12(2): 115.     CrossRef
• Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
  Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, Rosalba D’Alessandro, Giorgio Frega, Giovanni Brandi, Endrit Shahini, Raffaele Cozzolongo, Claudio Lotesoriere, Gianluigi Giannelli
  Cancers.2024; 16(20): 3542.     CrossRef
• The Role of Macrophages in Hepatocellular Carcinoma and Their Therapeutic Potential
  Megan E. Bannister, Devnandan A. Chatterjee, Shishir Shetty, Daniel A. Patten
  International Journal of Molecular Sciences.2024; 25(23): 13167.     CrossRef
• Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab
  Jaejun Lee, Jae-Sung Yoo, Ji Hoon Kim, Dong Yeup Lee, Keungmo Yang, Bohyun Kim, Joon-Il Choi, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ji Won Han, Pil Soo Sung
  Frontiers in Immunology.2024;[Epub]     CrossRef
• An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation
  Soon Kyu Lee, Jong Young Choi, Eun Sun Jung, Jung Hyun Kwon, Jeong Won Jang, Si Hyun Bae, Seung Kew Yoon
  International Journal of Molecular Sciences.2023; 24(5): 5002.     CrossRef
• Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
  Min Jung Kwon, Soy Chang, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Higher Number of Tumor-Infiltrating PD-L1+ Cells Is Related to Better Response to Multikinase Inhibitors in Hepatocellular Carcinoma
  Ji Won Han, Ji Hoon Kim, Dong Hyun Kim, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jaegyoon Ahn, Hyun Yang, Pil Soo Sung
  Diagnostics.2023; 13(8): 1453.     CrossRef
• IL-8-induced CXCR2 down-regulation in circulating monocytes in hepatocellular carcinoma is partially dependent on MAGL
  Chong Zhong Liu, Xing Bao Liu, Jun Sun, Chao Qun Yu, Jing Chun Yao, Zhong Liu, Jing Cheng Hao
  BMC Cancer.2023;[Epub]     CrossRef
• Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma
  Kyoungdo Mun, Jiwon Han, Pureun Roh, Jonggeun Park, Gahee Kim, Wonhee Hur, Jeongwon Jang, Jongyoung Choi, Seungkew Yoon, Youngkyoung You, Hojoong Choi, Pilsoo Sung
  Journal of Liver Cancer.2023; 23(2): 341.     CrossRef
• Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
  Aloña Agirre-Lizaso, Maider Huici-Izagirre, Josu Urretabizkaia-Garmendia, Pedro M. Rodrigues, Jesus M. Banales, Maria J. Perugorria
  Cancers.2023; 15(20): 4977.     CrossRef
• Early C‐reactive Protein Kinetics Predict Response to Immune Checkpoint Blockade in Unresectable Hepatocellular Carcinoma
  Qiuying Qin, Xiaoxuan Kou, Yuanyuan Zheng, Fei Zhou, Xiaoyong Zhang, Hongyan Liu
  Journal of Hepatocellular Carcinoma.2023; Volume 10: 2009.     CrossRef
• Oxoaporphine Pr(III) complex inhibits hepatocellular carcinoma progression and metastasis by disrupting tumor cell–macrophage crosstalk
  Li Li, Wen-Tao Zuo, Hui Liu, Lan-Shan Liao, Wen-Ying Shen, Zhen-Feng Chen, Hong Liang
  Biomedicine & Pharmacotherapy.2023; 169: 115849.     CrossRef
• The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review
  Xinyi Zhang, Chao Yu, Siqi Zhao, Min Wang, Longcheng Shang, Jin Zhou, Yong Ma
  Cancer Medicine.2023; 12(24): 22109.     CrossRef
• A Unique Immune-Related Gene Signature Represents Advanced Liver Fibrosis and Reveals Potential Therapeutic Targets
  Pil-Soo Sung, Chang-Min Kim, Jung-Hoon Cha, Jin-Young Park, Yun-Suk Yu, Hee-Jung Wang, Jin-Kyeoung Kim, Si-Hyun Bae
  Biomedicines.2022; 10(1): 180.     CrossRef
• Intrahepatic inflammatory IgA+PD-L1high monocytes in hepatocellular carcinoma development and immunotherapy
  Pil Soo Sung, Dong Jun Park, Pu Reun Roh, Kyoung Do Mun, Sung Woo Cho, Gil Won Lee, Eun Sun Jung, Sung Hak Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Jonghwan Choi, Jaegyoon Ahn, Seung Kew Yoon
  Journal for ImmunoTherapy of Cancer.2022; 10(5): e003618.     CrossRef
• The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
  Zhang Guizhen, Ji Guanchang, Liu Liwen, Wang Huifen, Ren Zhigang, Sun Ranran, Yu Zujiang
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies
  Ruixue Bai, Yunong Li, Lingyan Jian, Yuehui Yang, Lin Zhao, Minjie Wei
  Molecular Cancer.2022;[Epub]     CrossRef
• Multiplexed Digital Spatial Protein Profiling Reveals Distinct Phenotypes of Mononuclear Phagocytes in Livers with Advanced Fibrosis
  Jaejun Lee, Chang Min Kim, Jung Hoon Cha, Jin Young Park, Yun Suk Yu, Hee Jung Wang, Pil Soo Sung, Eun Sun Jung, Si Hyun Bae
  Cells.2022; 11(21): 3387.     CrossRef
• Multidisciplinary approach for hepatocellular carcinoma arising from cirrhotic liver with Budd-Chiari syndrome: a case report
  Sangmi Kim, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
  Journal of Liver Cancer.2022; 22(2): 202.     CrossRef
• Tenofovir alafenamide alleviates nonalcoholic steatohepatitis in mice by blocking the phosphorylation of AKT in intrahepatic mononuclear phagocytes
  Pu Reun Roh, Sung Min Kim, Byung-Yoon Kang, Kyoung Do Mun, Jong Geun Park, Min Woo Kang, Wonhee Hur, Ji Won Han, Heechul Nam, Seung Kew Yoon, Pil Soo Sung
  Biomedicine & Pharmacotherapy.2022; 156: 113952.     CrossRef
• Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities
  Qingqing Xie, Pengfei Zhang, Yuanyuan Wang, Wuxuan Mei, Changchun Zeng
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to go
  Pil Soo Sung, Isaac Kise Lee, Pu Reun Roh, Min Woo Kang, Jaegyoon Ahn, Seung Kew Yoon
  Frontiers in Oncology.2022;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Identifying risk factors of dose reduction or treatment discontinuation due to fatigue or gastrointestinal symptoms in patients receiving lenvatinib treatment for hepatocellular carcinoma
  Michio Kimura, Shiori Yamada, Makiko Go, Satoshi Yasuda, Hidenori Toyoda, Eiseki Usami
  Journal of Oncology Pharmacy Practice.2026; 32(1): 24.     CrossRef
• The Impact of Rifaximin on Hepatic Encephalopathy during Lenvatinib Therapy in Patients with Hepatocellular Carcinoma and Splenorenal Shunt
  Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Tomotake Shirono, Etsuko Moriyama, Takumi Kawaguchi
  Internal Medicine.2026; 65(11): 1450.     CrossRef
• Optimizing Nutrition to Counter Sarcopenia in Hepatocellular Carcinoma: A Narrative Review of Mechanisms, Clinical Consequences, and Supportive Therapeutic Options
  Hiroki Tai, Asahiro Morishita, Tomoko Tadokoro, Kyoko Oura, Rie Yano, Mai Nakahara, Koji Fujita, Shima Mimura, Joji Tani, Miwa Tatsuta, Takashi Himoto, Hideki Kobara
  Nutrients.2026; 18(3): 494.     CrossRef
• Quality of life in patients with hepatocellular carcinoma: a bibliometric analysis
  Can Huang, Meng Chen, Yanfang Sun, Lin Zhang, Wei Liu
  Discover Oncology.2026;[Epub]     CrossRef
• Strategic drug sequencing in hepatocellular carcinoma in the era of chemo-diversity: maximizing the therapeutic benefit of lenvatinib
  Hideki Iwamoto, Shigeo Shimose, Hironori Koga, Takumi Kawaguchi
  Journal of Liver Cancer.2026; 26(1): 83.     CrossRef
• The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
  Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming-Hua Zheng, Takumi Kawaguchi, Wah-Kheong Chan, Diana Payawal, Soek-S
  Hepatology International.2025; 19(2): 261.     CrossRef
• Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives
  Yuhang Chen, Suoyi Dai, Chien-shan Cheng, Lianyu Chen
  Journal of Hematology & Oncology.2024;[Epub]     CrossRef
• The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
  Yuri Cho, Bo Hyun Kim, Joong-Won Park
  Clinical and Molecular Hepatology.2023; 29(1): 99.     CrossRef
• Telephone follow‐up contributes to improving adherence and treatment duration in patients with hepatocellular carcinoma treated with lenvatinib
  Sayo Tsumura, Shigeo Shimose, Takashi Niizeki, Eri Kuboyama, Hideki Iwamoto, Masatoshi Tanaka, Etusko Moriyama, Tomotake Shirono, Kota Takaki, Yu Noda, Masahito Nakano, Mitsutoshi Inoue, Kazuki Tsustumi, Ryoko Kuromatsu, Hironori Koga, Kyoko Higuchi, Taku
  Journal of Gastroenterology and Hepatology.2023; 38(7): 1140.     CrossRef
• Correlation between branched-chain amino acids intake and total lymphocyte count in head and neck cancer patients: a cross-sectional study
  Yosua Yan Kristian, Rahmat Cahyanur, Yohannessa Wulandari, Wina Sinaga, Widjaja Lukito, Findy Prasetyawaty, Wiji Lestari
  BMC Nutrition.2023;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Application of different energy ablations in the treatment of solid tumors
  Liangliang Meng, Xiao Zhang, Xiaobo Zhang, YingtianWei, Yueyong Xiao
  Med-X.2026;[Epub]     CrossRef
• Enhanced magnetic thermal ablation combined with immunotherapy for hepatocellular carcinoma using engineering microspheres
  Zepeng Yu, Yaping He, Mengmeng Wang, Jiaofeng Shen, Di Wang, Andong Yu, Jun Gu, Zhihui Hong, Zhijun Pei, Xingwei Sun
  Materials Today Bio.2025; 35: 102597.     CrossRef
• NEDD4 and NEDD4L: Ubiquitin Ligases Closely Related to Digestive Diseases
  Jiafan Xu, Wang Jiang, Tian Hu, Yan Long, Yueming Shen
  Biomolecules.2024; 14(5): 577.     CrossRef

Citations

Citations to this article as recorded by  

• Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early‐Stage Viral Disease
  Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, Hidenori Toyoda, Satoshi Yasuda, Toshifumi Tada, Kazunari Tanaka, Kunihiko Tsuji, Ei Itobayashi, Akemi Tsutsui, Koichi Takaguchi, Michitaka Imai, Toru Ishikawa, Takeshi Hatanak
  Hepatology Research.2026; 56(3): 351.     CrossRef
• Reduced Local Tumor Progression After Thermal Ablation During Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma
  Tasuku Nakabori, Kaori Mukai, Taku Miyanaga, Hiroki Takiyama, Keita Sekiya, Takumi Kinomoto, Takanori Masumoto, Jun Murata, Makiko Urabe, Yugo Kai, Ryoji Takada, Toshitaka Morishima, Minoru Shigekawa, Kazuyoshi Ohkawa
  Cancers.2026; 18(11): 1800.     CrossRef
• Efficacy of ultrasound-guided microwave ablation for vascular malformations in children
  Shuting Huang, Fenglin Xu, Xin Li, Hongxia Zhang, Jingyu Chen, Zhenzhen Zhao, Jun Zhang, Liang Peng, Xiangru Kong
  Journal of Vascular Surgery: Venous and Lymphatic Disorders.2025; 13(4): 102240.     CrossRef
• The impact of ultrasound contrast-enhanced fusion virtual navigation technology-guided microwave ablation (MWA) and standard MWA on the local tumor progression of hepatocellular carcinoma with unclear ultrasound images
  Ping Zhang, Qiong Zhou, Zhiyong Zeng
  European Journal of Medical Research.2025;[Epub]     CrossRef
• Microwave Thermosphere Ablation Versus Radiofrequency Ablation in Hepatocellular Carcinoma: Optimizing Treatment Strategies for Tumor Size and Malignancy Grade
  Hideyuki Tamai, Jumpei Okamura
  Hepatology Research.2025; 55(9): 1274.     CrossRef
• Advancing Gene Mutation Analysis Through Post‐Ablation Liver Tumor Biopsy Specimens
  Tasuku Nakabori, Yoji Kukita, Hidetoshi Satomi, Kaori Mukai, Minoru Shigekawa, Shigenori Nagata, Kazuyoshi Ohkawa
  Hepatology Research.2025; 55(10): 1416.     CrossRef
• Biopsy After Ablation: Expanding the Frontier of Genomic Insight
  Takuma Nakatsuka, Hayato Nakagawa, Mitsuhiro Fujishiro, Ryosuke Tateishi
  Hepatology Research.2025; 55(11): 1559.     CrossRef
• Circumventing tumor immune evasion: Coordinated immunotherapy via in situ tumor nanovaccines and local ablation
  Yukun Chen, Chi Zhang, Zhongyang Yu, Kaiwen Hu, Tian Zhou
  Chemical Engineering Journal.2025; 523: 168636.     CrossRef
• Development of a weighted Alpha-Fetoprotein tumor burden score-integrated nomogram for predicting overall survival in locally ablated hepatocellular carcinoma patients
  Yang Wang, Zhixia Gu, Wenying Qiao, Xiaoxue Yuan, Caixia Hu, Ronghua Jin
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Efficacy analysis of ultrasound-guided percutaneous hepatic microwave ablation for hepatocellular carcinoma
  Pei Liu, Weirong Huang, Yimei Ji
  Journal of Radiation Research and Applied Sciences.2025; 18(4): 101960.     CrossRef
• Local Contractive Registration With Biomechanical Model: Assessing Microwave Ablation After Compensation for Tissue Shrinkage
  Dingkun Liu, Danni Ai, Tianyu Fu, Yuanjin Gao, Jingfan Fan, Hong Song, Deqiang Xiao, Ping Liang, Jian Yang
  IEEE Journal of Biomedical and Health Informatics.2024; 28(1): 415.     CrossRef
• Perfluorobutane application value in microwave ablation of small hepatocellular carcinoma (<3 cm)
  Yanghong Pan, Delin Liu, Fei Liang, Zixiang Kong, Xu Zhang, Qinqin Ai
  Clinical Hemorheology and Microcirculation.2024; 87(3): 323.     CrossRef
• Comparative Efficacy of Microwave versus Radiofrequency Ablation in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of Randomized-Controlled Trials
  Imelda Rey, Darmadi Darmadi
  Romanian Journal of Internal Medicine.2024; 62(4): 374.     CrossRef
• Contribution and advances of robotics in percutaneous oncological interventional radiology
  Sylvain Bodard, Sylvain Guinebert, Platon M. Dimopoulos, Vania Tacher, Francois H. Cornelis
  Bulletin du Cancer.2024; 111(10): 967.     CrossRef
• Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  European Journal of Internal Medicine.2023; 107: 66.     CrossRef
• Statin use is associated with better post‐operative prognosis among patients with hepatitis B virus‐related hepatocellular carcinoma
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
  European Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Comparisons of Radiofrequency Ablation, Microwave Ablation, and Irreversible Electroporation by Using Propensity Score Analysis for Early Stage Hepatocellular Carcinoma
  Takuya Wada, Katsutoshi Sugimoto, Kentaro Sakamaki, Hiroshi Takahashi, Tatsuya Kakegawa, Yusuke Tomita, Masakazu Abe, Yu Yoshimasu, Hirohito Takeuchi, Takao Itoi
  Cancers.2023; 15(3): 732.     CrossRef
• Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
  Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Hye Won Lee, Seng Gee Lim, Tae Seop Lim, Masayuki Kurosaki, Hiroyuki Marusawa, Toshie Mashiba, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Namiki Izumi,
  Hepatology.2023; 77(5): 1746.     CrossRef
• Anatomical ablation for small hepatocellular carcinomas using multiple applicators: a preliminary study
  Jae Hyun Kim, Hee Soo Kim, Jeong Hee Yoon, Ijin Joo, Jung-Hwan Yoon, Yoon Jun Kim, Su Jong Yu, Jeong Min Lee
  Cancer Imaging.2023;[Epub]     CrossRef
• Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis
  Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim
  Clinical and Molecular Hepatology.2023; 29(4): 1013.     CrossRef
• Clinical Outcomes of Next-Generation Microwave Thermosphere Ablation for Hepatocellular Carcinoma with Primarily Hepatitis-Related Etiology
  Shinichiro Nakamura, Toshifumi Tada, Masahiko Sue, Yu Matsuo, Shiho Murakami, Toshiro Muramatsu, Kazuhiko Morii, Hiroyuki Okada
  Journal of Clinical Medicine.2023; 12(24): 7577.     CrossRef
• Technical and Clinical Outcomes of Laparoscopic–Laparotomic Hepatocellular Carcinoma Thermal Ablation with Microwave Technology: Case Series and Review of Literature
  Riccardo Muglia, Paolo Marra, Domenico Pinelli, Ludovico Dulcetta, Francesco Saverio Carbone, Alessandro Barbaro, Antonio Celestino, Michele Colledan, Sandro Sironi
  Cancers.2023; 16(1): 92.     CrossRef
• Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  Cancers.2022; 14(20): 5002.     CrossRef
• A clinical study on microwave ablation of multifocal (≤ 3) T1N0M0 papillary thyroid carcinoma
  Hui-di Zhou, Xin-yu Yu, Ying Wei, Zheng-long Zhao, Lili Peng, Yan Li, Nai-cong Lu, Ming-an Yu
  European Radiology.2022; 33(6): 4034.     CrossRef
• Efficacy and safety of single- and multiple-antenna microwave ablation for the treatment of hepatocellular carcinoma and liver metastases: A systematic review and network meta-analysis
  Yi Han, Wangyang Zhao, Min Wu, Yingjun Qian
  Medicine.2022; 101(51): e32304.     CrossRef
• Microwave thermosphere versus radiofrequency ablation for hepatocellular carcinoma: Are we approaching the time to end the debate?
  Man-Deuk Kim
  Clinical and Molecular Hepatology.2021; 27(4): 560.     CrossRef
• Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go
  Kunpeng Wang, Cong Wang, Hao Jiang, Yaqiong Zhang, Weidong Lin, Jinggang Mo, Chong Jin
  Frontiers in Immunology.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-Male-Albumin-Bilirubin-Platelet (aMAP) and Liver Stiffness Assessed by Vibration-Controlled Transient Elastography
  Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2026; 24(7): 1897.     CrossRef
• Urgent need for education on hepatocellular carcinoma surveillance among high-risk population in China
  Lei Cai, Chao Li, Li-Yang Sun, Yong-Kang Diao, Ming-Da Wang, Tian Yang
  Clinical and Molecular Hepatology.2025; 31(1): e39.     CrossRef
• Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis
  Shi-Jia Liu, Xiao Zhang, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Hui Liu, Guo-Qiang Pan, Cheng-Long Han, Bao-Wen Tian, Zhao-Ru Dong, Dong-Xu Wang, Yu-Chuan Yan, Tao Li
  Journal of Cancer Research and Clinical Oncology.2025;[Epub]     CrossRef
• Comparative risk of osteoporosis and fractures in chronic hepatitis B patients: Tenofovir disoproxil fumarate vs. entecavir in a Korean nationwide cohort
  Yoon E. Shin, Jae Young Kim, Hyuk Kim, Jeong Ju Yoo, Sang Gyune Kim, Young Seok Kim
  JHEP Reports.2025; 7(9): 101489.     CrossRef
• Drug Repurposing for Kala-Azar
  Biljana Arsić, Budimir S. Ilić, Andreas Maier, Michael Hartung, Jovana Janjić, Jelena Milićević, Jan Baumbach
  Pharmaceutics.2025; 17(8): 1021.     CrossRef
• Tenofovir disoproxil fumarate: safe and effective option for managing high-viral-load chronic hepatitis B
  Wenyuan Song
  American Journal of Translational Research.2025; 17(4): 3228.     CrossRef
• MDSC-targeted liposomal all-trans retinoic acid suppresses mMdscs and improves immunotherapy in HBV infection
  Samuel Kesse, Yuhong Xu, Sanyuan Shi, Shanshan Jin, Shafi Ullah, Yongchao Dai, Miao He, Anjie Zheng, Fengwei Xu, Zixiu Du, Raphael N. Alolga, Jinliang Peng
  Expert Opinion on Drug Delivery.2024; 21(2): 347.     CrossRef
• Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study
  Yixin Hou, Jianguo Yan, Ke Shi, Xiaoli Liu, Fangyuan Gao, Tong Wu, Peipei Meng, Min Zhang, Yuyong Jiang, Xianbo Wang
  OncoTargets and Therapy.2024; Volume 17: 215.     CrossRef
• Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
  Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
  Clinical and Molecular Hepatology.2024; 30(3): 500.     CrossRef
• Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”
  Yewan Park, Dong Hyun Sinn
  Clinical and Molecular Hepatology.2024; 30(4): 718.     CrossRef
• Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  European Journal of Internal Medicine.2023; 107: 66.     CrossRef
• Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta‐analysis
  Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Amrit Gopan, Sumaswi Angadi, Sridhar Sundaram
  Journal of Viral Hepatitis.2023; 30(2): 108.     CrossRef
• Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study
  Byungyoon Yun, Juyeon Oh, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
  American Journal of Gastroenterology.2023; 118(6): 1001.     CrossRef
• ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis
  Mi Na Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Se Young Jang, Won Young Tak, Young-Oh Kweon, Soo Young Park, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2023; 21(9): 2278.     CrossRef
• Statin use is associated with better post‐operative prognosis among patients with hepatitis B virus‐related hepatocellular carcinoma
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
  European Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Lower risk of hepatocellular carcinoma with tenofovir than entecavir in antiviral treatment-naïve chronic hepatitis B patients: a systematic review and meta-analysis involving 90,897 participants
  Jinman Shao, Yishu Wang, Ling Hu, Lianchao Zhang, Chunmei Lyu
  Clinical and Experimental Medicine.2023; 23(6): 2131.     CrossRef
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
  
  Journal of Liver Cancer.2023; 23(1): 1.     CrossRef
• Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
  Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Hye Won Lee, Seng Gee Lim, Tae Seop Lim, Masayuki Kurosaki, Hiroyuki Marusawa, Toshie Mashiba, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Namiki Izumi,
  Hepatology.2023; 77(5): 1746.     CrossRef
• Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis
  Hui Liu, Cheng-Long Han, Bao-Wen Tian, Zi-Niu Ding, Ya-Fei Yang, Yun-Long Ma, Chun-Cheng Yang, Guang-Xiao Meng, Jun-Shuai Xue, Dong-Xu Wang, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
  Expert Review of Gastroenterology & Hepatology.2023; 17(6): 623.     CrossRef
• Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
  Beom Kyung Kim, Sang Hoon Ahn
  Journal of the Formosan Medical Association.2023; 122(12): 1238.     CrossRef
• A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
  Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Liver International.2023; 43(8): 1813.     CrossRef
• Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
  Sang Hyun Seo, Kyung Joo Cho, Hye Jung Park, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jae Hee Cheon, Jong In Yook, Man-Deuk Kim, Dong Jin Joo, Seung Up Kim
  Cell Communication and Signaling.2023;[Epub]     CrossRef
• Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta‐analysis
  Bao‐Hong Yuan, Ru‐Hong Li, Rong‐Rui Huo, Min‐Jun Li, George Papatheodoridis, Jian‐Hong Zhong
  Journal of Gastroenterology and Hepatology.2022; 37(5): 782.     CrossRef
• Comparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma
  Mi Na Kim, Beom Kyung Kim, Yun Ho Roh, Na Ryung Choi, Su Jong Yu, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2022; 20(8): 1877.     CrossRef
• A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients
  Hyung Joon Kim, Ju Hyun Kim, Jong Eun Yeon, Yeon Seok Seo, Jeong Won Jang, Yong Kyun Cho, Byoung Kuk Jang, Byung Hoon Han, Changhyeong Lee, Joon Hyeok Lee, Jung-Hwan Yoon, Kang Mo Kim, Moon Young Kim, Do Young Kim, Neung Hwa Park, Eun Young Cho, June Sung
  Journal of Korean Medical Science.2022;[Epub]     CrossRef
• Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts
  Sang Il Choi, Yuri Cho, Moran Ki, Bo Hyun Kim, In Joon Lee, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Eun Kyung Hong, Chang-Min Kim, Joong-Won Park, Hamidreza Karimi-Sari
  PLOS ONE.2022; 17(3): e0265668.     CrossRef
• KASL clinical practice guidelines for management of chronic hepatitis B
  
  Clinical and Molecular Hepatology.2022; 28(2): 276.     CrossRef
• The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
  Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, Jin-Woo Lee
  Clinical and Molecular Hepatology.2022; 28(3): 351.     CrossRef
• Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  European Journal of Internal Medicine.2022; 103: 122.     CrossRef
• Real‐world clinical features, health‐care utilization, and economic burden in decompensated cirrhosis patients: A national database
  Hankil Lee, Beom Kyung Kim
  Journal of Gastroenterology and Hepatology.2022; 37(11): 2154.     CrossRef
• Effect of metabolic dysfunction‐associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
  Hepatology Research.2022; 52(12): 975.     CrossRef
• 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
  
  Korean Journal of Radiology.2022; 23(12): 1126.     CrossRef
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
  
  Clinical and Molecular Hepatology.2022; 28(4): 583.     CrossRef
• Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
  Jae Lee, Tae Lim, Hye Lee, Seung Kim, Jun Park, Do Kim, Sang Ahn, Hyun Lee, Jung Lee, Ja Kim, In Min, Beom Kim
  Diagnostics.2022; 13(1): 3.     CrossRef
• Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
  Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Dong Hyun Sinn, Seung Up Kim
  Hepatology International.2021; 15(6): 1328.     CrossRef
• Association between HBs Ag quantification and the risk of hepatocellular carcinoma in patients treated with tenofovir disoproxil fumarate or entecavir
  Jung Hyun Lim, Jung Hwan Yu, Young Ju Suh, Jin-Woo Lee, Young-Joo Jin
  Medicine.2021; 100(39): e27417.     CrossRef
• Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
  Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Cancers.2021; 13(23): 5892.     CrossRef
• The association between hepatocarcinogenesis and intracellular alterations due to hepatitis B virus infection
  Masataka Tsuge
  Liver International.2021; 41(12): 2836.     CrossRef

Citations

Citations to this article as recorded by  

• Association of HBV serological markers with host antiviral immune response relevant hepatic inflammatory damage in chronic HBV infection
  Bei Jiang, Leijie Wang, Huan Liu, Lin Wang, Rui Su, Liang Xu, Guochao Wei, Jia Li, Fengmin Lu, Xiangmei Chen
  Journal of Medical Virology.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Liver elastography-based risk score for predicting hepatocellular carcinoma risk
  Chan Tian, Chunyan Ye, Haiyan Guo, Kun Lu, Juan Yang, Xiao Wang, Xinyuan Ge, Chengxiao Yu, Jing Lu, Longfeng Jiang, Qun Zhang, Ci Song
  JNCI: Journal of the National Cancer Institute.2025; 117(4): 761.     CrossRef
• Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study
  Yixin Hou, Jianguo Yan, Ke Shi, Xiaoli Liu, Fangyuan Gao, Tong Wu, Peipei Meng, Min Zhang, Yuyong Jiang, Xianbo Wang
  OncoTargets and Therapy.2024; Volume 17: 215.     CrossRef
• Comparison of models to predict incident chronic liver disease: a systematic review and external validation in Chinese adults
  Xue Cong, Shuyao Song, Yingtao Li, Kaiyang Song, Cameron MacLeod, Yujie Cheng, Jun Lv, Canqing Yu, Dianjianyi Sun, Pei Pei, Ling Yang, Yiping Chen, Iona Millwood, Shukuan Wu, Xiaoming Yang, Rebecca Stevens, Junshi Chen, Zhengming Chen, Liming Li, Christia
  BMC Medicine.2024;[Epub]     CrossRef
• Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  European Journal of Internal Medicine.2023; 107: 66.     CrossRef
• Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study
  Byungyoon Yun, Juyeon Oh, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
  American Journal of Gastroenterology.2023; 118(6): 1001.     CrossRef
• Statin use is associated with better post‐operative prognosis among patients with hepatitis B virus‐related hepatocellular carcinoma
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
  European Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
  Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Sang Hoon Ahn, Chai Hong Rim
  Hepatology Communications.2023; 7(2): e0011.     CrossRef
• Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
  Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Hye Won Lee, Seng Gee Lim, Tae Seop Lim, Masayuki Kurosaki, Hiroyuki Marusawa, Toshie Mashiba, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Namiki Izumi,
  Hepatology.2023; 77(5): 1746.     CrossRef
• Prognostic Significance of Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) Score in Hepatocellular Carcinoma
  Jing Zhou, Daofeng Yang
  Journal of Hepatocellular Carcinoma.2023; Volume 10: 821.     CrossRef
• Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
  Beom Kyung Kim, Sang Hoon Ahn
  Journal of the Formosan Medical Association.2023; 122(12): 1238.     CrossRef
• A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
  Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Liver International.2023; 43(8): 1813.     CrossRef
• HBV seroprevalence and liver fibrosis status among population born before national immunization in Southern Thailand: Findings from a health check-up program
  Supinya Sono, Jirayu Sae-Chan, Apichat Kaewdech, Naichaya Chamroonkul, Pimsiri Sripongpun, Jason T. Blackard
  PLOS ONE.2022; 17(6): e0270458.     CrossRef
• The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis
  Kai Liu, Zeyu Huang, Suhua Yang, Lin Lin, Shuqin Zheng, Xiujun Zhang, Yuan Xue, Weibin Xie
  Journal of Hepatocellular Carcinoma.2022; Volume 9: 1057.     CrossRef
• Surveillance for hepatocellular carcinoma: It is time to move forward
  Bo Hyun Kim, Yuri Cho, Joong-Won Park
  Clinical and Molecular Hepatology.2022; 28(4): 810.     CrossRef
• Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
  Jae Lee, Tae Lim, Hye Lee, Seung Kim, Jun Park, Do Kim, Sang Ahn, Hyun Lee, Jung Lee, Ja Kim, In Min, Beom Kim
  Diagnostics.2022; 13(1): 3.     CrossRef
• Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
  Ho Soo Chun, Minjong Lee
  Clinical and Molecular Hepatology.2021; 27(3): 448.     CrossRef

Citations

Citations to this article as recorded by  

• Development and validation of a nomogram for predicting moderate-to-severe pain in hepatitis B virus-related liver cancer patients after CyberKnife treatment
  Yating Chi
  American Journal of Translational Research.2025; 17(9): 7058.     CrossRef
• A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
  Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Liver International.2023; 43(8): 1813.     CrossRef
• Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries
  Ben Kang, Dae Yong Yi, Byung-Ho Choe
  Frontiers in Pediatrics.2022;[Epub]     CrossRef
• Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
  Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
  Cancers.2021; 13(14): 3424.     CrossRef

Citations

Citations to this article as recorded by  

• Breaking Barriers in Hepatocellular Carcinoma: Synergistic Potential of Stereotactic Body Radiotherapy Combined with Immunotherapy
  Deepti Sharma, Babu Lal Meena, Divya Khosla
  Journal of Clinical and Experimental Hepatology.2026; : 103593.     CrossRef
• Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles
  Chou-Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, Atreyi Pramanik, Rajiv Sharma, Faraj Mohammed, Israa Abed Jawad, Imad Jasim Mohammed, Mohammad Y. Alshahrani, Noor Alhuda Mohammad Ali khalil, Ali Turki Shnishil, Munther Kadhim Abosaoda
  Pathology - Research and Practice.2024; 256: 155266.     CrossRef

Citations

Citations to this article as recorded by  

• Integrated Multi-Omics Analysis Reveals Cytokine Network Dynamics and Prognostic Signatures in Hepatitis B Virus-Associated Hepatocellular Carcinoma
  Mo-Han Liu, Fu-Yong Zhang, Yuan-Jun Huang, Zhi-Hua Jiang, Qin-Yan Chen, Lu-Juan Zhang, Li-Ping Hu, Zhong-Liao Fang
  Applied Biochemistry and Biotechnology.2026; 198(3): 1591.     CrossRef
• Comprehensive analysis and therapeutic implications of prognostic value of circadian rhythm genes in hepatocellular carcinoma
  Jichun Sun, Jiaxing Hou, Hongbo Xu, Zhiqiang Li, Zhen Deng, Zhi Yang, Wuqing Cao, Junning Hou, Xiaoxin Jin
  Journal of Physiology and Biochemistry.2026;[Epub]     CrossRef
• Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
  Reetobrata Basu, Cesar L Boguszewski, John J Kopchick
  Endocrine Reviews.2025; 46(2): 224.     CrossRef
• Deciphering the Oncogenic Landscape of Hepatocytes Through Integrated Single‐Nucleus and Bulk RNA‐Seq of Hepatocellular Carcinoma
  Huanhou Su, Xuewen Zhou, Guanchuan Lin, Chaochao Luo, Wei Meng, Cui Lv, Yuting Chen, Zebin Wen, Xu Li, Yongzhang Wu, Changtai Xiao, Jian Yang, Jiameng Lu, Xingguang Luo, Yan Chen, Paul KH Tam, Chuanjiang Li, Haitao Sun, Xinghua Pan
  Advanced Science.2025;[Epub]     CrossRef
• Multiscale identification of DNASE1L3 as a key target in MASLD progression to hepatocellular carcinoma
  Lintao Xia, Xiuli Yan, Hui Zhang
  Pathology - Research and Practice.2025; 275: 156192.     CrossRef
• Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy
  Jialin Qu, Fenghao Sun, Yichen Hou, Haoran Qi, Xiaorong Sun, Ligang Xing
  BMC Cancer.2023;[Epub]     CrossRef
• Growth hormone receptor agonists and antagonists: From protein expression and purification to long‐acting formulations
  Yue Wang, Minah Kim, Chantal Buckley, Heather D. Maynard, Ries J. Langley, Jo K. Perry
  Protein Science.2023;[Epub]     CrossRef
• Three E2F target-related genes signature for predicting prognosis, immune features, and drug sensitivity in hepatocellular carcinoma
  Baozhu Zhang, Boyang Chang, Lu Wang, Yuzhong Xu
  Frontiers in Molecular Biosciences.2023;[Epub]     CrossRef
• Ring Finger Protein 125 Is an Anti-Proliferative Tumor Suppressor in Hepatocellular Carcinoma
  Takahiro Kodama, Michiko Kodama, Nancy A. Jenkins, Neal G. Copeland, Huanhuan Joyce Chen, Zhubo Wei
  Cancers.2022; 14(11): 2589.     CrossRef
• Development and Verification of a Combined Immune- and Metabolism-Related Prognostic Signature for Hepatocellular Carcinoma
  Yuanyuan Guo, Jing Yang, Hua Gao, Xin Tian, Xiaojian Zhang, Quancheng Kan
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor
  Mona A. Abu El-Makarem, Mariana F. Kamel, Ahmed A. Mohamed, Hisham A. Ali, Mahmoud R. Mohamed, Alaa El-Deen M. Mohamed, Ahmed M. El-Said, Mahmoud G. Ameen, Alshymaa A. Hassnine, Hatem A. Hassan, Gianfranco D. Alpini
  PLOS ONE.2022; 17(11): e0277266.     CrossRef
• MustSeq, an alternative approach for multiplexible strand-specific 3’ end sequencing of mRNA transcriptome confers high efficiency and practicality
  Liyao Mai, Yinbin Qiu, Zhiwei Lian, Caiming Chen, Linlin Wang, Yao Yin, Siqi Wang, Xiang Yang, Yazi Li, Wanwan Peng, Chaochao Luo, Xinghua Pan
  RNA Biology.2021; 18(sup1): 232.     CrossRef

Citations

Citations to this article as recorded by  

• Immune Predictors of Radiotherapy Outcomes in Cervical Cancer
  Linghao Wang, Jie Zhu, Zequn Ding, Zhiyuan Xie, Xingchen Liu, Feihong Zhang, Xiaojun Liu, Yan Zhang, Haiyan Chen
  Advanced Science.2026;[Epub]     CrossRef
• Case Report: Pathologic complete response to PRaG therapy in an elderly patient with refractory metastatic gastric cancer
  Jun Lv, Fayi Yu, Linjiang Pan, Yeying Fang, Zhenghong Zhong, Xue Bai, Jinbiao Gao, Zhuxin Wei
  Frontiers in Oncology.2026;[Epub]     CrossRef
• Clinical Characteristics of Patients With Advanced Hepatocellular Carcinoma Who Transitioned to Subsequent Therapies Following Systemic Therapy
  Kenji Imai, Koji Takai, Masashi Aiba, Shinji Unome, Takao Miwa, Tatsunori Hanai, Hiroyasu Sakai, Yohei Shirakami, Atsushi Suetsugu, Masahito Shimizu
  Cancer Medicine.2026;[Epub]     CrossRef
• Nervous and immune system crosstalk shapes cancer progression and treatment response
  Mustafa TArdah, Raghda AliBakr, H. Malathi, Vimal Arora, Priya PriyadarshiniNayak, Dilbar Urazbaeva, Mukhayya Djumaniyazova, Sadullayeva Moxinur, Farid KarkonShayan
  Discover Oncology.2026;[Epub]     CrossRef
• Breaking Barriers in Hepatocellular Carcinoma: Synergistic Potential of Stereotactic Body Radiotherapy Combined with Immunotherapy
  Deepti Sharma, Babu Lal Meena, Divya Khosla
  Journal of Clinical and Experimental Hepatology.2026; : 103593.     CrossRef
• Evaluation of the abscopal-like effect of radioimmunotherapy on sentinel lymph nodes in H22 hepatocellular carcinoma via dynamic lymphography
  Hui Wang, Dengyun Chen, Zhehan Liu, Xuefeng Zhao, Jinzhou Zhang, Dan Zhang
  BMC Cancer.2026;[Epub]     CrossRef
• Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances
  Dong Xie, Yang Liu, Fangbiao Xu, Zhibo Dang, Mengge Li, Qinsheng Zhang, Zhongqin Dang
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Radiosensitization strategies for hepatocellular carcinoma: Mechanisms, therapeutic advances, and clinical perspectives
  Jiahui Yang, Rong Chen
  Critical Reviews in Oncology/Hematology.2025; 213: 104773.     CrossRef
• Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma
  Ke Xu, Tao Gu, Ke Su, Xin Liu, Bingsheng He, Jie He, Hao Chi, Xuancheng Zhou, Hanlin Liu, Rui Xiao, Xue Tang, Qinni Ye, Xue Zhou, Yingpeng Liu, Jie Xiong, Pan Wang, Han Li, Kun He, Lu Guo, Yunwei Han
  Discover Oncology.2025;[Epub]     CrossRef
• Sorafenib with or without co-interventions for hepatocellular carcinoma
  Shanshan Chen, Jian Ping Liu, Xinyu Li, Shoutao Dang, Wei Li
  Cochrane Database of Systematic Reviews.2025;[Epub]     CrossRef
• Recent Advances in Combination Therapy of YAP Inhibitors with Physical Anti-Cancer Strategies
  Junchi Zhou, Changyan Yu, Wanhong Yang, Nian Jiang, Sanhua Li, Yun Liu, Xinting Zhu
  Biomolecules.2025; 15(7): 945.     CrossRef
• Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma
  Brandon M. Meyers, Howard J. Lim, Mayur Brahmania, Dave M. Liu, Vincent C. Tam, Deanna McLeod, Ravi Ramjeesingh, Jennifer J. Knox, Arndt Vogel
  Therapeutic Advances in Medical Oncology.2025;[Epub]     CrossRef
• Synergies between radiotherapy and immunotherapy: a systematic review from mechanism to clinical application
  JingLong Jiang, HouZe Li, QingCui Ma, Jing Liu, Fu Ren, YingQiu Song, TianLu Wang, KeYan Li, Ning Li
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Local therapy overcomes primary resistance to target-immunotherapy combination in unresectable hepatocellular carcinoma
  Xiangqi Chen, Mingjian Piao, Zixiang Zhou, Shanshan Wang, Shuofeng Li, Nan Zhang, Boyu Sun, Kai Liu, Xu Yang, Xiaobo Yang, Xiaohua Shi, Chengpei Zhu, Haitao Zhao
  Cancer Immunology, Immunotherapy.2025;[Epub]     CrossRef
• Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancer
  Xiangqi Chen, Zixiang Zhou, Shuofeng Li, Guanhua Yu, Shi Feng, Ze Zhou, Boyu Sun, Shanshan Wang, Kai Liu, Chengjie Li, Mingjian Piao, Mingming Wang, Yihong Zhang, Hu Li, Chengpei Zhu, Zhenyu Zhu, Haitao Zhao
  Cancer Immunology, Immunotherapy.2025;[Epub]     CrossRef
• Molecular mechanisms underlying the abscopal effect induced by radiotherapy and its synergistic translational potential with immunotherapy
  Xinyi Chen, Mu Yang, Yongbiao Huang, Jingyao Tu, Yuwen Cai, Xianglin Yuan
  Therapeutic Advances in Medical Oncology.2025;[Epub]     CrossRef
• Hepatocellular Carcinoma Showing Tumor Shrinkage Due to an Abscopal Effect
  Ryo Yano, Masashi Hirooka, Makoto Morita, Yuki Okazaki, Yoshiko Nakamura, Yusuke Imai, Takao Watanabe, Yohei Koizumi, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa
  Internal Medicine.2024; 63(2): 241.     CrossRef
• Multidisciplinary treatment for patients with advanced hepatocellular carcinoma complicated by Vp4 portal vein tumor thrombosis: Combination of atezolizumab and bevacizumab after hepatic arterial infusion chemotherapy and radiotherapy: A case series
  Kenji Yamaoka, Tomokazu Kawaoka, Yasutoshi Fujii, Shinsuke Uchikawa, Hatsue Fujino, Takashi Nakahara, Atsushi Ohno, Eisuke Murakami, Daiki Miki, Masataka Tsuge, Keigo Chosa, Kazuo Awai, Junichi Hirokawa, Yasushi Nagata, Shiro Oka
  Medicine: Case Reports and Study Protocols.2024; 5(6): e00325.     CrossRef
• Enhancing Magnetic Hyperthermia Efficacy through Targeted Heat Shock Protein 90 Inhibition: Unveiling Immune-Mediated Therapeutic Synergy in Glioma Treatment
  Ruby Gupta, Anjali Chauhan, Tashmeen Kaur, Bijoy Kumar Kuanr, Deepika Sharma
  ACS Nano.2024; 18(26): 17145.     CrossRef
• Lymphatic system regulation of anti-cancer immunity and metastasis
  Pin-Ji Lei, Cameron Fraser, Dennis Jones, Jessalyn M. Ubellacker, Timothy P. Padera
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
  Wenya Li, Guojie Chen, Hailin Peng, Qingfang Zhang, Dengyun Nie, Ting Guo, Yinxing Zhu, Yuhan Zhang, Mei Lin
  Biomolecules.2024; 14(9): 1161.     CrossRef
• Evaluation of Treatments with Radiotherapy Alone and Radiotherapy Plus Chemo-immunotherapy in Patients with Primary Liver Cancer based on Blood Biomarkers
  Shigao Huang, Yutian Yin, Jianping Li, Mei Shi, Huijie Bian, Lina Zhao
  Current Medicinal Chemistry.2024; 31(40): 6586.     CrossRef
• Novel VEGFR2 inhibitors with thiazoloquinoxaline scaffold targeting hepatocellular carcinoma with lower cardiotoxic impact
  Reham M. M. El-Hazek, Nashwa H. Zaher, Mostafa G. M. El-Gazzar, Noha A. Fadel, Walaa A. El-Sabbagh
  Scientific Reports.2023;[Epub]     CrossRef
• The paradoxical role of radiation‐induced cGAS–STING signalling network in tumour immunity
  Xiaoyi Zhang, Han Zhang, Jiajia Zhang, Mengdie Yang, Mengqin Zhu, Yuzhen Yin, Xin Fan, Fei Yu
  Immunology.2023; 168(3): 375.     CrossRef
• Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis
  Quan Wang, Xiaoquan Ji, Jing Sun, Wengang Li, Xuezhang Duan, Aimin Zhang
  Journal of Cancer Research and Clinical Oncology.2023; 149(10): 7441.     CrossRef
• Hepatocellular carcinoma (HCC) immunotherapy by anti-PD-1 monoclonal antibodies: A rapidly evolving strategy
  Marzieh Nikoo, Zahraa F. Hassan, Mahsa Mardasi, Elmira Rostamnezhad, Fatemeh Roozbahani, Sahel Rahimi, Javad Mohammadi
  Pathology - Research and Practice.2023; 247: 154473.     CrossRef
• Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma
  Alexander H. Shannon, Ashish Manne, Dayssy A. Diaz Pardo, Timothy M. Pawlik
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma
  Perla Chami, Youssef Diab, Danny N. Khalil, Hassan Azhari, William R. Jarnagin, Ghassan K. Abou-Alfa, James J. Harding, Joseph Hajj, Jennifer Ma, Maria El Homsi, Marsha Reyngold, Christopher Crane, Carla Hajj
  International Journal of Molecular Sciences.2023; 24(23): 16773.     CrossRef
• Inducing the Abscopal Effect in Liver Cancer Treatment: The Impact of Microwave Ablation Power Levels and PD-1 Antibody Therapy
  Changli Liao, Guiyuan Zhang, Ruotong Huang, Linyuan Zeng, Bin Chen, Haitao Dai, Keyu Tang, Run Lin, Yonghui Huang
  Pharmaceuticals.2023; 16(12): 1672.     CrossRef
• Prognostic significance of albumin–bilirubin score in patients with unresectable hepatocellular carcinoma undergoing combined immunotherapy and radiotherapy
  Dezuo Dong, Xianggao Zhu, Hongzhi Wang, Lijuan Li, Meng Wan, Shuai Li, Yangzi Zhang, Jianhao Geng, Yongheng Li, Weihu Wang
  Journal of Medical Imaging and Radiation Oncology.2022; 66(5): 662.     CrossRef
• Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the Present
  Joseph W. Franses, Andrew X. Zhu
  Clinical Cancer Research.2022; 28(13): 2738.     CrossRef
• Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
  Pil Soo Sung
  Clinical and Molecular Hepatology.2022; 28(3): 333.     CrossRef
• Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial
  Jian-Xu Li, Ting-Shi Su, Wen-Feng Gong, Jian-Hong Zhong, Liu-Ying Yan, Jie Zhang, Li-Qing Li, Mei-Ling He, Rui-Jun Zhang, You-Qin Du, Xiao-Ting Wang, Shi-Xiong Liang, Bang-De Xiang
  Hepatology International.2022; 16(5): 1179.     CrossRef
• PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
  Qian Li, Jingjing Han, Yonglin Yang, Yu Chen
  Frontiers in Immunology.2022;[Epub]     CrossRef
• An Abscopal Effect in a Gastric Cancer Patient Treated with Combined Chemoimmunotherapy and Palliative Radiotherapy
  Zengtao Bao, Qiang Tang, Huiyu Chen, Baoming Zhang, Wenchao Shi, Dezhi Gu
  Immunotherapy.2022; 14(18): 1429.     CrossRef
• Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma
  Jun Won Kim, Ik Jae Lee
  Clinical and Molecular Hepatology.2021; 27(1): 103.     CrossRef
• Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments
  Sung-Won Shin, Kyungmi Yang, Miso Lee, Jiyoung Moon, Arang Son, Yeeun Kim, Suha Choi, Do-hyung Kim, Changhoon Choi, Nohyun Lee, Hee Chul Park
  International Journal of Molecular Sciences.2021; 22(5): 2637.     CrossRef
• Immunogenic Cell Death Induction by Ionizing Radiation
  Mengqin Zhu, Mengdie Yang, Jiajia Zhang, Yuzhen Yin, Xin Fan, Yu Zhang, Shanshan Qin, Han Zhang, Fei Yu
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Current role of proton beam therapy in patients with hepatocellular carcinoma
  Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park
  International Journal of Gastrointestinal Intervention.2021; 10(4): 175.     CrossRef
• Antigen-Capturing Mesoporous Silica Nanoparticles Enhance the Radiation-Induced Abscopal Effect in Murine Hepatocellular Carcinoma Hepa1-6 Models
  Kyungmi Yang, Changhoon Choi, Hayeong Cho, Won-Gyun Ahn, Shin-Yeong Kim, Sung-Won Shin, Yeeun Kim, Taekyu Jang, Nohyun Lee, Hee Chul Park
  Pharmaceutics.2021; 13(11): 1811.     CrossRef

Citations

Citations to this article as recorded by  

• Systemic hematologic, metabolic, and inflammatory dysregulation in liver cirrhosis and hepatocellular carcinoma: diagnostic utility of novel indices in an Egyptian cohort
  Dalia E. Sherief, Hadeer Hamdy Shehata, Nahla Nosair, Amira A. A. Othman, Mohamed W. Saleh, Emad Sadaka, Rasha Elgamal
  BMC Gastroenterology.2026;[Epub]     CrossRef
• Integrative transcriptomic analysis reveals miR-26a-5p downregulation and a potential predictive gene signature for the progression of metabolic liver disease
  Andrei Sorop, Alina-Veronica Ghionescu, Diana Larisa Ancuța, Maria-Gabriela Croitoru, Cristin Coman, Daniela Lixandru, Simona Olimpia Dima
  Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
• Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
  Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee, Do Young Kim
  Cancers.2025; 17(4): 566.     CrossRef
• Biosocial Determinants of Health Among Patients with Chronic Liver Disease and Liver Cancer
  Tagari Samanta, Jun Hyoung Park, Benny Abraham Kaipparettu
  Cancers.2025; 17(5): 844.     CrossRef
• Global, regional, and national burden of NASH related liver cancer in adults aged 45 and above: an analysis from the GBD 2021 and forecast to 2050
  Jianing Shi, Xuan Wu, Jiali Yu, Qingli Zhou
  Frontiers in Nutrition.2025;[Epub]     CrossRef
• Large duct primary sclerosing cholangitis with or without inflammatory bowel disease in Saudi patients
  Hamdan S. AlGhamdi, Nawaf M. AlYahya, Ibrahim M. Bahabri, Majed A. Al Ashaikh, Abdulrahman K. Habib, Abdulaziz A. AlAhmary, Nuha Al Ajlan, Abdulrahman I. AlAbdulgader, Abduljaleel M. Alalwan, Faisal M. Sanai
  Saudi Journal of Gastroenterology.2025; 31(6): 356.     CrossRef
• Non-Viral Hepatocellular Carcinoma with Normal Alpha-Fetoprotein but Elevated CA19-9 in an Older Patient with Obesity: A Case Report
  Seung Hun Lee, Mi Soo Kim, Jeong Gyu Lee
  Korean Journal of Geriatrics & Gerontology.2025; 26(3): 147.     CrossRef
• Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma
  Alok Raghav, Goo Bo Jeong
  Cells.2024; 13(7): 638.     CrossRef
• Hepatitis B-related hepatocellular carcinoma: classification and prognostic model based on programmed cell death genes
  Jinyue Tian, Jiao Meng, Zhenkun Yang, Li Song, Xinyi Jiang, Jian Zou
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels
  Zhan Lin, Mei Gan, Xiangping Wang, Zhonghua Su
  Reproductive Health.2024;[Epub]     CrossRef
• Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques
  Shivani R Kale, Geeta Karande, Anand Gudur, Aishwarya Garud, Monika S Patil, Satish Patil
  Cureus.2024;[Epub]     CrossRef
• Reply to correspondence on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
  Seren M. Gedallovich, Paul Y. Kwo
  Clinical and Molecular Hepatology.2024; 30(4): 1050.     CrossRef
• The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
  Yuri Cho, Bo Hyun Kim, Joong-Won Park
  Clinical and Molecular Hepatology.2023; 29(1): 99.     CrossRef
• Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
  Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
  Clinical and Molecular Hepatology.2023; 29(2): 433.     CrossRef
• Occurrence of Liver Cancer in People without Traditional Risk Factors
  Junho Choi, Joohyun Park, Jae Kwang Lee, Kyunghee Cho
  Korean Journal of Clinical Geriatrics.2023; 24(1): 41.     CrossRef
• The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
  K. P. Divya, Parneet Hari, Navjot Kanwar, Navita Aggarwal, Preeti Singh Dhoat, Lu Liu, Abhinav Kanwal, Shailendra Pratap Singh, Jiong Yu
  Advanced Gut & Microbiome Research.2023; 2023: 1.     CrossRef
• Bursatella leachii Purple Ink Secretion Concentrate Exerts Cytotoxic Properties against Human Hepatocarcinoma Cell Line (HepG2): In Vitro and In Silico Studies
  Zeyad I. Alehaideb, Anuradha Venkatraman, Mahadev Kokane, Syed Ali Mohamed, Saranya Rameshbabu, Rasha S. Suliman, Sahar S. Alghamdi, Hamad Al-Eidi, Bandar Alghanem, Maha-Hamadien Abdulla, Sabine Matou-Nasri
  Molecules.2022; 27(3): 826.     CrossRef
• The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study
  Yuri Cho, Eun Ju Cho, Jeong-Ju Yoo, Young Chang, Goh Eun Chung, In Young Choi, Sang-Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study
  Mengmeng Song, Tong Liu, Hai Liu, Qi Zhang, Qingsong Zhang, Yiming Wang, Xiangming Ma, Liying Cao, Hanping Shi
  BMC Cancer.2022;[Epub]     CrossRef
• Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease
  Joo Hyun Oh, Je Hee Lee, Min Seok Cho, Hyeree Kim, Jongsik Chun, Joon Hyeok Lee, Yeup Yoon, Wonseok Kang
  Nutrients.2021; 13(3): 1013.     CrossRef
• Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
  Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
  Cancers.2021; 13(14): 3424.     CrossRef
• Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
  Kyung Joo Cho, Sun Yeong Shin, Hyuk Moon, Beom Kyung Kim, Simon Weonsang Ro
  Translational Oncology.2021; 14(9): 101158.     CrossRef
• Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
  Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
  International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef

Citations

Citations to this article as recorded by  

• AASLD IDSA Practice Guideline on treatment of chronic hepatitis B
  Marc G. Ghany, Calvin Q. Pan, Anna S. Lok, Jordan J. Feld, Joseph K. Lim, Su H. Wang, Arthur Y. Kim, Amy S. Tang, Mindie H. Nguyen, Susanna Naggie, Mark S. Sulkowski, Rodriguez-Baez Norberto, Jacki Chen, M. Hassan Murad, Khaled S. Mohammad, Norah A. Terra
  Hepatology.2026; 83(4): 974.     CrossRef
• Natural history of chronic hepatitis B in untreated adults without cirrhosis according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysis
  Daniela Yucuma, Arthur Rakover, Zakary Ismail Warsop, Yu Ri Im, Si Emma Chen, Rukmini Jagdish, Gibril Ndow, Maud Lemoine, Hailemichael Desalegn, Asgeir Johannessen, Hwai-I Yang, Yasuhito Tanaka, Roger Chou, Philippa Easterbrook, Yusuke Shimakawa
  The Lancet Gastroenterology & Hepatology.2026; 11(5): 380.     CrossRef
• Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: A systematic review and meta-analysis
  Jimmy Che-To Lai, Grace Lai-Hung Wong, Yee-Kit Tse, Vicki Wing-Ki Hui, Mandy Sze-Man Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
  Journal of Hepatology.2025; 82(6): 992.     CrossRef
• Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States
  Kevin Pak, Ryan Sachar, Sammy Saab
  Digestive Diseases and Sciences.2025; 70(4): 1547.     CrossRef
• Antiviral treatment response to nucleos(t)ide analogues in chronic hepatitis B patients with normal alanine aminotransferase levels: a retrospective multi-center study
  Fei Cao, Jian Wang, Ye Xiong, Ying Zhang, Xinrong Zhang, Tao Fan, Li Zhu, Shaoqiu Zhang, Zhiyi Zhang, Yifan Pan, Yuanyuan Li, Chao Jiang, Juan Xia, Yu Shi, Xiaomin Yan, Yuxin Chen, Xingxiang Liu, Chuanwu Zhu, Chao Wu, Rui Huang
  Emerging Microbes & Infections.2025;[Epub]     CrossRef
• Gray zone of hepatitis B virus infection
  Young-Suk Lim
  Saudi Journal of Gastroenterology.2024; 30(2): 76.     CrossRef
• Treatment decisions based on HBV DNA
  Young‐Suk Lim
  Journal of Viral Hepatitis.2024; 31(S2): 36.     CrossRef
• HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx
  Marc Ringelhan, Svenja Schuehle, Maarten van de Klundert, Elena Kotsiliti, Marie-Laure Plissonnier, Suzanne Faure-Dupuy, Tobias Riedl, Sebastian Lange, Karin Wisskirchen, Frank Thiele, Cho-Chin Cheng, Detian Yuan, Valentina Leone, Ronny Schmidt, Juliana H
  JHEP Reports.2024; 6(10): 101128.     CrossRef
• Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B
  Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Gwang Hyeon Choi, Won-Mook Choi, Jonggi Choi, Dong Hyun Sinn, Yong-Han Paik, Jeong-Hoon Lee, Yun Bin Lee, Ju-Yeon Cho, Nae-Yun Heo, Man-Fung Yuen, Vincent Wai-Sun Wong, Stephen L. Chan, Hwai-I Yang, Chien-Jen Chen
  Annals of Internal Medicine.2024; 177(10): 1308.     CrossRef
• Canadian Association for the Study of the Liver Single Topic Conference on Hepatitis B Virus: ‘Progress toward hepatitis B elimination in Canada’
  Julian Hercun, Golasa Samadi Kochaksaraei, Simmone D'souza, Rachel Talavlikar, Jennifer Van Gennip, Carla Osiowy, Carla S Coffin, Harley Crowshoe
  Canadian Liver Journal.2024; 7(3): 385.     CrossRef
• Management of antiviral treatment for chronic hepatitis B patients with high viral load
  Ken Lin, Su-Wen Jiang, Ai-Rong Hu
  World Chinese Journal of Digestology.2024; 32(9): 625.     CrossRef
• A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L
  Lu Zhang, Xiaoyue Bi, Xiaoxue Chen, Luxue Zhang, Qiqiu Xiong, Weihua Cao, Yanjie Lin, Liu Yang, Tingting Jiang, Wen Deng, Shiyu Wang, Shuling Wu, Ruyu Liu, Yuanjiao Gao, Ge Shen, Min Chang, Hongxiao Hao, Mengjiao Xu, Leiping Hu, Yao Lu, Minghui Li, Yao Xi
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
  Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Sang Hoon Ahn, Chai Hong Rim
  Hepatology Communications.2023; 7(2): e0011.     CrossRef
• The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
  Moon Haeng Hur, Jeong-Hoon Lee
  Clinical and Molecular Hepatology.2023; 29(2): 363.     CrossRef
• Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
  Joo Hyun Oh, Dong Hyun Sinn
  Clinical and Molecular Hepatology.2023; 29(2): 367.     CrossRef
• Research Progress on the Need for Antiviral Therapy in Chronic HBV Infected Patients with Normal ALT
  益帆 胡
  Advances in Clinical Medicine.2023; 13(04): 5360.     CrossRef
• Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
  Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
  Clinical and Molecular Hepatology.2023; 29(2): 482.     CrossRef
• Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”
  Chia-Ming Chu, Yun-Fan Liaw
  Clinical and Molecular Hepatology.2023; 29(2): 510.     CrossRef
• Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication
  Su-Wen Jiang, Xiang Lian, Ai-Rong Hu, Jia-Lin Lu, Zhe-Yun He, Xiao-Jun Shi, De-Dong Zhu, Zong-Yi Wang, Guan-Cheng Huang
  World Journal of Gastroenterology.2023; 29(16): 2479.     CrossRef
• Management of Immune-Tolerant Patients with Chronic HBV Infection
  Tai-Chung Tseng, Hung-Yao Lin, Jia-Horng Kao
  Current Hepatology Reports.2023; 22(3): 130.     CrossRef
• Global importance of new treatment strategies to efforts to control hepatitis B virus
  Carol Forbes, Louis Lavoie, Sacha Satram, Ling Shen, Vaidehi Thanawala, Andre Arizpe, Norah Terrault
  Expert Review of Anti-infective Therapy.2023; 21(8): 847.     CrossRef
• HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
  Soon Kyu Lee, Jung Hyun Kwon
  Clinical and Molecular Hepatology.2023; 29(3): 825.     CrossRef
• Chronic Hepatitis B
  Feng Su, Ira M. Jacobson
  Clinics in Liver Disease.2023; 27(4): 791.     CrossRef
• KASL clinical practice guidelines for management of chronic hepatitis B
  
  Clinical and Molecular Hepatology.2022; 28(2): 276.     CrossRef
• Early Treatment Consideration in Patients with Hepatitis B ‘e’ Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift?
  Apostolos Koffas, Lung-Yi Mak, Upkar S. Gill, Patrick T. F. Kennedy
  Viruses.2022; 14(5): 900.     CrossRef
• Genotypes Variation and Molecular Epidemiology Of The Hbv Chronic Liver Infection In The Local Population Of Pakistan: An Overview Of The Recent Literature
  Bushra Tahreem, Ghadir Ali, Haroon Ahmad, Asim Shahzad, Muhammad Khurram, Nabiha Naeem, Aquib Nazar, Muhammad Haris, Hassan ., Shahrukh .
  Pakistan BioMedical Journal.2022;[Epub]     CrossRef
• Surveillance for hepatocellular carcinoma: It is time to move forward
  Bo Hyun Kim, Yuri Cho, Joong-Won Park
  Clinical and Molecular Hepatology.2022; 28(4): 810.     CrossRef
• Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
  Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
  Clinical and Molecular Hepatology.2021; 27(2): 273.     CrossRef
• Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
  Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
  Cancers.2021; 13(14): 3424.     CrossRef

Citations

Citations to this article as recorded by  

• MRI‐Based Score to Predict Retreatment Response for Viable Hepatocellular Carcinomas After Transarterial Chemoembolization
  Weilang Wang, Xiuming Zhang, Yixing Yu, Feng Feng, Wu Cai, Shuwei Zhou, Shuhang Zhang, Binrong Li, Tianyi Xia, Shenghong Ju, Yuan‐Cheng Wang
  Liver International.2026;[Epub]     CrossRef
• Tumor growth rate for prognostic stratification and treatment optimization in unresectable hepatocellular carcinoma treated with TACE combined with systemic therapy
  Guobin Chen, Meixia Wang, Xing Huang, Zhenzhen Zhang, Yanfang Wu, Xiaochun Chen, Xinkun Guo, Susu Zheng, Tanghui Zheng, Hong Chen, Jingfang Wu, Boheng Zhang
  BMC Gastroenterology.2026;[Epub]     CrossRef
• Progress in hepatoprotective strategies during TACE treatment
  Chenlu Qian, Yan Wu, Chuan Yin, Jie Gao
  Advanced Interventional Materials.2026; 1(1): 100012.     CrossRef
• Discovery of Novel Selenocyanate Derivatives as Histone Deacetylase 6 Inhibitors for the Treatment of Hepatocellular Carcinoma
  Zeping Yang, Yuanqing Wu, Feizhi Kong, Yue Zhang, Lijun Jia, Chu Tang, Fu Wang
  Journal of Medicinal Chemistry.2026; 69(3): 2850.     CrossRef
• Hepatic immune prognostic index as a prognostic biomarker in hepatocellular carcinoma patients treated with transarterial chemoembolization
  Jing Li, Yi Ren, Guilin Zhang, Yusheng Guo, Suyue Wu, Weimin Zhao, Chuansheng Zheng, Lian Yang, Xuefeng Kan
  Therapeutic Advances in Medical Oncology.2026;[Epub]     CrossRef
• Prognostic significance of combined PCPE-1 and α-fetoprotein for hepatocellular carcinoma
  Ruhua Zhang, Wanqi Chen, Xuelan Peng, Zhiguang Zhang, Shangjiu Yang, Li Zhong
  Translational Oncology.2025; 51: 102185.     CrossRef
• Prediction of treatment response and outcome of transarterial chemoembolization in patients with hepatocellular carcinoma using artificial intelligence: A systematic review of efficacy
  Pedram Keshavarz, Nariman Nezami, Fereshteh Yazdanpanah, Maryam Khojaste-Sarakhsi, Zahra Mohammadigoldar, Mobin Azami, Azadeh Hajati, Faranak Ebrahimian Sadabad, Jason Chiang, Justin P. McWilliams, David S.K. Lu, Steven S. Raman
  European Journal of Radiology.2025; 184: 111948.     CrossRef
• Advanced targeted microsphere embolization for arteriovenous malformations: state-of-the-art and future directions
  Ali Mortezaei, Khaled M. Taghlabi, Nadir Al-Saidi, Saketh Amasa, Rachael E. Whitehead, Alex Hoang, Kurt Yaeger, Amir H. Faraji, Ramanathan Kadirvel, Sherief Ghozy
  Neuroradiology.2025; 67(4): 1009.     CrossRef
• Extrahepatic Recurrence After Surgical Resection of Hepatocellular Carcinoma Without Intrahepatic Recurrence: A Multi-Institutional Observational Study
  Ga Ram You, Shin Young Park, Su Hyeon Cho, Sung Bum Cho, Yang Seok Koh, Chang Hun Lee, Hoon Gil Jo, Sung Kyu Choi, Jae Hyun Yoon
  Cancers.2025; 17(9): 1417.     CrossRef
• Exosomal miRNA-720 as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
  Ji Min Kim, Hye Seon Kim, Jin Seoub Kim, Ji Won Han, Soon Kyu Lee, Heechul Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  The Korean Journal of Internal Medicine.2025; 40(6): 939.     CrossRef
• Outcomes of robotic liver resection and intraoperative radiofrequency ablation for hepatocellular carcinoma in posterior segments VII and VIII
  Cheng-Ming Peng, Shao-Chieh Lin, Yung-Yin Cheng, Teng-Chieh Cheng, Ching-Lung Hsieh, Chia-Hong Hsieh, Mei-Fang Hsieh, Chun-Han Liao, Ming-Cheng Liu, Yi-Jui Liu
  World Journal of Gastrointestinal Surgery.2025;[Epub]     CrossRef
• Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea
  Sojung Han, Do Young Kim, Ho Yeong Lim, Jung-Hwan Yoon, Baek-Yeol Ryoo, Yujeong Kim, Kookhee Kim, Bo Yeon Kim, So Young Yi, Dong-Sook Kim, Do-Yeon Cho, Jina Yu, Suhyun Kim, Joong-Won Park
  Gut and Liver.2024; 18(1): 116.     CrossRef
• Identification of patients with favorable prognosis after resection in intermediate-stage-hepatocellular carcinoma
  Han Ah Lee, Minjong Lee, Jeong-Ju Yoo, Ho Soo Chun, Yewan Park, Hwi Young Kim, Tae Hun Kim, Yeon Seok Seo, Dong Hyun Sinn
  International Journal of Surgery.2024; 110(2): 1008.     CrossRef
• A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
  Hae Lim Lee, Seok Hwan Kim, Hee Yeon Kim, Sung Won Lee, Myeong Jun Song
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
  Jungnam Lee, Young‐Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Jung Hwan Yu, Jin‐Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim
  Journal of Gastroenterology and Hepatology.2024; 39(9): 1924.     CrossRef
• Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma
  Ji Kim, Young Kim, Hee-Chul Nam, Chang-Wook Kim, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Ho Jong Chun, Jung Oh, Suho Kim, Sung Lee, Pil Sung
  Oncology Letters.2024;[Epub]     CrossRef
• Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study
  Ji Won Han, Won Sohn, Gwang Hyeon Choi, Jeong Won Jang, Gi Hyeon Seo, Bo Hyun Kim, Jong Young Choi
  Journal of Liver Cancer.2024; 24(2): 274.     CrossRef
• Percutaneous radiofrequency ablation for stage B1 of modified Bolondi’s subclassification for intermediate-stage hepatocellular carcinoma
  Ragaey Ahmad Eid, Ali M. Abdel Fattah, Alaa Farouk Haseeb, Ahmed Moheyeldien Hamed, Marwa Abdallah Shaker
  Egyptian Liver Journal.2024;[Epub]     CrossRef
• Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  European Journal of Internal Medicine.2023; 107: 66.     CrossRef
• The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
  Yuri Cho, Bo Hyun Kim, Joong-Won Park
  Clinical and Molecular Hepatology.2023; 29(1): 99.     CrossRef
• Barriers to palliative care in hepatocellular carcinoma: A review of the literature
  Mostafa Abasseri, Shakira Hoque, BA Slavica Kochovska, Kim Caldwell, Linda Sheahan, Amany Zekry
  Journal of Gastroenterology and Hepatology.2023; 38(7): 1047.     CrossRef
• Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada
  Jason K. Wong, Howard J. Lim, Vincent C. Tam, Kelly W. Burak, Laura A. Dawson, Prosanto Chaudhury, Robert J. Abraham, Brandon M. Meyers, Gonzalo Sapisochin, David Valenti, Setareh Samimi, Ravi Ramjeesingh, Amol Mujoomdar, Ilidio Martins, Elijah Dixon, Maj
  Cancer Treatment Reviews.2023; 115: 102526.     CrossRef
• Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
  Min Jung Kwon, Soy Chang, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
  Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
  Clinical and Molecular Hepatology.2023; 29(2): 206.     CrossRef
• Understanding the causes of recurrent HCC after liver resection and radiofrequency ablation
  Carlo Bosi, Margherita Rimini, andrea Casadei-Gardini, Giorgio Ercolani
  Expert Review of Anticancer Therapy.2023; 23(5): 503.     CrossRef
• The clinical management of hepatocellular carcinoma in China: Progress and challenges
  Shan Shan, Jidong Jia
  Clinical and Molecular Hepatology.2023; 29(2): 339.     CrossRef
• Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection
  Yue Xu, Xiaoqin Yao, Jinmei Li, Guoyuan Zhang, Guangcheng Luo, Qiang Wang
  Cancer Medicine.2023; 12(12): 13329.     CrossRef
• Comparative efficacy and safety of molecular targeted agents combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a network meta-analysis
  Jiaye Long, Baoxiang Chen, Zhaohui Liu
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
  Beom Kyung Kim, Sang Hoon Ahn
  Journal of the Formosan Medical Association.2023; 122(12): 1238.     CrossRef
• Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
  Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
  Clinical and Molecular Hepatology.2023; 29(3): 593.     CrossRef
• Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
  Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim
  Clinical and Molecular Hepatology.2023; 29(3): 763.     CrossRef
• Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance
  Sangmi Jang, Young-Joo Jin, Jin-Woo Lee, Dam Kwon, Jung Hwan Yu
  Medicine.2023; 102(32): e34637.     CrossRef
• Efficacy and safety of CalliSpheres® Microsphere transcatheter-arterial chemoembolization versus conventional TACE in treating renal angiomyolipoma patients
  Tianshi Lyu, Jian Wang, Xiaoqiang Tong, Tianai Mi, Chao An, Yinghua Zou
  Journal of Cancer Research and Therapeutics.2023; 19(4): 933.     CrossRef
• Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management
  Jessica Elderkin, Najeeb Al Hallak, Asfar S. Azmi, Hussein Aoun, Jeffrey Critchfield, Miguel Tobon, Eliza W. Beal
  Cancers.2023; 15(21): 5118.     CrossRef
• Polyamines: their significance for maintaining health and contributing to diseases
  Mengjuan Xuan, Xinyu Gu, Juan Li, Di Huang, Chen Xue, Yuting He
  Cell Communication and Signaling.2023;[Epub]     CrossRef
• Feasibility and safety of a novel indwelling catheter system via the femoral artery for intermittent transarterial therapy for treating malignant liver tumors
  Hideki Iwamoto, Satoshi Itano, Osamu Itano, Masatsugu Ishii, Takashi Niizeki, Tomotake Shirono, Shigeo Shimose, Hiroyuki Suzuki, Akira Kajiwara, Taizo Yamaguchi, Hironori Koga, Takuji Torimura
  Japanese Journal of Radiology.2022; 40(3): 326.     CrossRef
• Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study
  Beom Kyung Kim, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do Young Kim, Seong Gyu Hwang, Young Eun Chon, Hong Jae Chon
  Cancers.2022; 14(7): 1747.     CrossRef
• Effect of postoperative administration of nafamostat mesilate on posthepatectomy liver failure
  Boram Lee, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Moonhwan Kim, Yeongsoo Jo
  HPB.2022; 24(9): 1569.     CrossRef
• Is multidisciplinary treatment effective for hepatocellular carcinoma with portal vein tumor thrombus?
  Won Hyeok Choe
  Journal of Liver Cancer.2022; 22(1): 1.     CrossRef
• Association between achieving textbook outcomes and better survival after laparoscopic liver resection in the anterolateral segments in patients with hepatocellular carcinoma
  Mizelle D'Silva, Jai Young Cho, Ho‐Seong Han, Yoo‐Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim, Yeongsoo Jo
  Journal of Hepato-Biliary-Pancreatic Sciences.2022; 29(8): 855.     CrossRef
• A Case-Matched Analysis of Laparoscopic Liver Resection for Hepatocellular Carcinoma Located in Posterosuperior Segments of the Liver According to Adaption of Developed Techniques
  Yujin Kwon, Boram Lee, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Munwhan Kim, Youngsoo Jo
  Medicina.2022; 58(4): 543.     CrossRef
• Long-Term Outcomes of Laparoscopic Liver Resection for Centrally Located Hepatocellular Carcinoma
  Hyo Jun Kim, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Yeongsoo Jo, Meeyouong Kang, Yeshong Park, Eunhye Lee
  Medicina.2022; 58(6): 737.     CrossRef
• Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis
  Man Yao, Simo Cheng, Xiaofeng Zhai, Hetong Zhao, Jing Hong, Xiaoyan Li, Yongbin Meng, Wei Chen, Ye Liu
  Applied Bionics and Biomechanics.2022; 2022: 1.     CrossRef
• Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  Cancers.2022; 14(20): 5002.     CrossRef
• Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study
  Jae Hyun Yoon, Sung Kyu Choi, Sung Bum Cho, Hee Joon Kim, Yang Seok Ko, Chung Hwan Jun
  World Journal of Gastroenterology.2022; 28(36): 5351.     CrossRef
• Low-grade hepatocellular carcinoma characteristics, a practical nomogram and risk stratification system: a SEER population-based study
  Dashuai Yang, Yang Su, Fangrui Zhao, Yong Hu, Kailiang Zhao, Xiangyun Xiong, Mingqiang Zhu, Junpeng Pei, Youming Ding
  Expert Review of Gastroenterology & Hepatology.2022; 16(11-12): 1115.     CrossRef
• The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial Treatment
  Janett Fischer, Stella Wellhöner, Sebastian Ebel, Thomas Lincke, Albrecht Böhlig, Florian Gerhardt, Rhea Veelken, Holger Goessmann, Karen Geva Steinhoff, Timm Denecke, Osama Sabri, Thomas Berg, Florian van Bömmel
  Cancers.2022; 14(21): 5323.     CrossRef
• Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
  Jae Lee, Tae Lim, Hye Lee, Seung Kim, Jun Park, Do Kim, Sang Ahn, Hyun Lee, Jung Lee, Ja Kim, In Min, Beom Kim
  Diagnostics.2022; 13(1): 3.     CrossRef
• New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
  Hankil Lee, Jeong-Ju Yoo, Sang Hoon Ahn, Beom Kyung Kim
  Clinical and Translational Gastroenterology.2022; 13(12): e00542.     CrossRef
• Realization of improved outcomes following liver resection in hepatocellular carcinoma patients aged 75 years and older
  Jong Man Kim, Jinsoo Rhu, Sang Yun Ha, Gyu-Seong Choi, Choon Hyuck David Kwon, Gaabsoo Kim, Jae-Won Joh
  Annals of Surgical Treatment and Research.2021; 101(5): 257.     CrossRef
• Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
  David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
  Cancers.2021; 14(1): 67.     CrossRef
• Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
  Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
  International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
• Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study
  Beom Kyung Kim, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do Young Kim, Sung Kyu Hwang, Young Eun Chon, Hong Jae Chon
  SSRN Electronic Journal .2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic
  Hiroyuki Suzuki, Naoto Fujiwara, Amit G. Singal, Thomas F. Baumert, Raymond T. Chung, Takumi Kawaguchi, Yujin Hoshida
  Hepatology.2026; 84(1): 292.     CrossRef
• The impact of genetic and environmental risk factors on adverse liver outcomes
  Xinyuan Zhang, Longgang Zhao, Peter T. Campbell, Yun Chen, Aiping Fang, Zhenqiu Liu, Xue Li, Wanshui Yang, Jiangao Fan, Jessica L. Petrick, Katherine A. McGlynn, Michelle Lai, Xuehong Zhang
  International Journal of Cancer.2026; 158(9): 2317.     CrossRef
• Unravelling the obesity paradox in cancer: An umbrella review of protective associations and evidence credibility across 13 malignancies
  Lulin Yu, Jing Yuan, Mingxian Meng, Hejing Pan, Long Ge, Liaoyao Wang, Xuanlin Li
  Metabolism.2026; 175: 156461.     CrossRef
• Global, regional, and national burden of liver cancer attributable to high BMI, 1990-2021, with future projections to 2040
  Teng Ma, Yawen Lu, Kaiyan Liu, Na Liu, Qian Liu, Ziyuan Ding, Jianfeng Ma, Yongfeng Wang, Sheng Li
  Frontiers in Oncology.2026;[Epub]     CrossRef
• IGF-1 as a mediator in the association between body mass index and risk of liver cancer: A prospective analysis of 432,203 participants from the UK biobank
  Wenwen Yang, Zhixian Bao, Yuhua Chen, Jie Gao, Rui Ji
  Growth Hormone & IGF Research.2026; 84: 101684.     CrossRef
• Normal weight obesity and the risk of liver cancer in 0.3 million Chinese adults: a prospective multicenter cohort study
  Chun-Rui Wang, Wei-Hong Huang, Zhang-You Guo, Chen-Wei Tang, Xin Dai, Ling-Xiang Xu, Guo-Chao Zhong
  International Journal of Surgery.2026; 112(2): 3530.     CrossRef
• Large cohort studies assessing sex-specific associations between anthropometric indices and liver cancer death
  Dan-Ni Yang, Hong-Lan Li, Qiu-Ming Shen, Jing Wang, Jie Fang, Yu-Ting Tan, Zhuo-Ying Li, Yong-Bing Xiang
  JHEP Reports.2026; 8(6): 101812.     CrossRef
• Association between body mass index and major cancers with a focus on breast in South and Southeast Asia: A regional systematic review and meta-analysis
  Rokshana Parvin, Aliza K C Bhandari, Richa Shah, Mutsumi Murakami, Giulia Ollatuzzo, Paolo Boffetta, Sarah K Abe
  Asian Journal of Oncology.2026; 12: 7.     CrossRef
• Epidemiological trends and risk attribution of early-onset liver cancer: insights from the Global Burden of Disease study 2021
  Xiaofei Fan, Xin Huang, Qianqian Wu, Yajun Miao
  European Journal of Medical Research.2026;[Epub]     CrossRef
• Obesity, type 2 diabetes and cancers of the digestive system
  Simona Cernea, Dana Crişan, Cristina-Mihaela Lăcătuşu, Oana Patricia Zaharia, Sofiya Gancheva
  Seminars in Cancer Biology.2026; 121: 1.     CrossRef
• Identification of core genes mediating the association between obesity and hepatocellular carcinoma: A bioinformatics study based on mitochondrial metabolism and immune pathways
  Xiaocan Li, Rui Min, Jincheng Wang
  PLOS One.2026; 21(3): e0344452.     CrossRef
• Bidirectional Mendelian randomization analysis of the causal association between obesity and hepatocellular carcinoma in a European population
  Xiaoling Ding, Xuebing Zhou, Ning Tang, Xue Wang, Xuerong Jin, Xin Ma, Banglong Wu, Chaomeng Wu, Xia Yang, Jie Yang, Tong Wu, Qi Liang, Lijun Yin
  Medicine.2026; 105(10): e48000.     CrossRef
• Disentangling the Effect of BMI on Hepatocellular Carcinoma From Cirrhosis With Multivariable Mendelian Randomization
  Apostolos Gkatzionis, Eleanor Sanderson, George Davey Smith, Stefan Stender, Helene Gellert‐Kristensen
  Liver International.2026;[Epub]     CrossRef
• Minimally invasive vs. open hepatectomy in patients with obesity and liver tumors: a systematic review and meta-analysis
  Song Jiang, Wanjuan Li, Hongwei He, Yongchuan Huang, Wensong Liu, Qi Zheng
  Frontiers in Surgery.2026;[Epub]     CrossRef
• Global trends and thematic evolution of nursing in liver cancer: a bibliometric analysis of the web of science core collection (1944–2025)
  Yue Tian, Shun Li, Xiaoyan Zheng
  Discover Oncology.2026;[Epub]     CrossRef
• Associations between physical activity and health-related quality of life in cancer patients on active treatment
  Merve Gezen Bolukbas, Serife Vatansever, Deniz Zeynep Sonmez
  Biomedical Human Kinetics.2026; 18(1): 65.     CrossRef
• Is There an Ace Up One's Sleeve in the Preanalytical Phase of the Circulating Tumor DNA Analysis?
  Juscelino Carvalho de Azevedo Junior, Douglas Rafael da Cruz Carneiro, Fernanda Jardim da Silva, Ana Beatriz Lima Belicha, Anna Carolina Lima Rodrigues, Williams Fernandes Barra, Alessandro Leal, Danielle Queiroz Calcagno
  BioFactors.2026;[Epub]     CrossRef
• Association of ultra-processed food consumption with all-cause and cause-specific mortality: population-based cohort study
  Ya-Dong Li, Le-Lan Gong, Yuan-Bin Jiang, Qiong Qin, Fei-Qiang Ren, Sheng-Qiang Qian, Wei Tan
  Frontiers in Nutrition.2026;[Epub]     CrossRef
• Poly(3,4-ethylenedioxythiophene) Nanotube-Decorated Screen-Printed Electrodes with a Ferrocene-Derived Built-in Probe Enables Alpha-Fetoprotein Detection
  I-Chen Wang, Jayakrishnan Aerathupalathu Janardhanan, Jia-Wei She, Hsiao-hua Yu
  Langmuir.2026; 42(22): 15450.     CrossRef
• Burden, trends, and predictions of liver cancer in China, Japan, and South Korea: analysis based on the Global Burden of Disease Study 2021
  Si Yang, Yujiao Deng, Yi Zheng, Jing Zhang, Dongdong He, Zhijun Dai, Changcun Guo
  Hepatology International.2025; 19(2): 441.     CrossRef
• The impact of metabolic syndrome on hepatocellular carcinoma: a mendelian randomization study
  Chendong Yuan, Xufeng Shu, Xiaoqiang Wang, Wenzheng Chen, Xin Li, Wenguang Pei, Xujie Su, Zhenzhen Hu, Zhigang Jie
  Scientific Reports.2025;[Epub]     CrossRef
• Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
  Núria Granel, Gemma Iserte, Concepció Bartres, Neus Llarch, Anna Pla, Víctor Sapena, Zoe Mariño, Sabela Lens, Ramón Vilana, Isabel Nuñez, Anna Darnell, Ernest Belmonte, Ángeles García-Criado, Alba Díaz, Marco Sanduzzi-Zamparelli, Carla Fuster, Sergio Muño
  BMC Gastroenterology.2025;[Epub]     CrossRef
• The associations of obesity with demographic and lifestyle factors among Hong Kong adults
  Cynthia Sau Chun Yip
  Nutrition and Health.2025; 31(4): 1563.     CrossRef
• The impact of alpha-fetoprotein (AFP), child-turcotte-pugh (CTP) score and disease staging on the survival of hepatocellular carcinoma (HCC) patients: a retrospective cohort from single oncology center
  DUAA S. ALKHAYAT, NASSER MULLA, MOHAMED MOSAAD, YOUSEF KATIB, ASIM M. ALMUGHAMSI, SAMIR T. ALFOTIH, RAWAN ALAOFI
  Oncology Research.2025; 33(1): 149.     CrossRef
• The role and mechanism of selenium in the prevention and progression of hepatocellular carcinoma
  Qinying Luo, Xiaofang Bai, Xiaojiao Li, Chang Liu
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Association of BMI with mortality and health‐related quality of life among 4.4 million adults: Evidence from a nationwide, population‐based, prospective cohort study
  Yi Wu, Chunying Lin, Chunqi Wang, Runsi Wang, Bolin Jin, Xiaoyan Zhang, Bowang Chen, Yang Yang, Jianlan Cui, Wei Xu, Lijuan Song, Hao Yang, Wenyan He, Yan Zhang, Xi Li
  Diabetes, Obesity and Metabolism.2025; 27(6): 3132.     CrossRef
• Liver Cancer Etiology in Asian Subgroups and American Indian, Black, Latino, and White Populations
  Paulo S. Pinheiro, Juanjuan Zhang, Veronica Wendy Setiawan, Hannah M. Cranford, Robert J. Wong, Lihua Liu
  JAMA Network Open.2025; 8(3): e252208.     CrossRef
• The role of nutrition in cancer prevention: the effect of dietary patterns, bioactive compounds, and metabolic pathways on cancer development
  Sebastián Chapela, Julieta Locatelli, Facundo Saettone, Carla Antonella Forte, Pasqualina Memoli, Gabriela Cucalon, Florencia Ceriani, Gerardo Sarno, Luigi Coppola, Evelyn Frias-Toral
  Food and Agricultural Immunology.2025;[Epub]     CrossRef
• Vitamin D: What role in obesity-related cancer?
  Pierrick Martinez, William B. Grant
  Seminars in Cancer Biology.2025; 112: 135.     CrossRef
• Diagnosis and treatment of metabolic dysfunction-associated fatty liver disease -related hepatocellular carcinoma
  Ke-Gong Xiong, Tai-Shun Lin, Qing-Biao Lin, Jin-Feng Kong, Kun-Yu Ke
  Egyptian Liver Journal.2025;[Epub]     CrossRef
• The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021
  Jinli Liu, Tingling Xu, Yanan Wang, Fanpu Ji, Lei Zhang
  Global Health Research and Policy.2025;[Epub]     CrossRef
• Insulin resistance in cancer risk and prognosis
  Emmanuel Jacobo-Tovar, Andrea Medel-Sánchez, Cosette Durán-Castillo, Rodolfo Guardado-Mendoza
  Seminars in Cancer Biology.2025; 114: 73.     CrossRef
• The multifaceted impact of circadian disruption on cancer risk: a systematic review of insights and economic implications
  Vicente Javier Clemente-Suarez, Eduardo Navarro-Jiménez, Juan Camilo Benitez-Agudelo, Ana Isabel Beltrán-Velasco, Pedro Belinchón-deMiguel, Domingo Jesús Ramos-Campo, Carlota Valeria Villanueva-Tobaldo, Alexandra Martín-Rodríguez, Jose Francisco Tornero-A
  Journal of the National Cancer Center.2025; 5(5): 524.     CrossRef
• The impact of diabetes and social, biologic and behavioral determinants of health on liver cancer risk
  Marwa Shouman, Ayad A. Jaffa, Miran A. Jaffa
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• Comparing the trends of cancer burden attributed to high BMI in China and globally from 1990 to 2021, with multi-model prediction to 2036
  Nanting Chen, Lingzhi Xing, Fengyun Xiang, Chengmiao Li, Letai Li, Jingsong Cheng, Yangfan Yu, Yubowen Gong, Xiao Liu, Fangjiao Xie, Ling Chen
  Frontiers in Public Health.2025;[Epub]     CrossRef
• Advances in resistant starch: mechanisms, applications, and challenges in obesity management and low-fat food development
  Yangchao Ou, Ke Chen, Jie Guo, Chanjuan Ye, Xinqiao Zhou, Dagang Chen, Biansheng Li, Chuanguang Liu, Juan Liu
  International Journal of Biological Macromolecules.2025; 320: 145679.     CrossRef
• Cancer prevention and interception with antidiabetic and anti-obesity drugs: Current and future perspectives
  Adriana Albini, Anna Rita Cantelmo, Lorenzo Mortara, Douglas M. Noonan, Giovanni Corso
  Seminars in Cancer Biology.2025; 115: 40.     CrossRef
• Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review
  Mario Romeo, Fiammetta Di Nardo, Carmine Napolitano, Claudio Basile, Carlo Palma, Paolo Vaia, Marcello Dallio, Alessandro Federico
  Diabetology.2025; 6(8): 79.     CrossRef
• Synergistic impact of high body-mass index on HBV/HCV-related liver cancer burden globally: Analysis and projections 1990–2050
  Yicheng Liang, Xiaohong Lin, Min Zhang, Shuai Wang, Yuqi Dong, Zhonghao Xie, Xiaoshun He, Weiqiang Ju, Maogen Chen
  Public Health.2025; 247: 105893.     CrossRef
• Dynapenic obesity and all-Cause mortality: A systematic review and Meta-analysis of prospective cohort studies
  Amirabbas Nikkhah, Farshad Sharifi, Pouya Ebrahimi, Marjan Rahimi, Elaheh Karimi, Amirhosein Kefayat, Moloud Payab, Bagher Larijani, Mahbube Ebrahimpur
  Aging Clinical and Experimental Research.2025;[Epub]     CrossRef
• Analysis of influencing factors of concurrent primary liver cancer in hepatitis B patients and construction of column chart prediction model
  Qunmei Cao, Yilin Zhou, Changlong Wen, Qinglan Li
  Epidemiology and Infection.2025;[Epub]     CrossRef
• Temporal trends in cancer mortality attributable to high BMI in Asia: an age-period-cohort analysis based on GBD 1992–2021
  Minguang Huang, Liejiong Wang, Ying Lou, Zhaoqi Qiu, Shengjian Yu, Feng Xuan
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• Global, regional, and national epidemiology and risk factors of geriatric digestive system cancers from 1990 to 2021
  Congcong Xu, Jing Chen, Qingliang Wang, Ziyu Zheng, Chunju Fang, Hanyu Yu, Qingna Liang, Xin Wang
  Frontiers in Public Health.2025;[Epub]     CrossRef
• Assessment of Adipokine and Inflammation Biomarkers with Cancer Risk among Chinese Men: A Prospective Cohort Study
  Douglas DeMoulin, Hui Cai, Qiuyin Cai, Wei Zheng, Xiao-Ou Shu
  Cancer Epidemiology, Biomarkers & Prevention.2025; 34(11): 2104.     CrossRef
• Association of nutritional status and mortality in a population with cardiovascular disease: Predictive role of CONUT score
  Luo-Xiang Fang, Tao Yao, Peng Zheng, Zi Tao, Yuan-Nan Lin
  Obesity Research & Clinical Practice.2025; 19(6): 490.     CrossRef
• Liver cancer burden attributable to high body mass index and high fasting plasma glucose in BRICS countries (1990–2021): a Global Burden of Disease 2021 analysis with projections to 2050
  Jianya Cai, Yanhong Lan, Ying Wang, Hongwei Cheng, Shuangta Xu
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Visceral and ectopic fat are more predictively associated with primary liver cancer than overall obesity from genetic sights: A Mendelian randomization study
  Fei‐Qi Xu, Qing‐Yun Xu, Zhang‐Ji Zhu, Lei Jin, Tai‐Wei Ye, Cheng‐Fei Du, Zhen‐Yu Gao, Xiao‐Kun Huang, Zhe Zhang, Li‐Ming Jin, Wei‐Feng Yao
  International Journal of Cancer.2024; 154(3): 530.     CrossRef
• Association between hypertension grades and cancer mortality among Japanese men and women
  Tsubasa Tanabe, Masayuki Teramoto, Kokoro Shirai, Akiko Tamakoshi, Hiroyasu Iso
  Cancer Causes & Control.2024; 35(3): 497.     CrossRef
• Association of systemic inflammation with the obesity paradox in cancer: results from multi-cohort studies
  Hailun Xie, Lishuang Wei, Heyang Zhang, Guotian Ruan, Xiaoyue Liu, Shiqi Lin, Jinyu Shi, Chenan Liu, Xin Zheng, Yue Chen, Hanping Shi
  Inflammation Research.2024; 73(2): 243.     CrossRef
• The Growing Landscape of NAFLD-Associated Hepatocellular Carcinoma and Its Impact in Surveillance
  Mariana Verdelho Machado
  GE - Portuguese Journal of Gastroenterology.2024; 31(1): 14.     CrossRef
• Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data
  Yimo Qu, Xiaocheng Gong, Ziyuan Zhao, Zimei Zhang, Qian Zhang, Yuting Huang, Qingsong Xie, Yunfei Liu, Jinfen Wei, Hongli Du
  International Journal of Molecular Sciences.2024; 25(2): 919.     CrossRef
• Identification of phenomic data in the pathogenesis of cancers of the gastrointestinal (GI) tract in the UK biobank
  Shirin Hui Tan, Catherina Anak Guan, Mohamad Adam Bujang, Wei Hong Lai, Pei Jye Voon, Edmund Ui Hang Sim
  Scientific Reports.2024;[Epub]     CrossRef
• Obesity and Cancer Rehabilitation for Functional Recovery and Quality of Life in Breast Cancer Survivors: A Comprehensive Review
  Lorenzo Lippi, Alessandro de Sire, Arianna Folli, Alessio Turco, Stefano Moalli, Marco Marcasciano, Antonio Ammendolia, Marco Invernizzi
  Cancers.2024; 16(3): 521.     CrossRef
• Insulin Resistance: The Increased Risk of Cancers
  Leszek Szablewski
  Current Oncology.2024; 31(2): 998.     CrossRef
• Obesity- and lipid-related indices as a predictor of type 2 diabetes in a national cohort study
  Ying Wang, Xiaoyun Zhang, Yuqing Li, Jiaofeng Gui, Yujin Mei, Xue Yang, Haiyang Liu, Lei-lei Guo, Jinlong Li, Yunxiao Lei, Xiaoping Li, Lu Sun, Liu Yang, Ting Yuan, Congzhi Wang, Dongmei Zhang, Jing Li, Mingming Liu, Ying Hua, Lin Zhang
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• RETRACTED: Effect of body mass index on the wound infection and complications in patients with liver cancer: A meta‐analysis
  Yan‐Ping Li, Zhuo Gan, Bing Shi
  International Wound Journal.2024;[Epub]     CrossRef
• Anthropometric indicators may explain the high incidence of follicular lymphoma in Europeans: Results from a bidirectional two-sample two-step Mendelian randomisation
  Yanqun Zhou, Xiongfeng Zhang, Xiaozhen Li, Guoqing Zhu, Tianqi Gao, Yingying Deng, Liming Huang, Zenghui Liu
  Gene.2024; 911: 148320.     CrossRef
• Lifestyle factors, glycemic traits, and lipoprotein traits and risk of liver cancer: a Mendelian randomization analysis
  Honglu Zhang, Jiyong Liu
  Scientific Reports.2024;[Epub]     CrossRef
• Combined effects of smoking and alcohol consumption on the risk of liver cancer according to metabolic syndrome: A nested case–control study in South Korea
  Thi Tra Bui, Eunjung Park, Hee‐Yeon Kang, Jin‐Kyoung Oh
  International Journal of Cancer.2024; 155(4): 654.     CrossRef
• Role of body mass index and weight change in the risk of cancer: A systematic review and meta-analysis of 66 cohort studies
  Xiaoye Shi, Gengwen Deng, Haiteng Wen, Anqi Lin, Haitao Wang, Lingxuan Zhu, Weiming Mou, Zaoqu Liu, Xiaohua Li, Jian Zhang, Quan Cheng, Peng Luo
  Journal of Global Health.2024;[Epub]     CrossRef
• Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
  Andrew Scott deLemos, Jing Zhao, Milin Patel, Banks Kooken, Karan Mathur, Hieu Minh Nguyen, Areej Mazhar, Maggie McCarter, Heather Burney, Carla Kettler, Naga Chalasani, Samer Gawrieh
  World Journal of Hepatology.2024; 16(3): 393.     CrossRef
• Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma
  Takahiro Kodama, Tetsuo Takehara
  Seminars in Liver Disease.2024; 44(02): 147.     CrossRef
• Separating the effects of early and later life body mass index on liver diseases: A Mendelian randomization study
  Feixiang Zhou, Xia Liu, Canyan Chang, Jing Liu, Simin He, Yan Yan
  Clinics and Research in Hepatology and Gastroenterology.2024; 48(6): 102352.     CrossRef
• WITHDRAWN: Unveiling the Protective Role of Metabolic and Bariatric Surgery Against Primary Liver Cancer in Obesity - A Nationwide French Administrative Data Study.
  Andrea CHIERICI, Fanny FOUR, Julie BULSEI, Eric FONTAS, Antonio IANNELLI
  Surgery for Obesity and Related Diseases.2024;[Epub]     CrossRef
• Association between human blood metabolome and the risk of gastrointestinal tumors
  Jiamin Lu, Yuqian Feng, Kaibo Guo, Leitao Sun, Shanming Ruan, Kai Zhang, Catherine Mounier
  PLOS ONE.2024; 19(5): e0304574.     CrossRef
• Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma
  Elena Piccinin, Maria Arconzo, Emanuela Pasculli, Angela Fulvia Tricase, Silvia Cultrera, Justine Bertrand-Michel, Nicolas Loiseau, Gaetano Villani, Hervé Guillou, Antonio Moschetta
  Cell & Bioscience.2024;[Epub]     CrossRef
• Advantages and Limitations of the Body Mass Index (BMI) to Assess Adult Obesity
  Yilun Wu, Dan Li, Sten H. Vermund
  International Journal of Environmental Research and Public Health.2024; 21(6): 757.     CrossRef
• Transcriptome analysis suggests broad jejunal alterations in Linghu’s obesity-diarrhea syndrome: A pilot study
  Xiao-Tong Niu, Xiang-Yao Wang, Yan Wang, Ke Han, Nan Ru, Jing-Yuan Xiang, En-Qiang Linghu
  World Journal of Gastroenterology.2024; 30(21): 2777.     CrossRef
• Phospholipid Acyltransferases: Characterization and Involvement of the Enzymes in Metabolic and Cancer Diseases
  Jan Korbecki, Mateusz Bosiacki, Maciej Pilarczyk, Magdalena Gąssowska-Dobrowolska, Paweł Jarmużek, Izabela Szućko-Kociuba, Justyna Kulik-Sajewicz, Dariusz Chlubek, Irena Baranowska-Bosiacka
  Cancers.2024; 16(11): 2115.     CrossRef
• Association between obesity and cancer risk in adults with HIV in Korea
  Yoonyoung Jang, Taehwa Kim, Yunsu Choi, Kyoung Hwan Ahn, Jung Ho Kim, Hye Seong, Youn Jeong Kim, Shin-Woo Kim, Jun Yong Choi, Hyo Youl Kim, Joon Young Song, Hee Jung Choi, Sang Il. Kim, Jang Wook Sohn, BumSik Chin, Bo-Youl Choi, Boyoung Park
  AIDS.2024; 38(9): 1386.     CrossRef
• Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients
  Maria Eva Argenziano, Mi Na Kim, Michele Montori, Alessandro Di Bucchianico, Daniele Balducci, Sang Hoon Ahn, Gianluca Svegliati Baroni
  Hepatology International.2024; 18(S2): 922.     CrossRef
• High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis Model
  Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai, Toshihide Maeda, Takao Miwa, Masaya Kubota, Kenji Imai, Takashi Ibuka, Masahito Shimizu
  Nutrients.2024; 16(15): 2506.     CrossRef
• Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia
  Cátia C. Ramos, José Pires, Esperanza Gonzalez, Clara Garcia-Vallicrosa, Celso A. Reis, Juan M. Falcon-Perez, Daniela Freitas
  Extracellular Vesicles and Circulating Nucleic Acids.2024; 5(3): 471.     CrossRef
• Association between obesity and liver cancer from 2012 to 2023: Bibliometric analysis and global trends
  Donghong Wang, Zhibin Ma
  Medicine.2024; 103(31): e39167.     CrossRef
• Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies
  Fouad Jaber, George Cholankeril, Hashem B El-Serag
  Journal of the Canadian Association of Gastroenterology.2024; 7(5): 331.     CrossRef
• Impact of exercise on cancer: mechanistic perspectives and new insights
  Ye Feng, Xingting Feng, Renwen Wan, Zhiwen Luo, Lijun Qu, Qing Wang
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Long-Term Effect of Temperature Increase on Liver Cancer in Australia: A Bayesian Spatial Analysis
  Ting Gan, Hilary Bambrick, Yumin Li, Kristie L. Ebi, Wenbiao Hu
  Environmental Health Perspectives.2024;[Epub]     CrossRef
• Ovothiol-A Mitigates High-Fat Diet-Induced Non-alcoholic Fatty Liver Disease in Rats
  Nada Hussien Arafa, Mohamed Refaat Shehata, Ayman Saber Mohamed
  Current Bioactive Compounds.2024;[Epub]     CrossRef
• Utilization of Microfluidic Droplet-Based Methods in Diagnosis and Treatment Methods of Hepatocellular Carcinoma: A Review
  Akvilė Zajanckauskaite, Miah Lingelbach, Dovilė Juozapaitė, Algirdas Utkus, Greta Rukšnaitytė, Goda Jonuškienė, Aistė Gulla
  Genes.2024; 15(10): 1242.     CrossRef
• The Role of Dietary Ingredients and Herbs in the Prevention of Non-Communicable Chronic Liver Disease
  Monika Maćków, Tomasz Dziubyna, Tatiana Jamer, Dmytro Slivinskyi, Tomasz Pytrus, Katarzyna Neubauer, Małgorzata Zwolińska-Wcisło, Andrzej Stawarski, Ewa Piotrowska, Dorian Nowacki
  Nutrients.2024; 16(20): 3505.     CrossRef
• Neighborhood-level deprivation mediates racial and ethnic disparities in HCC diagnosis in Texas
  Itunu O. Sokale, Aaron P. Thrift, Hashem B. El-Serag, Abiodun O. Oluyomi
  Hepatology Communications.2024;[Epub]     CrossRef
• Benefits of laparoscopic liver resection for liver tumors in obese patients: a meta-analysis
  Jie Zhang, Cuifang Zeng, Rui Chen, Gang Tang, Rongxing Zhou
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data
  Qianqian Guo, Xiaorong Zhu, Narasimha M. Beeraka, Ruiwen Zhao, Siting Li, Fengying Li, Padukudru Anand Mahesh, Vladimir N. Nikolenko, Ruitai Fan, Junqi Liu
  Scientific Reports.2024;[Epub]     CrossRef
• Research progress on natural products against hepatocellular carcinoma
  LINGLI ZHANG, YAN LI, JINGXIN MAO
  BIOCELL.2024; 48(6): 905.     CrossRef
• Statin use is associated with better post‐operative prognosis among patients with hepatitis B virus‐related hepatocellular carcinoma
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
  European Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Updated epidemiology of gastrointestinal cancers in East Asia
  Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong
  Nature Reviews Gastroenterology & Hepatology.2023; 20(5): 271.     CrossRef
• Why Are Obese People Predisposed to Severe Disease in Viral Respiratory Infections?
  Rafia Aziz, Afak Yusuf Sherwani, Saeed Al Mahri, Shuja Shafi Malik, Sameer Mohammad
  Obesities.2023; 3(1): 46.     CrossRef
• The higher body mass index is associated with a lower somatic mutation dependency in hepatocellular carcinoma
  Nazanin Hosseinkhan, Zahra Narimani, Nastaran Masoudi-Khoram, Mohammad E. Khamseh
  Informatics in Medicine Unlocked.2023; 37: 101187.     CrossRef
• Body Mass Index and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies
  Junhao Chen, Kaimin Ke, Zhenghuan Liu, Luchen Yang, Linchun Wang, Jing Zhou, Qiang Dong
  Nutrition and Cancer.2023; 75(4): 1051.     CrossRef
• Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysis
  Lun-Jie Yan, Long-Shan Yang, Yu-Chuan Yan, Si-Yu Tan, Zi-Niu Ding, Hui Liu, Dong-Xu Wang, Zhao-Ru Dong, Tao Li
  European Journal of Cancer.2023; 185: 150.     CrossRef
• Body mass index and serum alpha-fetoprotein level associated with PD1 expression and prognosis in patients with hepatocellular carcinoma
  Lili Yang, Jili Wang, Linpeng Yao, Cheng Chen, Junhan Pan, Ling Peng, Feng Chen
  Heliyon.2023; 9(4): e14460.     CrossRef
• Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
  Yi-wen Shi, Jian-Gao Fan
  Clinical and Molecular Hepatology.2023; 29(Suppl): S228.     CrossRef
• Can type 1 diabetes be an unexpected complication of obesity?
  Paulina Oboza, Natalia Ogarek, Magdalena Olszanecka-Glinianowicz, Piotr Kocelak
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Understanding the causes of recurrent HCC after liver resection and radiofrequency ablation
  Carlo Bosi, Margherita Rimini, andrea Casadei-Gardini, Giorgio Ercolani
  Expert Review of Anticancer Therapy.2023; 23(5): 503.     CrossRef
• Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
  Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
  Clinical and Molecular Hepatology.2023; 29(2): 433.     CrossRef
• Occurrence of Liver Cancer in People without Traditional Risk Factors
  Junho Choi, Joohyun Park, Jae Kwang Lee, Kyunghee Cho
  Korean Journal of Clinical Geriatrics.2023; 24(1): 41.     CrossRef
• Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease
  Ik Hyun Jo, Do Seon Song, U Im Chang, Jin Mo Yang
  Scientific Reports.2023;[Epub]     CrossRef
• Body composition and risk of liver cancer: a population-based prospective cohort study on gender difference
  Sainan Pi, Anran Liu, Beibei Zhu, Yunxiao Zhu, Jinqiu Yuan, Zheming Zhang, Chang Gao, Jinxian Fu, Yao Liu, Xujing Liang, Bin Xia, Youpeng Chen
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
  Beom Kyung Kim, Sang Hoon Ahn
  Journal of the Formosan Medical Association.2023; 122(12): 1238.     CrossRef
• Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes
  Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari
  Cancer Reports.2023;[Epub]     CrossRef
• Physiological and environmental factors affecting cancer risk and prognosis in obesity
  Paul F. Seke Etet, Lorella Vecchio, Armel H. Nwabo Kamdje, Patrice N. Mimche, Alfred K. Njamnshi, Abdu Adem
  Seminars in Cancer Biology.2023; 94: 50.     CrossRef
• Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
  Byeong Geun Song, Sung Chul Choi, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik
  JHEP Reports.2023; 5(9): 100810.     CrossRef
• Regional and sex differences in the mortality risk associated with primary liver cancer in obesity: A systematic review and meta-analysis
  Long-Shan Yang, Lun-Jie Yan, Yu-Chuan Yan, Zi-Niu Ding, Hui Liu, Si-Yu Tan, Zhao-Ru Dong, Dong-Xu Wang, Tao Li
  Nutrition.2023; 113: 112097.     CrossRef
• Adipose distribution patterns as prognostic factors in patients with HCC: A systematic review and meta-analysis
  Shuo Shi, Haiyan Yi, Yi Zheng, Yuxuan Zhao, Dexin Yu
  European Journal of Radiology.2023; 167: 111025.     CrossRef
• Impacto de la cirugía bariátrica en la incidencia de diferentes cánceres. Revisión narrativa
  Santiago Otero Parra, Juliana Pineda Ortega, Jorge Sebastián Ramírez Valbuena, William Alberto Otero Regino
  Revista colombiana de Gastroenterología.2023; 38(3): 321.     CrossRef
• Latin American and the Caribbean Code Against Cancer 1st edition: Weight, physical activity, diet, breastfeeding, and cancer
  Tania C. Aburto, Isabelle Romieu, Mariana C. Stern, Simón Barquera, Camila Corvalán, Pedro C. Hallal, Luz M. Reynales-Shigematsu, Joaquín Barnoya, Tania M. Cavalcante, Carlos Canelo-Aybar, Marilina Santero, Ariadna Feliu, Carolina Espina, Juan A. Rivera
  Cancer Epidemiology.2023; 86: 102436.     CrossRef
• Clinical significance of serum oxidative stress and serum uric acid levels before surgery for hepatitis B-related liver cancer
  Jin-Xia Hou, Yu-Bin Wang, Jing Wu, Guo-sheng Ding, Yang Wu, Lian-Hua Wei, Fang Wang, Zhe-Mei Zhang
  World Journal of Gastrointestinal Surgery.2023; 15(9): 1995.     CrossRef
• Cancers attributable to overweight and obesity in Italy
  Matteo Di Maso, Claudio Pelucchi, Giulia Collatuzzo, Gianfranco Alicandro, Matteo Malvezzi, Fabio Parazzini, Eva Negri, Paolo Boffetta, Carlo La Vecchia, Federica Turati
  Cancer Epidemiology.2023; 87: 102468.     CrossRef
• Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After Hepatectomy
  Shuo Shi, Yu-Xuan Zhao, Jin-Lei Fan, Ling-Yu Chang, De-Xin Yu
  Academic Radiology.2023; 30(12): 2940.     CrossRef
• Life‐course adiposity and severe liver disease: a Mendelian randomization analysis
  Xinyu Wang, Zhiyu Wu, Jun Lv, Canqing Yu, Dianjianyi Sun, Pei Pei, Ling Yang, Iona Y. Millwood, Robin Walters, Yiping Chen, Huaidong Du, Mingqiang Yuan, Dan Schmidt, Maxim Barnard, Junshi Chen, Zhengming Chen, Liming Li, Yuanjie Pang
  Obesity.2023; 31(12): 3077.     CrossRef
• Non-alcoholic fatty liver disease and the risk of malignant tumors
  M. A. Livzan, M. I. Syrovenko, T. S. Krolevets
  Meditsinskiy sovet = Medical Council.2023; (18): 75.     CrossRef
• Association between pro-inflammatory diet and liver cancer risk: a systematic review and meta-analysis
  Kaixia Chen, Fen Yang, Xinhong Zhu, Guiyuan Qiao, Chunmei Zhang, Junxiu Tao, Xiaolian Gao, Mingzhong Xiao
  Public Health Nutrition.2023; 26(12): 2780.     CrossRef
• Life-long consumption of high level of fruits and vegetables reduces tumor incidence and extends median lifespan in mice
  Weimin Guo, Edwin F. Ortega, Dayong Wu, Lijun Li, Roderick T. Bronson, Sarah K. Boehm, Simin Nikbin Meydani
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis
  Boqin Wang, Rong Pu
  World Journal of Surgical Oncology.2023;[Epub]     CrossRef
• Modeling the Risk of Liver Cancer in Adults: A Machine Learning Investigation into the Role of Obesity and Overweight
  Karamo Bah, Adama Ns Bah, Amadou Wurry Jallow
  Archives of Pathology and Clinical Research.2023; 7(1): 034.     CrossRef
• Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
  Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  American Journal of Gastroenterology.2022; 117(2): 288.     CrossRef
• NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options
  Friedrich Foerster, Simon Johannes Gairing, Lukas Müller, Peter Robert Galle
  Journal of Hepatology.2022; 76(2): 446.     CrossRef
• Changes in general and central fatness are associated with hepatocellular carcinoma: A Korean nationwide longitudinal study
  Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Seong Gyu Hwang
  International Journal of Cancer.2022; 150(10): 1587.     CrossRef
• Stratifying individuals into non-alcoholic fatty liver disease risk levels using time series machine learning models
  Ofir Ben-Assuli, Arie Jacobi, Orit Goldman, Shani Shenhar-Tsarfaty, Ori Rogowski, David Zeltser, Itzhak Shapira, Shlomo Berliner, Shira Zelber-Sagi
  Journal of Biomedical Informatics.2022; 126: 103986.     CrossRef
• Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer
  Lei Wang, Liping Liang, Shuzhen Shi, Chao Wang, Fahd Abd Algalil
  Applied Bionics and Biomechanics.2022; 2022: 1.     CrossRef
• Insulin and cancer: a tangled web
  Brooks P. Leitner, Stephan Siebel, Ngozi D. Akingbesote, Xinyi Zhang, Rachel J. Perry
  Biochemical Journal.2022; 479(5): 583.     CrossRef
• Effects of image-guided adaptive radiotherapy combined with hepatic artery chemoembolization in primary liver cancer patients
  Yingchun Zhao, Changwang Zhang, Yongqian Zhang, Changwen Bo, Yonghui An, Na Li, Wenhua Ma, Changpeng Zou, Liping Zhao, Sujing Zhang
  Clinics and Research in Hepatology and Gastroenterology.2022; 46(5): 101889.     CrossRef
• Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis
  Zijun Yan, Kun Yang, Xiang Tang, Yunfeng Bi, Yuzhen Ding, Mengyue Deng, Die Xia, Yunqi Zhao, Tong Chen, Fu Wang
  Journal of Immunology Research.2022; 2022: 1.     CrossRef
• Risk factors of liver malignancies in workers chronically exposed to ionizing radiation
  Galina V. Zhuntova, Mariya V. Bannikova, Tamara V. Azizova
  Ekologiya cheloveka (Human Ecology).2022; 29(5): 333.     CrossRef
• Exercise in cancer prevention and anticancer therapy: Efficacy, molecular mechanisms and clinical information
  Chuanmei Zhu, Hongbo Ma, Anqi He, Yi Li, Chengqi He, Yong Xia
  Cancer Letters.2022; 544: 215814.     CrossRef
• Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
  Pil Soo Sung
  Clinical and Molecular Hepatology.2022; 28(3): 333.     CrossRef
• The timing of adiposity and changes in the life course on the risk of cancer
  Zhe Fang, Edward L. Giovannucci
  Cancer and Metastasis Reviews.2022; 41(3): 471.     CrossRef
• Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study
  Mengmeng Song, Tong Liu, Hai Liu, Qi Zhang, Qingsong Zhang, Yiming Wang, Xiangming Ma, Liying Cao, Hanping Shi
  BMC Cancer.2022;[Epub]     CrossRef
• Response to Liao et al.
  Byungyoon Yun, Jin-Ha Yoon, Beom Kyung Kim
  American Journal of Gastroenterology.2022; 117(10): 1718.     CrossRef
• Current cancer burden in China: epidemiology, etiology, and prevention
  Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng, Wanqing Chen
  Cancer Biology & Medicine.2022; 19(8): 1121.     CrossRef
• Metabolic syndrome, obesity and cancer risk
  Federico Belladelli, Francesco Montorsi, Alberto Martini
  Current Opinion in Urology.2022; 32(6): 594.     CrossRef
• Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  Cancers.2022; 14(20): 5002.     CrossRef
• Gender Dimorphism in Hepatic Carcinogenesis-Related Gene Expression Associated with Obesity as a Low-Grade Chronic Inflammatory Disease
  Andrea G. Izquierdo, Marcos C. Carreira, Gemma Rodriguez-Carnero, Raquel Perez-Lois, Luisa M. Seoane, Felipe F. Casanueva, Ana B. Crujeiras
  International Journal of Molecular Sciences.2022; 23(23): 15002.     CrossRef
• UEG position paper: Obesity and digestive health
  Patrizia Burra, Marianna Arvanitakis, Jorge Amil Dias, Michael Bretthauer, Ana Dugic, Daniel Hartmann, Patrick Michl, Thomas Seufferlein, Joana Torres, Hans Törnblom, Monique E. van Leerdam, Shira Zelber‐Sagi, Andreea Botos
  United European Gastroenterology Journal.2022; 10(10): 1199.     CrossRef
• Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
  Jae Lee, Tae Lim, Hye Lee, Seung Kim, Jun Park, Do Kim, Sang Ahn, Hyun Lee, Jung Lee, Ja Kim, In Min, Beom Kim
  Diagnostics.2022; 13(1): 3.     CrossRef
• Obesity as a Risk Factor for Different Cancers: Systematic Review
  Abdelrahman Mohamed Ahmed Abukanna, Ziyad Mubarak S Alanazi, Amer Meshal H Alanazi, Atheer Humaidy S Alenazi, Abdulrahman Obaid A Alanazi, Khaloud Attaulla Alenezi, Gharam Mahmood Alsalmi
  Clinical Cancer Investigation Journal.2022; 11(6): 45.     CrossRef
• Obesity as a Risk Factor for Various Cancers: A Systematic Review
  Abdelrahman Mohamed Ahmed Abukanna, Ziyad Mubarak S Alanazi, Amer Meshal H Alanazi, Atheer Humaidy S Alenazi, Abdulrahman Obaid A Alanazi, Khaloud Attaulla Alenezi, Gharam Mahmood Alsalmi
  Asian journal of Current Research in Clinical Cancer.2022; 2(2): 6.     CrossRef
• Metabolic disease as a risk of hepatocellular carcinoma
  Naoshi Nishida
  Clinical and Molecular Hepatology.2021; 27(1): 87.     CrossRef
• Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma
  De-Chen Yu, Xiang-Yi Chen, Xin Li, Hai-Yu Zhou, De-Quan Yu, Xiao-Lei Yu, Yi-Cun Hu, Rui-Hao Zhang, Xiao-Bo Zhang, Kun Zhang, Jiang-Dong An
  Scientific Reports.2021;[Epub]     CrossRef
• Obesity as a risk factor for diseases of the digestive system
  Dmitry N. Andreev, Yury A. Kucheryavyy
  Terapevticheskii arkhiv.2021; 93(8): 954.     CrossRef
• Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
  Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
  International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
• Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
  Shira Zelber-Sagi, Mazen Noureddin, Oren Shibolet
  Cancers.2021; 14(1): 103.     CrossRef

Citations

Citations to this article as recorded by  

• Multimodal evidence for the association between muscle mass and NAFLD: insights from hospital-based data, NHANES and mendelian randomization
  Weidong Xie, Sen Li, Shaoliang Han
  Frontiers in Genetics.2026;[Epub]     CrossRef
• Low skeletal muscle density is a risk factor for constipation in patients on maintenance dialysis
  Mengting Li, Qing Yin, Shimei Hou, Lirong Hao, Jianbing Hao, Liuping Zhang, Wei He, Qinglei Xie
  Frontiers in Physiology.2025;[Epub]     CrossRef
• Serum Myostatin among Excessive Drinkers
  Candelaria Martín-González, Onán Pérez-Hernández, Alen García-Rodríguez, Pedro Abreu-González, Paula Ortega-Toledo, Camino María Fernández-Rodríguez, Julio César Alvisa-Negrín, Antonio Martínez-Riera, Emilio González-Reimers
  International Journal of Molecular Sciences.2023; 24(3): 2981.     CrossRef
• Association between Regional Body Muscle Mass and Non-Alcoholic Fatty Liver Disease: An Observational Study Using Data from the REACTION Study
  Jing Du, Shizhan Ma, Li Fang, Meng Zhao, Zhongshang Yuan, Yiping Cheng, Jiajun Zhao, Xiude Fan, Qingling Guo, Zhongming Wu
  Journal of Personalized Medicine.2023; 13(2): 209.     CrossRef
• Interaction between sarcopenia and nonalcoholic fatty liver disease
  Sae Kyung Joo, Won Kim
  Clinical and Molecular Hepatology.2023; 29(Suppl): S68.     CrossRef
• Lack of association between serum myonectin levels and sarcopenia in older Asian adults
  Sunghwan Ji, So Jeong Park, Jin Young Lee, Ji Yeon Baek, Hee-Won Jung, Kyunggon Kim, Hyun Ju Yoo, Il-Young Jang, Beom-Jun Kim
  Experimental Gerontology.2023; 178: 112229.     CrossRef
• Computed tomography‐determined skeletal muscle density predicts 3‐year mortality in initial‐dialysis patients in China
  Ming‐jie Sheng, Jing‐yuan Cao, Shi‐mei Hou, Min Li, Yao Wang, Qiang Fang, A‐feng Miao, Min Yang, Shu‐su Liu, Chun‐hong Hu, Cui‐lan Liu, Shi‐yuan Wang, Jing Zheng, Jing‐jie Xiao, Xiao‐liang Zhang, Hong Liu, Bi‐cheng Liu, Bin Wang
  Journal of Cachexia, Sarcopenia and Muscle.2023; 14(6): 2569.     CrossRef
• Regulator 1-Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Signaling Pathway in Investigating the Pathological Characteristics and Molecular Mechanism of Liver Cirrhosis Complicated by Acute Kidney Injury
  Jieqi Gong, Huanhua Lu
  Journal of Biomaterials and Tissue Engineering.2022; 12(1): 112.     CrossRef
• Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
  Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song
  Clinical and Molecular Hepatology.2022; 28(2): 219.     CrossRef
• Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
  Takumi Kawaguchi, Takuji Torimura
  Clinical and Molecular Hepatology.2022; 28(2): 177.     CrossRef
• Viral eradication by direct-acting antivirals does not decrease the serum myostatin level in patients infected with hepatitis C virus
  Kei Endo, Takuro Sato, Yuichi Yoshida, Keisuke Kakisaka, Akio Miyasaka, Yasuhiro Takikawa
  Nutrition.2022; 101: 111699.     CrossRef
• Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
  Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman
  Journal of Cellular Biochemistry.2022; 123(10): 1553.     CrossRef
• Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
  Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
  Cancers.2021; 13(14): 3424.     CrossRef

Citations

Citations to this article as recorded by  

• Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: Molecular mechanisms and therapeutic implications
  Jayanta Das, Bhupen Barman, Phulen Sarma, Bipul Kumar Das, Rajiv Chetia, Partha Pratim Kalita
  Biochemistry and Biophysics Reports.2026; 45: 102403.     CrossRef
• Therapeutic potential of diosgenin in hepatocellular carcinoma through molecular mechanisms and nanodelivery strategies
  Charmi Jyotishi, Mansi Patel, Suresh Prajapati, Reeshu Gupta
  Discover Oncology.2026;[Epub]     CrossRef
• Long noncoding RNA H19 in liver development and disease
  Diego Elias Montoya-Durango, Leila Gobejishvili
  Cellular Signalling.2026; 142: 112413.     CrossRef
• FAM216A Promotes Hepatocellular Carcinoma Proliferation and Invasion through the PLK1/ERK Signaling Pathway
  Peng Ma, Ying Hao, Yuefeng Zhang, Weiguo Tang, Wei Wang, Zuo Muo, Kaihuan Yu, Weixing Wang
  Genetic Testing and Molecular Biomarkers.2026; 30(3): 55.     CrossRef
• Deciphering the signaling landscape of YAP in the tumor microenvironment—Insights into hepatocellular carcinoma progression
  Prachi Sharma, Shaikh Maryam Ghufran, Bornika Roy, Sampa Ghose, Subhrajit Biswas
  FEBS Letters.2026; 600(7): 1006.     CrossRef
• The Regulation and Function of Hippo/YAP Pathway in Cancer
  Chinmoy Ghosh, Ruchi Kakar, Seline Torkamboor, Yue Sun
  The FASEB Journal.2026;[Epub]     CrossRef
• Targeted Therapy and Immunotherapies in Hepatocellular Carcinoma: Mechanisms and Clinical Studies
  Penghui He, Sinan Xie, Kunlin Xie, Fengwei Gao, Yunshi Cai, Yan Huang, Chang Liu, Hong Wu, Yinghao Lyu, Tian Lan
  MedComm.2026;[Epub]     CrossRef
• LINC01184 promotes hepatocellular carcinoma development via the miR-193a-3p/DCAF7 axis
  Bing Wang, Xun Zou, Yuanchu Xiao
  Archives of Biochemistry and Biophysics.2026; 781: 110821.     CrossRef
• Unveiling the Intricate Dance: Signaling Pathways in Liver Cancer Metabolism and Immunity
  Yichi Xu, Bo Wen, Dai Zhang, Fangxin Tang, Shu Liu
  Current Oncology Reports.2026;[Epub]     CrossRef
• LATS kinase activity and tumor suppressor function are regulated by a second autophosphorylation site
  Ruxin Jin, Zhenxing Zhong, Rui Zhu, Anlan Zhang, Jian Li, Fa-Xing Yu, Yu Wang
  Journal of Biological Chemistry.2026; 302(7): 113177.     CrossRef
• Comparative Analysis of Classical and Emerging Experimental Animal Models of Liver Injury: A Comprehensive Review
  Ibtehal Nasser Salman, Roaa Khaled Jabbar, Israa Emad, Zain Al‐Abidin Ahmed Hassan, Abeer Mahdi Harbi, Aseel Yass Khudhair, Malak Ali Mohammed Hussein, Ali Majid Hamid, Mahdi Abd Al Amir, Mustafa Wafi Ali, Mohamed M. Khalifa
  Journal of Applied Toxicology.2026;[Epub]     CrossRef
• Machine learning-driven evaluation of protein kinase D3 as a co-diagnostic biomarker in hepatocellular carcinoma
  Jing Li, Yifan Zhao, Yicheng Ma, Bei Xie, Li Huang, Haitang Yang, Xingyuan Ma, Haohua Deng, Shuaiyang Wang, Chanjuan Sun, Pengfei Cao, Linjing Li
  Journal of Zhejiang University-SCIENCE B.2026;[Epub]     CrossRef
• Integrative analysis of exosomal ncRNAs and their regulatory networks in liver cancer progression
  Farzin Mirzaei-nasab, Ahmad Majd, Yousef Seyedena, Nazanin Hosseinkhan, Najma Farahani, Mehrdad Hashemi
  Practical Laboratory Medicine.2025; 45: e00464.     CrossRef
• Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications
  Mohamed J. Saadh, Hanan Hassan Ahmed, Radhwan Abdul Kareem, Ashok Kumar Bishoyi, R. Roopashree, Debasish Shit, Renu Arya, Abhishek Sharma, Kakhramon Khaitov, Hayder Naji Sameer, Ahmed Yaseen, Zainab H. Athab, Mohaned Adil
  Molecular Biology Reports.2025;[Epub]     CrossRef
• CXCR7 promoted proliferation, migration and invasion in HCC Cells by inactivating Hippo-YAP signaling
  Genwang Wang, Yu Pang, Nan Li, Yongfeng Hui, Dong Jin
  Discover Oncology.2025;[Epub]     CrossRef
• Wogonin potentiates the irradiation effect on hepatocellular carcinoma by activating the Hippo-Yes-associated protein/transcriptional co-activator with PDZ-binding motif pathway
  Xiao Xu, Yan Cheng, Zeyu Yang, Yong Yin, Yonghong Qian, Haiyu Yang, Shusheng Zhu, Hu Tian, Yanshuang Zhuang, Shimin Zhu, Pingjin Yang, Songbing Qin, Weigan Shen
  International Immunopharmacology.2025; 157: 114740.     CrossRef
• Schottky barrier in pea-like Au@Bi2S3 nanoreactor enabling efficient photodynamic therapy of hepatocellular carcinoma
  Liangsong Tao, Rongrong Gu, Junfa Yang, Jiewei Wang, Tiling Wu, Xianyue Rao, Hao Wang, Cheng Qian, Jian Liu, Sheng Ye, Tao Xu
  Materials Today Bio.2025; 33: 102001.     CrossRef
• COPB2 promotes hepatocellular carcinoma progression through regulation of YAP1 nuclear translocation
  BIAO WU, XIANLIN GUO, ZHISHI WU, LIANG CHEN, SUQING ZHANG
  Oncology Research.2025; 33(4): 975.     CrossRef
• DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery
  Wei Lan, Haibo Liao, Qingfeng Chen, Lingzhi Zhu, Yi Pan, Yi-Ping Phoebe Chen
  Briefings in Bioinformatics.2024;[Epub]     CrossRef
• Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments—An Overview
  Raluca-Margit Szilveszter, Mara Muntean, Adrian Florea
  Biomolecules.2024; 14(6): 656.     CrossRef
• The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation
  Mengjia Lin, Xiaoyun Zheng, Jianing Yan, Fei Huang, Yilin Chen, Ran Ding, Jinkai Wan, Lei Zhang, Chenliang Wang, Jinchang Pan, Xiaolei Cao, Kaiyi Fu, Yan Lou, Xin-Hua Feng, Junfang Ji, Bin Zhao, Fei Lan, Li Shen, Xianglei He, Yunqing Qiu, Jianping Jin
  Nature Communications.2024;[Epub]     CrossRef
• Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer
  Manasi Kotulkar, Diego Paine-Cabrera, Udayan Apte
  Seminars in Liver Disease.2024; 44(03): 383.     CrossRef
• Targeting the Hippo/YAP1 signaling pathway in hepatocellular carcinoma: From mechanisms to therapeutic drugs (Review)
  Shenghao Li, Liyuan Hao, Na Li, Xiaoyu Hu, Huimin Yan, Erhei Dai, Xinli Shi
  International Journal of Oncology.2024;[Epub]     CrossRef
• Genomic landscape of hepatocellular carcinoma in Egyptian patients by whole exome sequencing
  Perihan Hamdy Kassem, Iman Fawzy Montasser, Ramy Mohamed Mahmoud, Rasha Ahmed Ghorab, Dina A. AbdelHakam, Marium EL Sayed Ahmad Fathi, Marwa A. Abdel Wahed, Khaled Mohey, Mariam Ibrahim, Mohamed El Hadidi, Yasmine M. Masssoud, Manar Salah, Arwa Abugable,
  BMC Medical Genomics.2024;[Epub]     CrossRef
• Targeting the Hippo- Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Signaling Pathway in Primary Liver Cancer Therapy
  Yina Wang, Liangyou Rui
  Onco.2024; 4(3): 217.     CrossRef
• M6A modification-mediated LIMA1 promotes the progression of hepatocellular carcinoma through the wnt-βcatenin/Hippo pathway
  Chao Zhang, Xiaoxiao Wang, Huangqin Song, Junlong Yuan, Xiaomin Zhang, Yiran Yuan, Zhuangqiang Wang, Zhang Lei, Jiefeng He
  Cell Biology and Toxicology.2024;[Epub]     CrossRef
• Hepatitis C virus nonstructural protein 4B induces lipogenesis via the Hippo pathway
  Chen Zou, Hongxi Tan, Jun Zeng, Minqi Liu, Guangping Zhang, Yi Zheng, Zhanfeng Zhang
  Archives of Virology.2023;[Epub]     CrossRef
• Crosstalk between miRNAs and DNA Methylation in Cancer
  Michela Saviana, Patricia Le, Lavender Micalo, Daniel Del Valle-Morales, Giulia Romano, Mario Acunzo, Howard Li, Patrick Nana-Sinkam
  Genes.2023; 14(5): 1075.     CrossRef
• MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way
  Shiji Fang, Liyun Zheng, Xiaoxiao Chen, Xiaoju Guo, Yiming Ding, Ji Ma, Jiayi Ding, Weiqian Chen, Yang Yang, Minjiang Chen, Zhongwei Zhao, Jianfei Tu, Jiansong Ji
  Hepatology International.2023; 17(6): 1500.     CrossRef
• Maternal-Periconceptional Vitamin B12 Deficiency in Wistar Rats Leads to Sex-Specific Programming for Cardiometabolic Disease Risk in the Next Generation
  Praveen Singh, Lovejeet Kaur, Subhoshree Ghose, Swati Varshney, Vislavath Jyothi, Sourav Ghosh, Pujitha Kommineni, Shamsudheen KV, Vinod Scaria, Sridhar Sivasubbu, Giriraj Ratan Chandak, Shantanu Sengupta
  The Journal of Nutrition.2023; 153(12): 3382.     CrossRef
• The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP
  Zelin Tian, Chen Xu, Weixiang He, Zhibin Lin, Wenjie Zhang, Kaishan Tao, Rui Ding, Xuan Zhang, Kefeng Dou
  Cancer Letters.2023; 577: 216439.     CrossRef
• Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment
  Noor N. Al-Bzour, Ayah N. Al-Bzour, Obada E. Ababneh, Moayad M. Al-Jezawi, Azhar Saeed, Anwaar Saeed
  International Journal of Molecular Sciences.2023; 24(22): 16505.     CrossRef
• Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
  Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  American Journal of Gastroenterology.2022; 117(2): 288.     CrossRef
• TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome
  Maryam Naghib, Ashraf Kariminik, Mohammad Kazemi Arababadi
  Viral Immunology.2022; 35(1): 15.     CrossRef
• CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity
  Yan Fu, Hongfei Ci, Wei Du, Qiongzhu Dong, Huliang Jia
  Pharmaceutics.2022; 14(2): 275.     CrossRef
• Construction and Comprehensive Analysis of a circRNA-miRNA-mRNA Regulatory Network to Reveal the Pathogenesis of Hepatocellular Carcinoma
  Meile Mo, Bihu Liu, Yihuan Luo, Jennifer Hui Juan Tan, Xi Zeng, Xiaoyun Zeng, Dongping Huang, Changhua Li, Shun Liu, Xiaoqiang Qiu
  Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
• External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
  Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Cancers.2022; 14(3): 711.     CrossRef
• Parafibromin Is Highly Expressed in Hepatocellular Carcinoma and Its Expression Correlates with Poor Prognosis
  Min-Kyung Kim
  Journal of Clinical Medicine.2022; 11(7): 1773.     CrossRef
• CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
  Zibo Chen, Tao Yuan, Fangjie Yan, Song Ye, Qin Xie, Bo Zhang, Nengmin Lin, Qiaojun He, Bo Yang, Hong Zhu
  BMC Cancer.2022;[Epub]     CrossRef
• Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors
  Hyunjung Park, Hyerin Park, Jiyeon Baek, Hyuk Moon, Simon Weonsang Ro
  Biology.2022; 11(4): 585.     CrossRef
• Hippo in Gastric Cancer: From Signalling to Therapy
  Lornella Seeneevassen, Pierre Dubus, Caroline Gronnier, Christine Varon
  Cancers.2022; 14(9): 2282.     CrossRef
• Intrahepatic inflammatory IgA+PD-L1high monocytes in hepatocellular carcinoma development and immunotherapy
  Pil Soo Sung, Dong Jun Park, Pu Reun Roh, Kyoung Do Mun, Sung Woo Cho, Gil Won Lee, Eun Sun Jung, Sung Hak Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Jonghwan Choi, Jaegyoon Ahn, Seung Kew Yoon
  Journal for ImmunoTherapy of Cancer.2022; 10(5): e003618.     CrossRef
• MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight
  Luis M. Ruiz-Manriquez, Oscar Carrasco-Morales, E. Adrian Sanchez Z, Sofía Madeline Osorio-Perez, Carolina Estrada-Meza, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul
  Frontiers in Genetics.2022;[Epub]     CrossRef
• Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
  Geofrey Mahiki Mranda, Zhi-Ping Xiang, Jun-Jian Liu, Tian Wei, Yinlu Ding
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data
  Lianghe Yu, Ningjia Shen, Yan Shi, Xintong Shi, Xiaohui Fu, Shuang Li, Bin Zhu, Wenlong Yu, Yongjie Zhang
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Molecular Classification of Hepatocellular Carcinoma Using Wnt–Hippo Signaling Pathway-Related Genes
  Ya-Sian Chang, Yu-Pao Chou, Chin-Chun Chung, Ya-Ting Lee, Ju-Chen Yen, Long-Bin Jeng, Jan-Gowth Chang
  Cancers.2022; 14(19): 4580.     CrossRef
• Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis
  Ran Cheng, Xiaoyuan Xu
  Journal of Hepatocellular Carcinoma.2022; Volume 9: 987.     CrossRef
• Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p
  Samer A. Tadros, Yasmin M. Attia, Nadine W. Maurice, Sally A. Fahim, Fatma M. Abdelwahed, Samar Ibrahim, Osama A. Badary
  International Journal of Molecular Sciences.2022; 23(24): 15904.     CrossRef
• Ring finger protein 128 promotes, rather than inhibits, colorectal cancer progression by regulating the Hippo signaling pathway
  Shili Ning, Yuzhuo Chen, Guangzhi Wang, Yongtai Liu, Yingchi Yang, Zhongtao Zhang
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
  Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
  Journal of Viral Hepatitis.2021; 28(11): 1570.     CrossRef
• Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
  Kyung Joo Cho, Sun Yeong Shin, Hyuk Moon, Beom Kyung Kim, Simon Weonsang Ro
  Translational Oncology.2021; 14(9): 101158.     CrossRef
• The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
  Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
• Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy
  Ishfaq Hassan Mir, Shreyoshi Guha, Jajnasenee Behera, Chinnasamy Thirunavukkarasu
  Cell Biology International.2021; 45(11): 2161.     CrossRef
• Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches
  Zahra Farzaneh, Massoud Vosough, Tarun Agarwal, Maryam Farzaneh
  Cancer Cell International.2021;[Epub]     CrossRef
• FAT1 and PTPN14 Regulate the Malignant Progression and Chemotherapy Resistance of Esophageal Cancer through the Hippo Signaling Pathway
  Yingzhi Lu, Zhenxin Wang, Ling Zhou, Zhaoming Ma, Jianguo Zhang, Yan Wu, Yan Shao, Yunyun Yang, Lubna H. Tahtamouni
  Analytical Cellular Pathology.2021; 2021: 1.     CrossRef
• External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
  Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
• The Hippo Pathway: A Master Regulatory Network Important in Cancer
  Qiuping Liu, Xiaomeng Liu, Guanbin Song
  Cells.2021; 10(6): 1416.     CrossRef
• MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer
  Na-Hyun Lee, So Jung Kim, Jeongeun Hyun
  Biomedicines.2021; 9(4): 347.     CrossRef
• Yes‑associated protein expression is associated with poor prognosis in patients with colorectal cancer
  Liyu Cao, Cong Zhang, Qingqing Wu, Zhenzhen Bai, Jing Chen
  Oncology Letters.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis
  Isabella R. Buonopane, Erick F. Saldanha, Júnior Samuel Alonso de Menezes, Lucas Diniz da Conceição, Camila Mariana de Paiva Reis, Luís Felipe Leite, Thiago Francischetto, Renata D’Alpino Peixoto, Tiago Biachi de Castria
  British Journal of Cancer.2026; 134(5): 699.     CrossRef
• Recurrence risk prediction model for hepatitis B virus-associated hepatocellular carcinoma patients: a systematic review and meta-analysis
  Ke-Hao Zhao, Jiajun Liu, Yun-Shan Chen, Wen-Ting Yi, Juan-Juan Liu, Ying Zeng
  Frontiers in Oncology.2026;[Epub]     CrossRef
• Cone-beam computed tomography-guided precise chemoembolization for hypovascular hepatocellular carcinoma
  Chengzi Sun, Jiahui Zhou
  Vojnosanitetski pregled.2026; 83(5): 273.     CrossRef
• Reappraising the T category in hepatocellular carcinoma: Prognostic impact of the type and extent of vascular invasion
  Shigeaki Kurihara, Hiroji Shinkawa, Ryota Tanaka, Sadaaki Nishimura, Jun Tauchi, Genki Watanabe, Masahiko Kinoshita, Kohei Nishio, Kenjiro Kimura, Takeaki Ishizawa
  Surgery.2026; 197: 110403.     CrossRef
• IL‑6/STAT3 signaling pathway‑mediated apoptosis induced by medical ozone water in liver cancer: A mechanistic study
  Shixiang Qiu, Chao Chen, Zihang Zhang, Ningjun Yu, Jingang Huang, Dan Deng, Liming Zhong
  Biomedical Reports.2026; 25(2): 1.     CrossRef
• Prognostic nomogram based on coagulation for individualized prediction after radical resection of hepatocellular carcinoma
  Ming Lu, Haibo Yuan, Mengjie Wu, Heng Li, Congyin Tu, Kongwang Hu
  European Journal of Medical Research.2025;[Epub]     CrossRef
• Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model
  Yi-Fan Li, Lan-Qing Yao, Chao Li, Hong Ren, Jin-Bo Gong, Han Wu, Li-Hui Gu, Ying-Jian Liang, Yu-Ze Yang, Kong-Ying Lin, Zi-Qiang Li, Qi-Xuan Zheng, Ting-Hao Chen, Ya-Hao Zhou, Hong Wang, Hong-Wei Guo, Jia-Hao Xu, Zhong Chen, Feng Shen, Ming-Da Wang, Tian
  Annals of Surgical Oncology.2025; 32(6): 4396.     CrossRef
• Magnetic resonance elastography as a preoperative assessment for predicting intrahepatic recurrence in patients with hepatocellular carcinoma
  Jeong Hyun Lee, Jeong Ah Hwang, Kyowon Gu, Jaeseung Shin, Seungchul Han, Young Kon Kim
  Magnetic Resonance Imaging.2024; 109: 127.     CrossRef
• Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma
  Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Myung Ji Goh, Wonseok Kang, Seung Up Kim
  European Journal of Gastroenterology & Hepatology.2023; 35(2): 191.     CrossRef
• Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy
  Yang Lu, Shuang Ren, Jianning Jiang
  BMC Surgery.2023;[Epub]     CrossRef
• Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
  Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
  Clinical and Molecular Hepatology.2023; 29(3): 593.     CrossRef
• Diagnosis of primary clear cell carcinoma of the liver based on Faster region-based convolutional neural network
  Bin Liu, Jianfei Li, Xue Yang, Feng Chen, Yanyan Zhang, Hongjun Li
  Chinese Medical Journal.2023; 136(22): 2706.     CrossRef
• Ketogenic Diets and Hepatocellular Carcinoma
  Yan Lan, Chaonan Jin, Pavitra Kumar, Xia Yu, Cameron Lenahan, Jifang Sheng
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Prognostic significance of combined α-fetoprotein and CA19-9 for hepatocellular carcinoma after hepatectomy
  Jie Zhang, Shang Dong Qin, Yan Li, Fei Lu, Wen Feng Gong, Jian Hong Zhong, Liang Ma, Jing Fei Zhao, Guo Hua Zhan, Peng Zhan Li, Bin Song, Bang De Xiang
  World Journal of Surgical Oncology.2022;[Epub]     CrossRef
• Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant
  Pil Soo Sung, Ji Won Han, Changho Seo, Joseph Ahn, Soon Kyu Lee, Hee Chul Nam, Ho Joong Choi, Young Kyoung You, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
  Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
  International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
• Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
  Chao-Wei Lee, Sey-En Lin, Ming-Chin Yu, Hao-Wei Kou, Cheng-Han Lee, Tony Kuo, Kuan-Chieh Lee, Hsin-I Tsai
  Journal of Personalized Medicine.2021; 11(11): 1078.     CrossRef
• Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
  Soon Kyu Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
  International Journal of Molecular Sciences.2021; 22(19): 10271.     CrossRef

Citations

Citations to this article as recorded by  

• Entinostat suppresses hepatocellular carcinoma metastasis by upregulating AZGP1 through histone acetylation
  Weiguo Cai, Xinru Pei, Xiaodie Ye, Yan Zhai, Na Wu, Ziyi Wang, Wei Lu
  Biochemical Pharmacology.2026; 246: 117718.     CrossRef
• Patatin‐Like Phospholipase Domain Containing 3 I148M Variant Affects Hepatocellular Carcinoma Recurrence After Liver Resection
  Yuki Nakayama, Kazuki Takeishi, Shinji Itoh, Takashi Motomura, Takeo Toshima, Kyohei Yugawa, Takahiro Tomiyama, Yuriko Tsutsui, Katsuya Toshida, Takuma Ishikawa, Junya Mita, Takeshi Kurihara, Alejandro Soto‐Gutierrez, Tomoharu Yoshizumi
  Liver International.2026;[Epub]     CrossRef
• Imperatorin: A Furanocoumarin with Potential in Combating Cancer Development and Progression—A Comprehensive Review
  Victória Dogani Rodrigues, Cláudia Rucco Penteado Detregiachi, Manuela dos Santos Bueno, Luíza Santos de Argollo Haber, Rachel Gomes Eleutério, Eliana de Souza Bastos Mazuqueli Pereira, Virgínia Maria Cavallari Strozze Catharin, Lidiane Indiani, Vitor Cav
  Pharmaceuticals.2026; 19(3): 436.     CrossRef
• Prognostic value of nutritional-inflammatory markers in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis
  Zhihong Chen, Han Zheng, Yunhan Mao, Zhenrong Chen, Peijia He, Yiyao Xu, Xin Lu
  International Journal of Surgery.2026; 112(3): 8271.     CrossRef
• Deciphering the role of SIRT6 in suppressing the AMPK-mTOR-TFEB axis: regulation of autophagy activation in HCC
  Cong Shan Li, Hua Jin, Ruoyu Meng, Seung-Woo Baek, Seong-Hun Kim, Ok Hee Chai, Byung Hyun Park, Ju-Seog Lee, Na Ri Lee, Soo Mi Kim
  Cancer Gene Therapy.2026; 33(4): 440.     CrossRef
• High Expression of Follistatin is a Risk Factor Predicting Poor Overall Survival in Hepatocellular Carcinoma Patients
  Yihua Dai, Baoying Pan, Jiali Zhao, Shanglin Cai, Jian Li, Baojia Zou
  Journal of Hepatocellular Carcinoma.2026; Volume 13: 1.     CrossRef
• Lenvatinib combined with immune checkpoint inhibitors for unresectable, recurrent, or metastatic hepatocellular carcinoma: a real-world study
  Huifang Kong, Yan Chen, Hong Li, Di Wang, Xiujuan Chang, Zhen Zeng, Wei Zhang
  The Oncologist.2026;[Epub]     CrossRef
• Navigating early recurrences in post-hepatectomy hepatocellular carcinoma: Preventive strategies and prognostic indicators
  Mizelle D'Silva, Gurudutt Varty, Shraddha Patkar, Tanvi Shah, Prem Kamal Patnala, Sunil Vishwanathan, Kunal Gala, Vikas Ostwal, Rahul Krishnatry, Mahesh Goel
  Surgical Oncology.2026; 66: 102438.     CrossRef
• Correspondence to editorial on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography”
  Dong Ho Lee
  Clinical and Molecular Hepatology.2026; 32(2): e221.     CrossRef
• Dynamic changes in magnetic resonance imaging (MRI) features improve sensitivity for diagnosing small recurrent hepatocellular carcinoma after resection
  J. Chen, X. Chen, W. Wang, W. Sun, S. Dong, G. Yang, M. Zeng, S. Rao
  Clinical Radiology.2026; 98: 107382.     CrossRef
• Beyond VEGF: AEG-1/MTDH as a Systems-Level Orchestrator of Angiogenesis in Hepatocellular Carcinoma
  Rabha M. Younis, Kayla A. Rodriguez, Devanand Sarkar
  Cells.2026; 15(13): 1214.     CrossRef
• Cure after surgery for hepato-pancreato-biliary cancers: A systematic review
  Marianna Maspero, Carlo Sposito, Vincenzo Mazzaferro, Giorgio Ercolani, Alessandro Cucchetti
  Digestive and Liver Disease.2025; 57(1): 1.     CrossRef
• What Is the Optimal Locoregional Approach for Recurrent Hepatocellular Carcinoma?
  Neil B. Newman, Colin M. Court, Alexander A. Parikh
  Journal of Clinical Oncology.2025; 43(9): 1050.     CrossRef
• Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review
  Edoardogregorio Galli, Giorgio Patelli, Federica Villa, Nicole Gri, Chiara Mazzarelli, Iacopo Mangoni, Cristiano Sgrazzutti, Silvia Ghezzi, Andrea Sartore-Bianchi, Luca Saverio Belli, Luciano De Carlis, Angelo Vanzulli, Salvatore Siena, Katia Bencardino
  Cancer Treatment Reviews.2025; 135: 102908.     CrossRef
• Extrahepatic Recurrence After Surgical Resection of Hepatocellular Carcinoma Without Intrahepatic Recurrence: A Multi-Institutional Observational Study
  Ga Ram You, Shin Young Park, Su Hyeon Cho, Sung Bum Cho, Yang Seok Koh, Chang Hun Lee, Hoon Gil Jo, Sung Kyu Choi, Jae Hyun Yoon
  Cancers.2025; 17(9): 1417.     CrossRef
• Mesenchymal circulating tumor cells as prognostic markers in HCC Post-Transplantation: Sirolimus as a potential therapeutic Modulator
  Jinyan Chen, Rongsen Wang, Huigang Li, Jiancai Sun, Ruijie Zhao, Jianyong Zhuo, Zuyuan Lin, Chiyu He, Xingzhu Chen, Jun Li, Leyi Chen, Xudong Yang, Xuyong Wei, Shusen Zheng, Xiao Xu, Di Lu
  European Journal of Surgical Oncology.2025; 51(9): 110147.     CrossRef
• Predictors of long-term survival outcomes of patients with hepatocellular carcinoma without recurrence at five years after liver resection
  Cheng-Ying Hsieh, Chee-Chien Yong, Yueh-Wei Liu, Wei-Feng Li, Chih-Chi Wang, Yi-Hao Yen, Chih-Yun Lin
  Langenbeck's Archives of Surgery.2025;[Epub]     CrossRef
• Landscape of T-cell exhaustion heterogeneity and HBV integration in virus-related HCC revealed by whole-exome, transcriptome, and single-cell sequencing
  Soon Kyu Lee, Jinyeong Lim, Joo Yeon Jhun, Jeonghyeon Moon, Hye Seon Kim, Jong Young Choi, Ho Joong Choi, Young Kyoung You, Ji Won Han, Pil Soo Sung, Kwon Yong Tak, Seung Kew Yoon, Woong-Yang Park, Mi-La Cho, Jeong Won Jang
  JHEP Reports.2025; 7(11): 101518.     CrossRef
• Targeting STAT3 by erianin to overcome sorafenib resistance in hepatocellular carcinoma: Integrated network pharmacology with molecular docking, dynamics simulations, and in vitro validation
  Zixian Liu, Ruoning Qian, Yuanchao Feng, Ruogu Qi, Zhengguang Zhang, Fuqiong Zhou
  Biochemical and Biophysical Research Communications.2025; 778: 152348.     CrossRef
• Relative survival among cancer survivors enrolled in private cancer insurance in Japan, using the internal insurance-enrolled population as the reference
  Makoto Hiraoka, Hayaka Uekusa, Akira Okada, Reiko Inoue, Kayo Ikeda-Kurakawa, Yusuke Otsuka, Daisuke Namiki, Ryuichi Yamamoto, Toshimasa Yamauchi, Masaomi Nangaku, Kazuhiko Ohe, Satoko Yamaguchi, Takashi Kadowaki
  International Journal of Clinical Oncology.2025; 30(11): 2178.     CrossRef
• Machine Learning‐Based Model for Predicting Recurrence‐Free Survival After Interventional Therapy in Malnourished Hepatocellular Carcinoma Patients
  Ningning Lu, Chunwang Yuan, Bin Sun, Xiongwei Cui, Wenfeng Gao, Yonghong Zhang
  Cancer Medicine.2025;[Epub]     CrossRef
• Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization and hepatic artery infusion chemotherapy in patients with BCLC stage 0-B hepatocellular carcinoma at high risk of recurrence following radical resection
  Xu Feng, Yupei Ao, Jiarui Liu, Jue Yuan, Zhengrong Shi, Chengjia Tang
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Efficacy of postoperative adjuvant hepatic artery infusion chemotherapy for hepatocellular carcinoma in microvascular invasion: a propensity-matched score
  Xu Feng, Xinhua Wu, Kai Chen, Yupei Ao, Zhengrong Shi, Yixuan Gong
  Frontiers in Surgery.2025;[Epub]     CrossRef
• Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography
  Dong Wook Kim, Won Chang, So Yeon Kim, Young-Suk Lim, Jonggi Choi, Jungheum Cho, Jin-Wook Kim, Jai Young Cho, Sun Kyung Jeon, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Kyung-Suk Suh, Kwang-Woong Lee, Dong Ho Lee
  Clinical and Molecular Hepatology.2025; 31(4): 1285.     CrossRef
• Microvascular Invasion in Hepatocellular Carcinoma (Hcc): Implications and Strategy
  Andrea Celotti, M. Bonafede, G. Baiocchi, M. Tomasoni, F. Petrelli, M. Bonomi, G. Grizzi
  Current Surgery Reports.2025;[Epub]     CrossRef
• Current Immunotherapy Strategies and Emerging Biomarkers for the Treatment of Hepatocellular Carcinoma
  Audrey Kapelanski-Lamoureux, Anthoula Lazaris, Nicholas Meti, Peter Metrakos
  Cancers.2025; 17(23): 3870.     CrossRef
• The therapeutic efficacy of radical resection for hepatocellular carcinoma varies markedly by tumor location: a retrospective real-world study
  Xu Feng, Yi-Qiu Wei, Jia-Rui Liu, Zheng-Rong Shi, Kai Chen, Yong-Shuang Lv
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Serum Tumor Necrosis Factor-alpha Concentration and its Prognostic Implication in Hepatocellular Carcinoma
  Vembi Rizky Fatmawati, Ulfa Kholili, Husin Thamrin, Ricky Indra Alfaray
  Biomolecular and Health Science Journal.2025; 8(2): 105.     CrossRef
• Comparative effectiveness of several adjuvant therapies for patients with hepatocellular carcinoma with high-risk factors for recurrence after hepatectomy: a systematic review and meta-analysis
  Zejin Zhao, Haizhao Yi, Yue Xiao, Zhiyan Li, Jinlong Liu
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma
  Jiaqi Wang, Chuchu Ma, Zhongyuan Tang, Zhengwu Sun, Eskandar Qaed, Xinming Chi, Jun Wang, Yazeed Jamalat, Zhaohong Geng, Zeyao Tang, Qiying Yao
  Cancer Cell International.2024;[Epub]     CrossRef
• Machine learning-based model for predicting tumor recurrence after interventional therapy in HBV-related hepatocellular carcinoma patients with low preoperative platelet-albumin-bilirubin score
  Qi Wang, Shugui Sheng, Yiqi Xiong, Ming Han, Ronghua Jin, Caixia Hu
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Smoking as a Risk Factor for Very Late Recurrence in Surgically Resected Early-Stage Primary Hepatocellular Carcinoma
  Wei-Ru Cho, Chih-Chi Wang, Mu-Jung Tsai, Chih-Che Lin, Yi-Hao Yen, Chien Hung Chen, Yuan-Hung Kuo, Chih-Chien Yao, Chao-Hung Hung, Pao-Yuan Huang, An-Che Liu, Ming-Chao Tsai
  Clinical Medicine Insights: Oncology.2024;[Epub]     CrossRef
• Tubuloside B, a major constituent of Cistanche deserticola, inhibits migration of hepatocellular carcinoma by inhibiting Hippo-YAP pathway
  Jie Yao, Haoqiang Wan, Jingmei Zhang, Wanying Shen, Xiaofang Wei, Chenyan Shi, Baoru Ou, Dongyu Liu, Lanlan Ge, Jia Fei, Xiaobin Zeng
  Phytomedicine.2024; 129: 155552.     CrossRef
• Magnetic resonance elastography as a preoperative assessment for predicting intrahepatic recurrence in patients with hepatocellular carcinoma
  Jeong Hyun Lee, Jeong Ah Hwang, Kyowon Gu, Jaeseung Shin, Seungchul Han, Young Kon Kim
  Magnetic Resonance Imaging.2024; 109: 127.     CrossRef
• Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis
  Yuhua Wen, Lianghe Lu, Jie Mei, Yihong Ling, Renguo Guan, Wenping Lin, Wei Wei, Rongping Guo
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 665.     CrossRef
• Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges
  Abdullah Jabri, Jibran Khan, Bader Taftafa, Mohamed Alsharif, Abdulaziz Mhannayeh, Raja Chinnappan, Alaa Alzhrani, Shadab Kazmi, Mohammad Shabab Mir, Aljohara Waleed Alsaud, Ahmed Yaqinuddin, Abdullah M. Assiri, Khaled AlKattan, Yogesh K. Vashist, Dieter
  Bioengineering.2024; 11(4): 346.     CrossRef
• Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment
  Hyun Joo Lee, Moon Seok Choi, Byeong Geun Song, Won Seok Kang, Geum Youn Gwak, Myung Ji Goh, Yong Han Paik, Joon Hyeok Lee, Dong Hyun Sinn
  Cancers.2024; 16(15): 2652.     CrossRef
• TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma
  Dongbo Qiu, Tiantian Wang, Yi Xiong, Kun Li, Xiusheng Qiu, Yuan Feng, Qinghai Lian, Yunfei Qin, Kunpeng Liu, Qi Zhang, Changchang Jia
  Oncogenesis.2024;[Epub]     CrossRef
• Stage dependent microbial dynamics in hepatocellular carcinoma and adjacent normal liver tissues
  Hee Eun Jo, Sophallika Khom, Sumi Lee, Su Hyeon Cho, Shin Young Park, Ga Ram You, Hyosin Kim, Nah Ihm Kim, Jae-Ho Jeong, Jae Hyun Yoon, Misun Yun
  Scientific Reports.2024;[Epub]     CrossRef
• Combining transarterial chemoembolization, radiofrequency ablation, and iodine-125 seed implantation for recurrent hepatocellular carcinoma post-hepatectomy
  Yong Zhong, Li Wang, Weibin Dan, Dan Liang
  Diagnostic and Interventional Radiology.2024;[Epub]     CrossRef
• Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  European Journal of Internal Medicine.2023; 107: 66.     CrossRef
• Statin use is associated with better post‐operative prognosis among patients with hepatitis B virus‐related hepatocellular carcinoma
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
  European Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma
  Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng, Ying-Tang Gao
  World Journal of Gastrointestinal Oncology.2023; 15(1): 1.     CrossRef
• Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
  Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
  Clinical and Molecular Hepatology.2023; 29(1): 173.     CrossRef
• Abbreviated MRI for Secondary Surveillance of Recurrent Hepatocellular Carcinoma After Presumed Curative Treatment
  Sun Kyung Jeon, Dong Ho Lee, Bo‐Yun Hur, Sae‐Jin Park, Se Woo Kim, Junghoan Park, Kyung‐Suk Suh, Kwang‐Woong Lee, Nam‐Joon Yi, Joon Koo Han
  Journal of Magnetic Resonance Imaging.2023; 58(5): 1375.     CrossRef
• The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes
  Asanda Koza, Ricky H. Bhogal, Nicos Fotiadis, Vasileios K. Mavroeidis
  Biomedicines.2023; 11(4): 1062.     CrossRef
• Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma
  Xu Feng, Guo-Ying Feng, Jie Tao, Yu-Pei Ao, Xin-Hua Wu, Shi-Guai Qi, Zheng-Rong Shi
  Journal of Cancer Research and Clinical Oncology.2023; 149(12): 10505.     CrossRef
• Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging
  Yoon Jung Hwang, Jae Seok Bae, Youngeun Lee, Bo Yun Hur, Dong Ho Lee, Haeryoung Kim
  Clinical and Molecular Hepatology.2023; 29(3): 733.     CrossRef
• Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA
  Shushan Zhang, Yongquan Huang, Songying Pi, Hui Chen, Feile Ye, Chaoqun Wu, Liujun Li, Qing Ye, Yuhong Lin, Zhongzhen Su
  Journal of Nanobiotechnology.2023;[Epub]     CrossRef
• Inflammation-related prognostic markers in resected hepatocellular carcinoma
  Fabio Giannone, Nevena Slovic, Patrick Pessaux, Catherine Schuster, Thomas F. Baumert, Joachim Lupberger
  Frontiers in Oncology.2023;[Epub]     CrossRef
• A Real-World Comparative Study of Microwave and Radiofrequency Ablation in Treatment-Naïve and Recurrent Hepatocellular Carcinoma
  Soon Kyu Lee, Dong Jin Chung, Se Hyun Cho
  Journal of Clinical Medicine.2022; 11(2): 302.     CrossRef
• External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
  Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Cancers.2022; 14(3): 711.     CrossRef
• Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo
  Xiaoyun Ma, Meile Mo, Chao Tan, Jennifer Hui Juan Tan, Huishen Huang, Bihu Liu, Dongping Huang, Shun Liu, Xiaoyun Zeng, Xiaoqiang Qiu
  Journal of Translational Medicine.2022;[Epub]     CrossRef
• MicroRNA miR-124-3p suppresses proliferation and epithelial–mesenchymal transition of hepatocellular carcinoma via ARRDC1 (arrestin domain containing 1)
  Qiannan Zhao, Fen Jiang, Hui Zhuang, Yanfeng Chu, Fang Zhang, Chenghong Wang
  Bioengineered.2022; 13(4): 8255.     CrossRef
• Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL
  Hankil Lee, Sungin Jang, Sang Hoon Ahn, Beom Kyung Kim
  Hepatology International.2022; 16(2): 294.     CrossRef
• Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area
  Bo Hyun Kim, Dahhay Lee, Kyu-Won Jung, Young-Joo Won, Hyunsoon Cho
  Clinical and Molecular Hepatology.2022; 28(2): 242.     CrossRef
• A Radiomics Model Based on Gd-EOB-DTPA-Enhanced MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma ≤ 5 cm
  Chengming Qu, Qiang Wang, Changfeng Li, Qiao Xie, Ping Cai, Xiaochu Yan, Ernesto Sparrelid, Leida Zhang, Kuansheng Ma, Torkel B. Brismar
  Frontiers in Oncology.2022;[Epub]     CrossRef
• L-Selenocysteine induced HepG-2 cells apoptosis through reactive oxygen species-mediated signaling pathway
  Kaiying Zhang, Jingyao Su, Danyang Chen, Binger Lin, Yucan Wu, Yibing Wang, Jiapei Lei, Ruilin Zheng, Bing Zhu, Yinghua Li
  Molecular Biology Reports.2022; 49(9): 8381.     CrossRef
• A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets
  Xinghao Fu, Feihong Ji, Qi He, Xinguang Qiu, Fu Wang
  Journal of Immunology Research.2022; 2022: 1.     CrossRef
• Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study
  Jae Hyun Yoon, Sung Kyu Choi, Sung Bum Cho, Hee Joon Kim, Yang Seok Ko, Chung Hwan Jun
  World Journal of Gastroenterology.2022; 28(36): 5351.     CrossRef
• Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis
  Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun
  Clinical and Molecular Hepatology.2022; 28(4): 876.     CrossRef
• Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  Cancers.2022; 14(20): 5002.     CrossRef
• New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
  Hankil Lee, Jeong-Ju Yoo, Sang Hoon Ahn, Beom Kyung Kim
  Clinical and Translational Gastroenterology.2022; 13(12): e00542.     CrossRef
• External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
  Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
• Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
  Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
  Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123.     CrossRef
• The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
  Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
• Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
  Chao-Wei Lee, Sey-En Lin, Ming-Chin Yu, Hao-Wei Kou, Cheng-Han Lee, Tony Kuo, Kuan-Chieh Lee, Hsin-I Tsai
  Journal of Personalized Medicine.2021; 11(11): 1078.     CrossRef
• Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
  Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
  International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
• Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
  Soon Kyu Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
  International Journal of Molecular Sciences.2021; 22(19): 10271.     CrossRef
• Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
  Kyung Joo Cho, Sun Yeong Shin, Hyuk Moon, Beom Kyung Kim, Simon Weonsang Ro
  Translational Oncology.2021; 14(9): 101158.     CrossRef
• Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
  Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
  Journal of Viral Hepatitis.2021; 28(11): 1570.     CrossRef
• Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
  Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Cancers.2021; 13(23): 5892.     CrossRef
• New next-generation microwave thermosphere ablation for small hepatocellular carcinoma
  Hideyuki Tamai, Jumpei Okamura
  Clinical and Molecular Hepatology.2021; 27(4): 564.     CrossRef
• Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
  Ying Liu, Yuzhu Wang, Xinkun Guo, Yifeng He, Jian Zhou, Qianzhou Lv, Xiaowu Huang, Xiaoyu Li
  Frontiers in Oncology.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Pharmacological modulation of the PI3K/AKT/GSK3β axis: a new frontier in Alzheimer’s disease treatment
  Saad Misfer Alqahtani, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ali K. Albuhadily, Mustafa M. Shokr, Athanasios Alexiou, Marios Papadakis, Gaber El-Saber Batiha
  Inflammopharmacology.2026; 34(1): 267.     CrossRef
• RALY promotes Epithelial-mesenchymal transition in Hepatocellular carcinoma by regulating Snail
  Hee-Won Kim, Jungsoo Kim, Jeong-Heon Ko, Jeong Gu Kang
  Biochemical and Biophysical Research Communications.2026; 805: 153402.     CrossRef
• The critical role of epithelial-mesenchymal transition (EMT) in colorectal cancer progression and therapeutic outcomes
  Hailang Jiang, Bingtian Xu
  Critical Reviews in Oncology/Hematology.2026; 220: 105189.     CrossRef
• FAM83D facilitates EMT and metastasis of cervical cancer via interaction with GSK3β and inactivation of GSK3β/stabilization of Snail signaling
  Jiaofeng Li, Fengtian Li, Xia Meng, Zhiling Yang, Zhengguang Li, Hualong Tang, Wanglong Zhu, Haoming Li, Xingqiang He, Xinyue Lin, Zhengyu Han, Mei Chen, Yuhan Yang, Jingyi Wang, Kun Zhang
  Biology Direct.2026;[Epub]     CrossRef
• Epithelial-Mesenchymal Transitional Markers in Endometrial Carcinoma: A Review of Clinicopathological Correlation
  M Kalaivani, Divya Dhanabal, Leena Dennis Joseph
  Cureus.2026;[Epub]     CrossRef
• Plasma-activated medium suppresses proliferation and migration of human lung cancer cells by regulating PI3K/AKT-Wnt signaling pathway
  Zhidan Sun, Chenglong Ding, Yuhan Wang, Han Zhou, Wencheng Song
  Journal of Bioscience and Bioengineering.2025; 139(1): 60.     CrossRef
• ARID4B Promotes the Progression of Hepatocellular Carcinoma Through the PI3K/AKT Pathway
  Munetoshi Akaoka, Mitsuru Yanagaki, Hoshiho Kubota, Koichiro Haruki, Kenei Furukawa, Tomohiko Taniai, Shinji Onda, Ryoga Hamura, Masashi Tsunematsu, Yoshihiro Shirai, Michinori Matsumoto, Masayuki Shimoda, Toru Ikegami
  Annals of Surgical Oncology.2025; 32(4): 3009.     CrossRef
• Anticancer Properties Against Select Cancer Cell Lines and Metabolomics Analysis of Tender Coconut Water
  Jaganathan Lakshmanan, Vaitheesh L. Jaganathan, Boachun Zhang, Grace Werner, Tyler S. Allen, David J. Schultz, Carolyn M. Klinge, Brian G. Harbrecht
  Anti-Cancer Agents in Medicinal Chemistry.2025; 25(3): 207.     CrossRef
• Targeting of the PI3 K/AKT/GSK3β Pathway in Parkinson's Disease: A Therapeutic Blueprint
  Raed AlRuwaili, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ali K. Albuhadily, Athanasios Alexiou, Marios Papadakis, Mohammed E. Abo-El Fetoh, Gaber El-Saber Batiha
  Molecular Neurobiology.2025; 62(11): 15108.     CrossRef
• SOAR elucidates biological insights and empowers drug discovery through spatial transcriptomics
  Yiming Li, Yanyi Ding, Saya Dennis, Meghan R. Hutch, Jiaqi Zhou, Yadi Zhou, Yawei Li, Maalavika Pillai, Sanaz Ghotbaldini, Mario Alberto Garcia, Mia S. Broad, Chengsheng Mao, Parambir S. Dulai, Feixiong Cheng, Zexian Zeng, Yuan Luo
  Science Advances.2025;[Epub]     CrossRef
• 2‐Hydroxy‐3‐Methylanthraquinone Suppresses Hepatocellular Carcinoma Progression by Blocking Annexin A5‐Mediated Phosphatidylinositol 3‐Kinase/Protein Kinase B Signaling
  Min Luo, Juanmei Mo, Chaoyuan Huang, Yan Mao, Hongzhi Wang, Xiaochen Wang
  Chemical Biology & Drug Design.2025;[Epub]     CrossRef
• TGFβ1–TNFα-regulated secretion of neutrophil chemokines is independent of epithelial–mesenchymal transition in breast tumor cells
  Shuvasree SenGupta, Erez Cohen, Joseph Serrenho, Kaleb Ott, Pierre A. Coulombe, Carole A. Parent, William Bement
  Molecular Biology of the Cell.2025;[Epub]     CrossRef
• Aberrant activation of the PI3K/AKT/HIF‑1α pathway promotes glycolysis and lenvatinib resistance in liver cancer
  Jinfeng Wang, Jianfei Shi, Lili Mi, Man Zhao, Guangjie Han, Fei Yin
  Molecular Medicine Reports.2025; 32(5): 1.     CrossRef
• Mechanistic role of gliflozins-induced ketosis in epileptogenesis and epilepsy: Rubric known and unknown
  Elyasa Elfaki, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ali K. Albuhadily, Duaa Eliwa, Athanasios Alexiou, Marios Papadakis, Gaber El-Saber Batiha
  Neuroscience.2025; 589: 288.     CrossRef
• SMARCD3 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer by Integrating PI3K-AKT and WNT/β-Catenin Pathways
  Ji-Ho Park, Sun Yi Park, Eun-Jung Jung, Young-Tae Ju, Chi-Young Jeong, Ju-Yeon Kim, Taejin Park, Miyeong Park, Young-Joon Lee, Sang-Ho Jeong
  Cancers.2025; 17(21): 3526.     CrossRef
• Combining lapatinib and palbociclib inhibits cell proliferation and invasion via AKT signaling pathway in endocrine-resistant breast cancer cells
  Kantasorn Horpratraporn, Patthamapon Adchariyasakulchai, Panot Sainamthip, Wannarasmi Ketchart
  Medical Oncology.2024;[Epub]     CrossRef
• Shrimp Lipids Inhibit Migration, Epithelial–Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression
  Chorpaka Thepthanee, Zin Zin Ei, Soottawat Benjakul, Hongbin Zou, Korrakod Petsri, Bhurichaya Innets, Pithi Chanvorachote
  Biomedicines.2024; 12(4): 722.     CrossRef
• Clinical Implications of EMT in HNSCC: A Review of the Factors and Pathways at Play
  Rakesh Kumar Barath, Ajay Vidyarthi, Neeti Dharamwat, Saumyta Mishra, Nirdhum Shikha, Nishit Kakka
  Qeios.2024;[Epub]     CrossRef
• Clinical Implications of EMT in HNSCC: A Review of the Factors and Pathways at Play
  Rakesh Kumar Barath, Ajay Vidyarthi, Neeti Dharamwat, Saumyta Mishra, Nirdhum Shikha, Nishit Kakka
  Qeios.2024;[Epub]     CrossRef
• The Wnt signaling pathway in hepatocellular carcinoma: Regulatory mechanisms and therapeutic prospects
  Shihui Ma, Guorui Meng, Tong Liu, Junqi You, Risheng He, Xudong Zhao, Yunfu Cui
  Biomedicine & Pharmacotherapy.2024; 180: 117508.     CrossRef
• The host cells suppress the proliferation of pseudorabies virus by regulating the PI3K/Akt/mTOR pathway
  Lei Xu, Qian Tao, Yang Zhang, Feng-qin Lee, Tong Xu, Li-shuang Deng, Zhi-jie Jian, Jun Zhao, Si-yuan Lai, Yuan-cheng Zhou, Ling Zhu, Zhi-wen Xu, Jie Wang, Christopher Aaron Rice
  Microbiology Spectrum.2024;[Epub]     CrossRef
• LINC00470 promotes malignant progression of testicular germ cell tumors
  Zhizhong Liu, Shanshan Lv, Zailong Qin, Jinhui Shu, Fang Zhu, Yanwei Luo, Liqing Fan, Mengqian Chen, Hao Bo, Lvjun Liu
  Molecular Biology Reports.2024;[Epub]     CrossRef
• Black rice bran‑derived anthocyanins attenuate cholangiocarcinoma cell migration via the alteration of epithelial‑mesenchymal transition and sialylation
  Sasikamon Khophai, Suwadee Chockchaisiri, Krajang Talabnin, James Ketudat Cairns, Chutima Talabnin
  Biomedical Reports.2024;[Epub]     CrossRef
• Knockdown of RASD1 improves MASLD progression by inhibiting the PI3K/AKT/mTOR pathway
  Guifang Zeng, Xialei Liu, Zhouying Zheng, Jiali Zhao, Wenfeng Zhuo, Zirui Bai, En Lin, Shanglin Cai, Chaonong Cai, Peiping Li, Baojia Zou, Jian Li
  Lipids in Health and Disease.2024;[Epub]     CrossRef
• The linker of nucleoskeleton and cytoskeleton complex is required for X-ray-induced epithelial-mesenchymal transition
  Hiromasa Imaizumi, Kazumasa Minami, Miki Hieda, Naomasa Narihiro, Masahiko Koizumi
  Journal of Radiation Research.2023;[Epub]     CrossRef
• Proactive and reactive roles of TGF-β in cancer
  Nick A. Kuburich, Thiru Sabapathy, Breanna R. Demestichas, Joanna Joyce Maddela, Petra den Hollander, Sendurai A. Mani
  Seminars in Cancer Biology.2023; 95: 120.     CrossRef
• Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds
  Hui Li Ang, Chakrabhavi Dhananjaya Mohan, Muthu K. Shanmugam, Hin Chong Leong, Pooyan Makvandi, Kanchugarakoppal S. Rangappa, Anupam Bishayee, Alan Prem Kumar, Gautam Sethi
  Medicinal Research Reviews.2023; 43(4): 1141.     CrossRef
• NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/Akt/mTOR/Snail pathway
  Lan Zheng, Shipeng Yang, Ran Xu, Yang Yang, Jishu Quan, Zhenhua Lin, Chunhua Quan
  International Journal of Oncology.2023;[Epub]     CrossRef
• The dual role of citrate in cancer
  Philippe Icard, Luca Simula, Grit Zahn, Marco Alifano, Maria E. Mycielska
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2023; 1878(6): 188987.     CrossRef
• Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins
  Angela M. Schab, Molly M. Greenwade, Elizabeth Stock, Elena Lomonosova, Kevin Cho, Whitney R. Grither, Hollie Noia, Daniel Wilke, Mary M. Mullen, Andrea R. Hagemann, Ian S. Hagemann, Premal H. Thaker, Lindsay M. Kuroki, Carolyn K. McCourt, Dineo Khabele,
  Molecular Cancer Research.2023; 21(11): 1234.     CrossRef
• Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
  Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  American Journal of Gastroenterology.2022; 117(2): 288.     CrossRef
• External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
  Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Cancers.2022; 14(3): 711.     CrossRef
• The miR-4732-5p/XPR1 axis suppresses the invasion, metastasis, and epithelial–mesenchymal transition of lung adenocarcinoma via the PI3K/Akt/GSK3β/Snail pathway
  Yaqiong Hu, Jun Bai, Dandan Zhou, Liping Zhang, Xinlu Chen, Lin Chen, Yuqing Liu, Baogang Zhang, Hongli Li, Chonggao Yin
  Molecular Omics.2022; 18(5): 417.     CrossRef
• Translocating proteins compartment-specifically alter the fate of epithelial-mesenchymal transition in a compartmentalized Boolean network model
  Péter Mendik, Márk Kerestély, Sebestyén Kamp, Dávid Deritei, Nina Kunšič, Zsolt Vassy, Péter Csermely, Daniel V. Veres
  npj Systems Biology and Applications.2022;[Epub]     CrossRef
• GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway
  Yuen Chak Tiu, Lanqi Gong, Yu Zhang, Jie Luo, Yuma Yang, Ying Tang, Wing-mui Lee, Xin-Yuan Guan
  Cancer Gene Therapy.2022; 29(11): 1720.     CrossRef
• Melatonin as an oncostatic agent: Review of the modulation of tumor microenvironment and overcoming multidrug resistance
  Niloufar Targhazeh, Karla J. Hutt, Amy L. Winship, Russel Reiter, Bahman Yousefi
  Biochimie.2022; 202: 71.     CrossRef
• Exosome-based delivery of RNAi leads to breast cancer inhibition
  Renata Silva, Débora Ferreira, Lígia R. Rodrigues
  Journal of Drug Delivery Science and Technology.2022; 78: 103931.     CrossRef
• Vitamin C Suppresses Pancreatic Carcinogenesis through the Inhibition of Both Glucose Metabolism and Wnt Signaling
  Ji Hye Kim, Sein Hwang, Ji-Hye Lee, Se Seul Im, Jaekyoung Son
  International Journal of Molecular Sciences.2022; 23(20): 12249.     CrossRef
• Role of Epithelial-to-Mesenchymal Transition for the Generation of Circulating Tumors Cells and Cancer Cell Dissemination
  Gaetan Aime Noubissi Nzeteu, Claudia Geismann, Alexander Arlt, Frederik J. H. Hoogwater, Maarten W. Nijkamp, N. Helge Meyer, Maximilian Bockhorn
  Cancers.2022; 14(22): 5483.     CrossRef
• Novel thiazolidine derivatives as potent selective pro-apoptotic agents
  Donia E. Hafez, Eman Hafez, Islam Eddiasty, Shou-Ping Shih, Leng-Chiang Chien, Yi-Jia Hong, Hung-Yu Lin, Adam B. Keeton, Gary A. Piazza, Mohammad Abdel-Halim, Ashraf H. Abadi
  Bioorganic Chemistry.2021; 114: 105143.     CrossRef
• External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
  Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
• Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma
  Sang Eun Ha, Seong Min Kim, Preethi Vetrivel, Hun Hwan Kim, Pritam Bhagwan Bhosale, Jeong Doo Heo, Ho Jeong Lee, Gon Sup Kim
  International Journal of Molecular Sciences.2021; 22(16): 8841.     CrossRef
• Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
  Kyung Joo Cho, Sun Yeong Shin, Hyuk Moon, Beom Kyung Kim, Simon Weonsang Ro
  Translational Oncology.2021; 14(9): 101158.     CrossRef
• Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
  Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
  International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
• Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update
  Philippe Icard, Antoine Coquerel, Zherui Wu, Joseph Gligorov, David Fuks, Ludovic Fournel, Hubert Lincet, Luca Simula
  International Journal of Molecular Sciences.2021; 22(12): 6587.     CrossRef
• Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
  Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Milad Ashrafizadeh, Ali Zarrabi, Gautam Sethi
  Journal of Hepatocellular Carcinoma.2021; Volume 8: 1415.     CrossRef
• The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
  Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
• Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway
  Sung Won Lee, Sung Min Kim, Wonhee Hur, Byung-Yoon Kang, Hae Lim Lee, Heechul Nam, Sun Hong Yoo, Pil Soo Sung, Jung Hyun Kwon, Jeong Won Jang, Seong-Jun Kim, Seung Kew Yoon, Partha Mukhopadhyay
  PLOS ONE.2021; 16(12): e0261067.     CrossRef
• Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
  Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
  Journal of Viral Hepatitis.2021; 28(11): 1570.     CrossRef
• Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
  Jaewhan Song
  Clinical and Molecular Hepatology.2020; 26(4): 484.     CrossRef
• METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner
  Yuntao Shi, Yingying Zhuang, Jialing Zhang, Mengxue Chen, Shangnong Wu
  Cancer Management and Research.2020; Volume 12: 13173.     CrossRef